MikeLigalig.com

The recent surge of COVID-19 cases has pushed hospitals on the local and national scale to the brink of staffing and capacity crises. The resource intensiveness of treating COVID-19 patients is well documented, and with ICU numbers skyrocketing, so is the physical demand for those left on the front lines – this is especially true when "proning" patients.

CORCORAN, MINN. (PRWEB) DECEMBER 07, 2020
The recent surge of COVID-19 cases has pushed hospitals on the local and national scale to the brink of staffing and capacity crises. The Star Tribune (St. Paul, MN) reported that Allina Health, CentraCare, and Mayo Clinic systems were absent more than 3,000 healthcare workers last week due to COVID-19 exposure or infection. Meanwhile, most hospitals in the Twin Cities such as Regions Hospital are reported to be at 115% capacity. The resource intensiveness of treating COVID-19 patients is well documented, and with ICU numbers skyrocketing, so is the physical demand for those left on the front lines – this is especially true when "proning" patients.
There is mounting evidence that rotating patients from their back (supine position) to their stomach (prone position) helps optimize pulmonary mechanics. By repositioning patients from the supine to prone position, thick secretions are kept from collecting and clogging inside the lungs. This practice improves blood oxygenation and mitigates or even prevents time spent on the ventilator. Many facilities prone patients for up to 16 hours while making around-the-clock adjustments to the head and arms, and although proning has yielded positive outcomes for patients, it has created significant workload for hospital staff.
More often than not, COVID-19 patients in the ICU are high-risk, high-BMI, and chock-full of pre-existing risk factors. Proning a patient of this profile twice daily requires multiple staff members to lift and rotate the sedated patient and safely re-position them in a way that mitigates the risk of pressure sores, a complication particular to elderly patients and those suffering from diabetes. Previously, teams of six to nine caregivers would collectively carry out proning protocol; now, with increased patient demand and diminished caregiver supply, proning teams are left to do far more with less. This perfect storm led Bone Foam Inc. to innovate a way to address positioning challenges in COVID-19 patients in a way that reduces the likelihood of pressure injuries and disburdens under-staffed ICU teams.
Now, numerous ICUs around the country have turned to Prone Foam to protect their at-risk patients and offload their staff. Prone Foam is a novel product that has helped depleted hospital staff safely and efficiently position COVID-19 patients. With ICUs overrun, additional rooms and beds have been repurposed to support patients suffering from COVID-19. This requires additional maneuvering and repositioning by hospital staff, unpredictable makeshift bumps/supports, and an increase in subsequent pressure-related injuries to the patient.
Early adopters across the country have praised Prone Foam and experienced significant improvements in their management of these complex patients. Jana Belisle (Grand Rapids, MI), a Clinical Nurse Specialist in Critical Care, describes a few of the many challenges associated with positioning COVID-19 patients, "Without Prone Foam, we struggled with proper offloading, facial support and endotracheal tube clearance, perceived comfort of the patient, and DTPIs (Deep Tissue Pressure Injuries)". Jana and her staff have been using Prone Foam to position COVID-19 patients as well as those suffering from ARDS. "(Prone Foam) has simplified our proning efforts. Respiratory Therapists love how it accommodates the endotracheal tube and we have seen a decrease in our facial pressure injuries".
Patient safety continues to be on the forefront of all caregivers' minds, and rightfully so. However, with a recent surge of COVID-19 cases, Bone Foam has developed a way to support not only patients, but also our brave frontline workers who are confronting the virus head on. Prone Foam offers a low-cost solution to aid patients, respiratory therapists, and all ICU staff in managing complex positioning challenges.
Bone Foam Inc. is an orthopaedic industry leader in medical grade foam positioners that are utilized in hospitals, clinics, and surgery centers around the world. Bone Foam is focused on discovering and developing innovations in patient positioning that are mutually beneficial to surgeons, medical staff, and patients. During these ambivalent times, Bone Foam has continued allocating resources to support the positioning needs of COVID-19 patients.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Most recent survey from The Centers for Disease Control and Prevention shows vast majority of Americans of all ages have been wearing face coverings since spring

COLUMBUS, OHIO (PRWEB) DECEMBER 07, 2020
Data recently released from researchers at the Mayo Clinic has made the strongest case yet for the use of masks. They found the most important measure for reducing the risk of exposure to COVID-19 is to wear a mask. Americans now appear to be listening. The most recent study conducted by the Centers for Disease Control and Prevention found that mask wearing is the only reported mitigation behavior that has increased over time by Americans of all ages. This is good news as COVID-19 rates are expected to surge again after millions traveled over the Thanksgiving weekend.
"While Americans are anxiously awaiting the roll out of effective vaccines, we recognize that masks are here to stay for some time. The evidence shows the easiest way for each of us to limit exposure and spread of the Coronavirus is to wear a mask," said Tammy Krings, owner of COPPERLINE MASKS US. "And a COPPERLINE MASK provides additional protection you won't find anywhere else."
Copper is widely recognized as a metallic antimicrobial agent. A very fine copper thread is knitted into COPPERLINE MASKS, not sprayed on copper like other masks. Accredited laboratory testing measured the neutralization capacity and reusability of masks infused with copper against regular masks without copper when exposed to the COVID-19 virus (SARS-CoV2). Dr. John Hwa LEE, DVM, PhD, Professor and Dean at Jeonbuk National University in South Korea led the study and found what scientists already suspected, that copper destroys pathogens faster and better than any other material tested. In turn, Coronavirus dies faster on copper than most other surfaces, thus essentially preventing the virus from replicating. The study and its findings can be accessed at http://www.copperlineus.com/pages/presentation.
"These findings are paramount when it comes to protecting yourself and others," Dr. Lee explained. A mask such as COPPERLINE, with copper woven into it, reduces the infectivity of the virus. This is additional protection that we can all use."
The findings are further bolstered by a recent study from the New England Journal of Medicine that found the COVID-19 virus died within hours when placed on a copper service. The COPPERLINE MASK is comprised of three layers; a striped face-contact layer, an inner net coiled layer and an outer layer, the first two of which are infused with ionized copper yarn at a density of 22%.
Copperline, Inc., headquartered in New Albany, Ohio, serves as Copperline's official distributor for the Americas and offers a dedicated website https://www.copperlineus.com for individual or bulk orders. The COPPERLINE MASK is available in four sizes (XS, S, M and L) and in nine colors. The XS is perfect for children, providing full coverage for their tiny faces



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Vaccertify's digital certificate prototype helps individuals to show they have been vaccinated against the virus.

SEATTLE (PRWEB) DECEMBER 07, 2020
Trending Seattle startup, Vaccertify, is pleased to announce the launch of its 'social pass' prototype of a digital vaccine certificate for COVID-19.
Vaccertify is a simple and easy-to-use digital vaccination certificate for phones. The certificate displays the user's name, picture of their face, identifies which COVID-19 vaccine was administered, and when final shots were completed. Additionally, the certificate includes a scannable QR code which takes the inquirer to a profile connected to Vaccertify.com, and only reveals the ID when a private pin is entered. To receive this unique digital certificate, users must complete a COVID-19 vaccination and submit the vaccine record, a government-issued ID, and a selfie to the platform.
"The idea for Vaccertify came to me as I prepared to search for a vaccinated babysitter after I gave birth during the pandemic," says co-founder and CEO of Vaccertify, Tiara Lyons. "I felt it was too risky for me to simply take the babysitter's word they were vaccinated, yet also felt it was too invasive to ask a stranger for medical records. At that moment, I knew there had to be a better way and I set about creating Vaccertify."
Vaccertify is the ultimate solution for assuring vaccination in social interactions where privacy can be maintained. The platform is currently a prototype, waiting for a vaccine to be released, in order to run a pilot program. Vaccertify will be offering three pricing tiers to meet the varying needs of individuals, including:

7 Day Delivery - $49.99

3 Day Delivery - $99.99

24 Hour Delivery - $199.99

While the Vaccertify digital certificate is not meant for situations such as boarding an airplane or crossing borders, it is ideal for other social situations, such as an elderly person wanting to confirm their plumber is vaccinated before entering the home.
Vaccertify's mission is to help everyday people get through the pandemic with a little less worry. After all, during these times, a little less worry can go a very long way.
For more information about Vaccertify, please visit http://www.vaccertify.com.
About the Company
Vaccertify is a Seattle-based business that provides a private COVID-19 vaccine verification service in the form of a digital certificate. The company takes the utmost care in nurturing privacy of their users while remaining effective and efficient.
Contact Information
Tiara Lyons, CEO
929-352-4587
contact@vaccertify.com
http://www.vaccertify.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

axialHealthcare today announced a new recovery program with Highmark Inc. to offer care navigation and peer support services for members seeking treatment for substance use in Pennsylvania. This is a new addition to Highmark's efforts to address substance use disorders and the opioid epidemic in the setting of the COVID-19 pandemic.

NASHVILLE, TENN. AND PITTSBURGH (PRWEB) DECEMBER 07, 2020
axialHealthcare today announced a new recovery program with Highmark Inc. to offer care navigation and peer support services for members seeking treatment for substance use in Pennsylvania. This is a new addition to Highmark's efforts to address substance use disorders and the opioid epidemic in the setting of the COVID-19 pandemic.
"This has been an extremely difficult year for individuals and families at all stages of recovery," said Dr. Caesar DeLeo, vice president and executive medical director of strategic initiatives for Highmark. "COVID-19 has increased social isolation, stress and economic problems, while presenting additional hurdles in staying connected to or accessing treatment. Telemedicine expansion has been a great innovation and now we are adding to that peer support counselors through an expanded partnership with axialHealthcare. Our members can now be guided by individuals with lived experience in the recovery space, have a simplified care navigation experience, and access resources to remove non-clinical barriers to care."
The recovery program deploys personalized services, using Pennsylvania-based clinicians and peer support from individuals in recovery to help members find and stay in treatment. Providing each member in need with a dedicated team, the program works with treatment providers to help coordinate care during critical transitions, connects members to social resources, and ultimately provides the dedicated, long-term support essential to sustained recovery.
"axialHealthcare is excited to expand our partnership with Highmark to help members and their families navigate a highly complex addiction treatment system," said Dr. Dirk Wales, chief medical officer at axialHealthcare. "Our goal is to ensure members not only receive quality, coordinated care, but are also connected with any additional resources needed to stay in treatment and achieve recovery. We look forward to partnering with the treatment and recovery community to support safe, effective care for those most in need."
The recovery program is an expansion of a multiyear partnership focused on ensuring evidence-based care for members in Pennsylvania and West Virginia. Since 2018, Highmark and axialHealthcare have tackled patient safety concerns related to substance use, spanning from decreased opioid overprescribing and polydrug use to increased naloxone prescribing and screening for SUD. These efforts have helped mitigate safety concerns, including decreasing the number of patients receiving opioids from multiple providers by 15.0%, reducing risky co-prescribing of benzodiazepines and opioids by 15.1% and increasing naloxone prescribing by 100% in two years.
Highmark strives to combat opioid addiction with a comprehensive approach that focuses on primary prevention, safe prescribing, high-quality treatment, community supports and combating stigma. Through these efforts, Highmark has reduced by 22.7% the number of commercial risk, Medicare Advantage and Affordable Care Act members in Pennsylvania who are prescribed opioids, while reducing opioid-related overdoses to a rate that is approximately half of the national average. Highmark has also provided more than $3 million to community organizations and programs fighting the opioid epidemic in its core markets of Pennsylvania, West Virginia and Delaware.
The recovery program is launching this month alongside select treatment providers in Pennsylvania. The program applies to Highmark's commercial risk, Medicare Advantage and Affordable Care Act members who are being discharged from select inpatient treatment facilities in the commonwealth. For more information, contact axialHealthcare at accessrecoveryPA@axialHealthcare.com.
About axialHealthcare
axialHealthcare connects patients, providers, and health plans with an end-to-end platform that covers the entire substance use spectrum. Leveraging services grounded in analytics, our risk to recovery platform identifies patients at risk, prevents escalation in their condition, and supports appropriate treatment enrollment and adherence. This high-tech, high-touch approach delivers measurable clinical and financial outcomes by effectively managing cost of care while supporting sustained recovery for patients with substance use disorder.
About Highmark Inc.
One of America's leading health insurance organizations and an independent licensee of the Blue Cross Blue Shield Association, Highmark Inc. (the Health Plan) and its affiliated health plans (collectively, the Health Plans) work passionately to deliver high-quality, accessible, understandable, and affordable experiences, outcomes, and solutions to customers. As the fourth-largest overall Blue Cross Blue Shield-affiliated organization, Highmark Inc. and its Blue-branded affiliates proudly cover the insurance needs of more than 5.6 million members in Pennsylvania, Delaware, and West Virginia. Its diversified businesses serve group customer and individual needs across the United States through dental insurance and other related businesses. For more information, visit http://www.highmark.com.

"Our Highmark members can now be guided by individuals with lived experience in the recovery space, have a simplified care navigation experience, and access resources to remove non-clinical barriers to care." -Dr. Caesar DeLeo, VP and executive medical director of strategic initiatives, Highmark



START your own Wordpress site, business or personal website, or online store at www.siteground.com

With more than 30 years of experience in the natural products industry, Craven is a seasoned cross- functional leader with specialization in education, formulation and marketing. In addition, she will lead the newly formed Scientific Advisory Board, positioning Enzymedica as the authoritative voice of education as it continues to be a leader in the industry.

VENICE, FLA. (PRWEB) DECEMBER 07, 2020
Enzymedica, a leading natural digestive health products company, announced today that Julia Craven has been appointed to Vice President of Education and Innovation and also will lead the Enzymedica Scientific Advisory Board. In her new position, she will establish Enzymedica as an authoritative voice of education in the natural products industry that is relevant, impactful and truthful to ensure the company continues to be a leader in any category in which it resides.
With more than three decades of experience in the natural products industry, Craven has proven success in the architecture and deployment of internal and external facing education platforms, research and development, team mentorship and corporate strategy. She joined Enzymedica as Key Accounts Manager/National Educator in 2007 before becoming VP of National Accounts in 2011 and added the role of General Manager, Digest Source by Enzymedica in 2015 where she launched as well as developed products and strategies for a new company division focused on new channels of trade. Previously she was Executive Vice President of Sales and Marketing at Encompass Sales LLC; Chief Operating Officer, USA for Pranarom USA; Board Member/Consultant for Veriditas Botanicals, LLC; and also held positions with Whole Foods Market and Wild Oats Market.
"Julia has been a great asset to Enzymedica throughout the past 13 years, and I'm pleased to announce her appointment to Vice President of Education and Innovation," said Scott Sensenbrenner, President & CEO of Enzymedica. "We know education is key to making it easier for everyone to have life-changing great health, and her new role leading the Scientific Advisory Board will be essential in this endeavor. In addition to being a seasoned executive with extensive sales, management and strategy experience, Julia's dedication to educational development and deep understanding of the natural products industry will be invaluable to us as we continue to drive our brand forward around the world."
"Enzymedica pioneered education in 1998 and now it's innovating with a revolution by creating new learning platforms and the formation of the Scientific Advisory Board," said Julia Craven, Vice President of Education and Innovation. "The level of diversity and expertise of the Board we're assembling is unprecedented. Accuracy and accessibility are at the forefront of our new initiatives for both consumers and retailers. This is a truly massive game-changer for the industry. Coming home to true education is the only way to ensure our healthiest future."
Visit https://enzymedica.com/ to learn more.
About Enzymedica
Enzymedica is a Florida-based, natural digestive health company since 1998 that sells to over 30,000 stores worldwide and online. Its top-selling enzyme brand is No. 1 in America. In addition to high quality products, Enzymedica also is dedicated to its People & Planet initiative, which is a core pillar within the company's mission - to leave a legacy that will make the world a better place. The company has received more than 50 industry awards including multiple Better Nutrition Magazine's People's Choice Awards, many Best of Supplements Awards and numerous VITY and Nexty Awards. Visit https://enzymedica.com/ for more information.
Media Contact
Ria Romano, Partner
RPR Public Relations, Inc.
Tel. 786-290-6413



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Louisville-based company bolsters national payor contracting and quality assurance programs through partnership with industry-leading network of private practice therapists

LOUISVILLE, KY. (PRWEB) DECEMBER 07, 2020
Confluent Health has announced a partnership with PTPN, the nation's premier network of private practice therapists.
"Since its inception 35 years ago, the Physical Therapy Provider Network (PTPN) has set the standard in outpatient physical, occupational and speech language-therapy services, including payor contracting, quality assurance and outcomes measurement programs that have helped our member therapists succeed," says PTPN President and founder Michael Weinper, PT, DPT, MPH. "Forging a partnership with Confluent Health takes our membership capabilities to the next level, by giving our network access to education opportunities and management tools to help them grow and continue to provide best-in-class patient care."
This partnership allows PTPN's hundreds of member clinics to access Confluent Health's resources, including payor innovation projects, talent acquisition, marketing, finance and expanded group purchasing. Confluent Health will share best practices for payor/network contracting and credentialing to elevate all practices under the Confluent Health and PTPN umbrella. In addition, PTPN members will have greater access to Evidence In Motion's nationally recognized physical therapy education programs including residency, fellowship, certification programs and specialized training in pain management and dry needling.
"Joining forces with PTPN was a natural fit," says Confluent Health CEO, Larry Benz, PT, DPT, OCS, MBA, MAPP. "Our mission aligns with PTPN, providing privately owned therapy clinics with expert resources, scale and growth opportunities to make them thrive in the market. We are excited to support the PTPN network and work with Michael and his team."
For further information on PTPN, please visit http://www.ptpn.com. To learn more about Confluent Health, please visit http://www.goconfluent.com.
###
About PTPN:
PTPN is the nation's first and premier specialty network of rehabilitation therapists in private practice. It has led the rehabilitation industry in pioneering national contracting and quality assurance programs since 1985. The network has more than 700 provider offices (including physical, occupational and speech-language therapists). PTPN contracts with major managed care organizations including insurers, workers' compensation companies, PPOs, HMOs, medical groups, and IPAs. For more information on PTPN, contact Stephen Moore at 818-737-0246 or smoore@ptpn.com, or visit ptpn.com.
About Confluent Health:
Confluent Health is a Louisville, Kentucky-based private equity holding company focused on creating a healthcare system that recognizes physical and occupational therapy providers as the Best First Choice for preventing and managing musculoskeletal and movement disorders. Confluent Health offers the following management services: evidence-based practice, patient loyalty, regulatory assurance, marketing and branding, clinic operations, hiring and retention, strategy, accounting and finance, and customer service to Advanced and Preferred Physical Therapy, Baton Rouge Physical Therapy-Lake, BreakThrough Physical Therapy, Capitol Physical Therapy, Confluent Physical Therapy, El Paso Physical Therapy Specialists, OSPT, the Evidence In Motion family of companies, Fit For Work, Lake Center for Rehab, Rehab Therapy Works, Physical Therapy Central, ProActive Physical Therapy Specialists, Pappas | OPT Physical Therapy, ProRehab Physical Therapy, Redbud Physical Therapy, RET Physical Therapy Group, SporTherapy, Texas Physical Therapy Specialists, and TOSPT. Together, these companies share a common ownership team and are committed to developing a learning, purpose, and



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Online gathering of more than 5,000 behavioral health professionals from 50 countries begins this week, with a program focused on strengthening and elevating the contemporary practice of psychotherapy

MALVERN, PA. (PRWEB) DECEMBER 07, 2020
HMP Global, a leading healthcare event and education company, announced today that "the father of modern linguistics," Noam Chomsky, PhD, will participate in a keynote interview to open the 35th Evolution of Psychotherapy Conference, the official meeting of the Milton H. Erickson Foundation, taking place online December 9-13, 2020.
Widely renowned as a trailblazer in cognitive psychology, Dr. Chomsky's revolutionary work in the fields of linguistics and the philosophies of mind and language have catalyzed and continued the ongoing "cognitive revolution." Dr. Chomsky's presentation will delve into communication and subconscious processes and focus on mastering linguistic strategies in order to become a better communicator and enhance patient relationships, understanding, and care. Dr. Jeffrey Zeig, director and founder of the Milton H. Erickson Foundation, will conduct the interview with Dr. Chomsky.
"The Evolution of Psychotherapy brings together the leading figures whose work has shaped the contemporary practice of psychotherapy," said Dr. Zeig. "It is an unheralded opportunity to learn about the latest advances in the treatment of depression, anxiety, trauma, habits and addictions, and relationship problems."
The multifaceted meeting's comprehensive agenda, comprising an array of discussions, state-of-the art addresses, and clinical demonstrations led by 50 expert faculty and 10 keynote speakers, is focused on strengthening clinical practice and highlighting the unifying principles that guide effective clinical work. Garnering worldwide attention and a global audience during its 35-year tenure, this leading event highlights theory-based practice to enhance patient care via practical application strategies. Notably, participants of the Evolution of Psychotherapy meeting have the ability to earn up to 165 CE/CME credits.
Joining Dr. Chomsky in the expert speaker lineup are:

Aaron Beck, MD on cognitive therapy;

Philip G. Zimbardo, PhD, delivering the address, "My Journey from Evil to Heroism."

Stephen W. Porges, PhD, Michael D. Yapko, PhD. and Dr. Zeig discussing the impact of COVID-19 pandemic on patient care

Singer-songwriter Alanis Morissette will be interviewed by Dr. Zeig, in a session titled, "The HeART of Communication" on Saturday, December 12 at 12:30 pm.

To register for Evolution of Psychotherapy 2020 or to learn more, visit evolutionofpsychotherapy.com. For press access and media inquiries, contact Kelly McCurdy at pr@hmpglobal.com.
ABOUT HMP GLOBAL
HMP Global is the force behind Healthcare Made Practical—and is a multichannel leader in healthcare events and education, with a mission to improve patient care. The company produces accredited medical education events and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include Consultant360, the year-round, award-winning platform relied upon by primary care providers and other specialists; Psych Congress, the largest independent mental health meeting in the U.S.; EMS World Expo, North America's largest EMT and paramedic event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.
ABOUT THE MILTON H. ERICKSON FOUNDATION
Established in 1979, the Milton H. Erickson Foundation is a federal nonprofit corporation formed to promote and advance the contributions to the health sciences by the late Milton H. Erickson, MD. It has grown to become one of the most globally recognized and influential organizations in the field of psychotherapy and fulfills its mission through the organization of congresses, workshops, programs, and the development of clinically relevant content for mental health professionals. For more information, visit erickson-foundation.org.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Biorez also exhibiting its BioBrace technology at virtual booth #316 from December 9 – 12

NEW HAVEN, CONN. (PRWEB) DECEMBER 07, 2020
Biorez Inc., a New Haven startup advancing tendon and ligament repair, today announced that the results of a recently concluded preclinical study of its BioBrace Technology will be presented virtually at The Fellow, Resident, Medical Student Summit of the Orthopaedic Summit: Emerging Technologies (OSET) 2020 Annual Meeting. Dr. Gregory Kanski, Orthopedic Sports Medicine Fellow at UConn Health, will virtually present the preclinical research conducted at both UConn Health and Prince of Wales Hospital in Sydney, Australia.
Dr. Robert Arciero is the senior author of the presentation and the Director of the Orthopedic Sports Medicine Fellowship at UConn.
"I am delighted by Dr. Kanski's participation in this collaborative research project and the opportunity for him to present at the conference," said Dr. Arciero. "Overall, the study found that the BioBrace implant increased the thickness of a repaired rotator cuff tendon through the rapid induction of host generated connective tissue and was as strong as a native rotator cuff tendon by 12 weeks."
The abstract, titled "Tissue-Engineered Augmentation of a Rotator Cuff Tendon Using A Novel Bio-Inductive Biocomposite Scaffold: A Preliminary Study In Sheep," was selected for a podium presentation by the 2020 Program Committee after a competitive submission process. According to conference organizers, the abstract was deemed to be in the top 10% of all submissions.
"We are excited that the results of our preclinical research have been selected by the 2020 Program Committee and to have our BioBrace technology featured at a conference that is held in such high regard within the orthopedic community," Kevin Rocco, founder and CEO. "This research project was a large collaborative effort by a world-class team of scientists, engineers, veterinarians and surgeons, and I am glad to see their work recognized."
Additional preclinical studies are ongoing to support regulatory and commercial initiatives throughout 2021. The BioBrace implant is in the development stage and has not been approved for use by any regulatory agency, including the U.S. Food and Drug Administration.
About Biorez Inc.
Biorez is a New Haven-based medical device start-up focused on advancing tendon and ligament repair using its proprietary BioBrace technology. Biorez has pioneered the BioBrace implant, a breakthrough biocomposite scaffold featuring a highly-porous collagen sponge reinforced with bioresorbable microfilaments. The BioBrace implant is intended to reinforce soft tissue repairs in a number of clinical applications. Biorez's products are in the development stage and have not been approved for use by any regulatory agency including the U.S. Food and Drug Administration. More information is available at http://www.biorez.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Proper vaccine handling and storing practices will play a vital role in the distribution of COVID-19 vaccines. The Sentinel monitoring system from Sensaphone can help health care professionals maintain strict ultra-cold storage temperature requirements. When paired with Sensaphone's Ultra Low Temperature Sensor, the Sentinel system can monitor temperatures as low as -85 °C / -109 °F. The system is ideal for hospitals, labs, pharmacies and clinics as they prepare to provide millions of vaccine doses.

ASTON, PA. (PRWEB) DECEMBER 07, 2020
Proper vaccine handling and storing practices will play a vital role in the distribution of COVID-19 vaccines. The Sentinel monitoring system from Sensaphone can help health care professionals maintain strict ultra-cold storage temperature requirements. When paired with Sensaphone's Ultra Low Temperature Sensor, the Sentinel system can monitor temperatures as low as -85 °C / -109 °F. The system is ideal for hospitals, labs, pharmacies and clinics as they prepare to provide millions of vaccine doses.
The Sentinel system delivers 24/7 remote monitoring of temperatures inside medical refrigerators and freezers from -85 °C to 76 °C (-109 °F to 168 °F). When the system detects the temperature has moved out of the desired range, it sends an alert via phone call, text or email to the designated contacts.
In addition to temperature monitoring, each unit can monitor up to 12 different environmental and equipment status conditions. Users can also monitor the freezer's alarm panel for power outages.
The Sentinel system's enhanced data logging capabilities allow users to print, graph or export reports via email, providing an audit trail of all user data activities. This function helps personnel maintain operational efficiency, uphold quality assurance and meet regulatory compliance.
The Sentinel system constantly communicates a signal to the Sensaphone cloud to validate its online status. If the communication link is interrupted—for example by a power outage or someone accidentally switching off the unit—the system generates an alert indicating that internet connection is lost. Users are notified about the disruption through phone, text or email.
The user-friendly system lets users change settings, disable alarms and readjust temperature limits from the Sensaphone iPhone/Android app or sensaphone.net.
For more details, visit Sensaphone's medical cold storage monitoring page: https://www.sensaphone.com/industries/medical-cold-storage.
About Sensaphone
Sensaphone offers a comprehensive line of remote monitoring products that safeguard valuable assets by tracking critical equipment and environmental data such as temperature, humidity and power failures. Sensaphone products provide alerts and proactive monitoring data to homeowners and facility managers in many areas including telecommunications, oil and gas, water and wastewater, HVACR, agriculture, healthcare, data centers and greenhouses. Nearly 500,000 Sensaphone systems are in use today around the world, and they continue to be manufactured in the USA. For more information, call 877-373-2700, email contact@sensaphone.com or visit https://www.sensaphone.com/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The International Association of Eating Disorders Professionals Foundation (iaedp) has announced the opening of early registration for the upcoming 2021 iaedp Symposium, available to February 12, 2021. Given the coronavirus environment, the 2021 iaedp Symposium will be provided to participants in a virtual format. Early registration offers $50 off full price to February 12, 2021.

PEKIN, ILL. (PRWEB) DECEMBER 07, 2020
The International Association of Eating Disorders Professionals Foundation (iaedp) has announced the opening of early registration for the upcoming 2021 iaedp Symposium, available to February 12, 2021. Given the coronavirus environment, the 2021 iaedp Symposium will be provided to participants in a virtual format. Early registration offers $50 off full price to February 12, 2021.
The theme, "As the World Turns: Unforeseen Challenges and Dynamic Solutions," sets the tone as a central focus for the more than 60 presentations and workshops, world-renowned keynote speakers, special networking events from all parts of the globe – all available to registered participants 24/7 from March 18, 2021 to September 1, 2021.
Established in 1985, iaedp (http://www.iaedp.com) provides educational programs in multiple languages and training standards for eating disorder specialists and other medical professionals caring for those suffering from the full spectrum of disordered eating.
"Each year, our mission at iaedp is to bring together the leading authorities in research and treatment of eating disorders and co-occurring addictions. Even with the challenges of Covid, this mission continues," said Bonnie Harken, Managing Director at the iaedp Foundation. "We identify those truly outstanding in our field – those professionals who have accomplished innovative treatment work and research -- to help all of us in the treatment of eating disorders do the best job possible to fight for those who suffer from addictive diseases."    
The 2021 iaedp Symposium in a virtual format offers training sessions and instructive presentations with experts from various disciplines in the field of eating disorders. Over the next several months, speakers, activities, workshops and other presentations as well as special offerings for participants will be announced for the upcoming 2021 iaedp Symposium.
About the iaedp Foundation: Since 1985, the International Association of Eating Disorders Professionals has provided education and training standards to an international and multidisciplinary group of various healthcare treatment providers and helping professions. MemberSHARE.iaedp.com is an iaedp business journal and online member resource to learn about noteworthy member achievements, continuing education webinars and U.S. and international chapter activity and events; for more information, visit MemberSHARE.
The Presidents Council provides iaedp support and includes: Center for Change; Center for Discovery; Eating Recovery Center; Willow Place; Laureate Eating Disorders Program; The Meadows Ranch; Rogers Behavioral Health; Rosewood Centers for Eating Disorders; Selah House; The Renfrew Center; Timberline Knolls; Veritas Collaborative; Alsana Eating Disorder Treatment & Recovery Centers; Walden Behavioral Care, KIPU and SunCloud Health.

"Each year, our mission at iaedp is to bring together the leading authorities in research and treatment of eating disorders and co-occurring addictions. Even with the challenges of Covid, this mission continues," said Bonnie Harken, Managing Director at the iaedp Foundation.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Versilk allows dairy and plant-based dairy alternative manufacturers to achieve high protein products with a clean taste, desirable texture and no off-flavors

WILMINGTON, DEL. (PRWEB) DECEMBER 07, 2020
DuPont Nutrition & Biosciences (DuPont) today announced the North American launch of Versilk, the latest in its range of enzymes to help yogurt and beverage manufacturers achieve optimal texture and taste in yogurts, drinkable dairy products and other drinkable fermented products. Manufacturers can achieve their label-friendly goals with this native enzyme, an easy-to-use processing aid.
Dairy and beverage makers have long struggled with formulation of high protein yogurts. Fortifying dairy or plant-based yogurt to reach higher protein content can result in increased thickness and bitter notes in the final product.
This innovation is a viscosity-modulating enzyme for high protein applications, giving manufacturers a new way to deliver the desired viscosity, mouthfeel and taste profile that meets consumers' needs for an indulgent product with health benefits. It allows manufacturers of dairy and plant-based yogurts to achieve up to 14 percent protein in the final product - a 30 percent increase over what is common today.
Versilk is also simple to implement into an established yogurt production, it is added with the cultures and can help deliver potential improvement to both flavor and fermentation time, depending on the protein base. It is versatile across many types of products.
"Versilk is the latest in our suite of solutions comprising enzymes, cultures, proteins and functional solutions. Together with our leading industry expertise, we can help manufacturers respond to market trends and deliver healthy and indulgent yogurt products to meet consumer demand," said Clementina Dellomonaco, global product manager, Dairy Enzymes, DuPont Nutrition & Biosciences.
Versilk is part of the DuPont Danisco range of enzymes with a wide variety of producer and consumer benefits.
To learn more about Versilk and other DuPont dairy enzyme offerings, visit https://www.dupontnutritionandbiosciences.com/product-range/food-enzymes/dairy-enzymes.html.
About DuPont Danisco
DuPont Danisco is the brand for a range of ingredients that help provide enhanced bioprotection, an improved nutritional profile, and better taste and texture with greater cost efficiency and lower environmental impact, meeting the needs of manufacturers of food and beverages, dietary supplements and pet food. Through the work of the global network of food scientists and technologists in DuPont, the Danisco range is supported by a uniquely broad spectrum of know-how across applications and processing. http://www.danisco.com.
About DuPont Nutrition & Biosciences
DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: http://www.dupontnutritionandbiosciences.com.
About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food, and worker safety. More information can be found at http://www.dupont.com/. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
# # #
12/07/2020
DuPont, the DuPont Oval Logo, and all trademarks and service marks denoted with , SM or are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

NJ Top Docs has reviewed and approved The Plastic Surgery Center for 2020. The practice's highly trained physicians continue to stand out with their vast knowledge of cutting-edge surgical techniques and advanced technology.

SCOTCH PLAINS, N.J. (PRWEB) DECEMBER 07, 2020
With a staff of more than 150 and offices across New Jersey, New York and the greater Philadelphia area, the physicians at the award-winning Plastic Surgery Center help patients improve how they look and feel.
The Plastic Surgery Center's philosophy is to provide exceptional services to patients throughout their care. From the moment they schedule their first appointments to post-operation, the doctors are with them every step of the way.
"Our practice stands out because of our distinguished surgeons; who have many years of experience and a vast knowledge of cutting-edge surgical techniques and advanced technology," say the doctors. "Our surgeons often collaborate in research aimed at improving surgical methods to provide the best possible care and results."
In addition to improving surgical methods and techniques, the doctors strive to improve their own skillsets by attending various conferences and trainings. They learn from other industry experts while researching new tools and techniques to implement in their daily practice.
As a result of the COVID-19 pandemic, the doctors have increased safety measures at all locations and implemented strict sanitation protocols, pre-screenings and temperature checks. The Plastic Surgery Center also now offers telemedicine appointments.
To learn more about this NJ Top Docs practice, please visit: https://njtopdocs.com/nj-doctors/theplasticsurgerycentermonmouthcounty/
----
About Us
NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.
NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.
For more information, please click here to contact us or visit http://www.njtopdocs.com.
You can also follow us on Facebook, Twitter, & Instagram



START your own Wordpress site, business or personal website, or online store at www.siteground.com

SLCC has benefitted immeasurably from long history of support for the college from donors Tim and Brenda Huval.

SALT LAKE CITY (PRWEB) DECEMBER 07, 2020
Salt Lake Community College is pleased to announce it has named the new Jordan Student Center for long-time SLCC supporters Tim and Brenda Huval. Tim is an SLCC alumnus and former employee at the college. He and Brenda have both committed much time and financial support toward the success of SLCC students.
Currently under construction at the Jordan campus and set to open in January 2021, the Tim and Brenda Huval Student Center will serve as a dynamic hub for students, supporting their success through student engagement opportunities, academic and career advising, financial aid, childcare and a health and counseling center. The Huvals' gift to SLCC will go directly to student scholarships, with particular emphasis on students in health sciences programs.
"Brenda and I are incredibly honored to be a part of this opportunity to help so many students pursue their hopes and dreams," said Tim Huval. "Over the years, we've been fortunate to be given chances that helped us personally and professionally, like the chance SLCC gave me to get the education and confidence needed to get started. In turn, we are passionate about giving back and providing opportunities for others to take the next steps in fulfilling their goals."
Tim and Brenda Huval have a long relationship with SLCC. Tim graduated from the college in 1989 with an associate's degree in business management. He also received an honorary doctorate from SLCC in 2007. Tim is currently the Chief Administrative Officer of Humana, Inc., and he is slated to offer the college's 2021 Commencement keynote address. Over the years, the Huvals have contributed to the college's student scholarship programs, and the South City childcare center carries their name.
"We are honored that the Huvals, our amazing friends, have opted to again support our students," said SLCC President Deneece G. Huftalin. "They have been remarkably generous partners for many years and have personally experienced the transformative power of education. I am so proud that SLCC has been a part of their journey and that together we can continue to impact students' lives. My gratitude for their collaboration, generosity and kindness is immeasurable."
Salt Lake Community College is Utah's largest open-access college, proudly educating the state's most diverse student body in 8 areas of study at 12 locations and online. The majority of SLCC graduates transfer to four-year institutions, and thousands more are trained in direct-to-workforce programs. In 2023, the institution will celebrate 75 years of providing Utahns with education and training in fields that contribute to the state's vibrant economy and high quality of life.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

GuideWell Connect, a provider of health insurance business sales systems, today announced the successful completion of their 2020 System and Organizational Controls (SOC) 2 Type 2 examination. With long-standing experience in the health insurance industry, the company has completed annual SOC examinations for five consecutive years, reflecting a long-standing commitment to secure internal controls.

BRENTWOOD, TENN, (PRWEB) DECEMBER 07, 2020
GuideWell Connect, a provider of health insurance business sales systems, today announced the successful completion of their 2020 System and Organizational Controls (SOC) 2 Type 2 examination. With long-standing experience in the health insurance industry, the company has completed annual SOC examinations for five consecutive years, reflecting a long-standing commitment to secure internal controls.
GuideWell Connect chooses to invest in their SOC 2 program because they take the security and privacy of their clients and customer data seriously. Continuous auditing and validation of their processes and procedures through SOC 2, supports the needs of their current and potential clients expectation of data security and protections.
GuideWell Connect was audited against the AICPA Trust Services Criteria for Security, Availability, Confidentiality and Privacy. The SOC 2 Type 2 examination provided assurance regarding the effectiveness of the company's controls over a period of time.
The effort was completed by the professional and independent third-party audit firm, 360 Advanced, Inc.
"We place great value on serving our customers;" says Dr. LuAna Boykins, COO at GuideWell Connect. An essential part of that service is our continual focus on maintaining high levels of security, privacy, confidentiality and availability for our clients' data. Securing our SOC 2 Type 2 Certification once again demonstrates that commitment to our clients."
About GuideWell Connect
A wholly owned subsidiary of the GuideWell Mutual Holding Corporation ("GuideWell"), GuideWell Connect is a leader in integrated consumer engagement solutions that helps health plans attract, engage and retain members. GuideWell Connect provides technology-enabled services across the member lifecycle to advance health plans' financial performance, grow membership, and drive better health outcomes for members. GuideWell Connect is the consumer engagement business of GuideWell Mutual Holding Corporation. Learn more at http://www.guidewellconnect.com.
For GuideWell Connect inquiries, please contact:
Meg Cook
Sr. Director of Marketing
megan_cook@onlifehealth.com
About 360 Advanced
360 Advanced is "Making Better Businesses" through their Cybersecurity and Compliance offerings. Services provided include SOC 1, SOC 2, SOC 3, SOC for Cybersecurity, SOC for Supply Chain, CSA STAR, HIPAA/HITECH, ISO 27001 and 27701, PCI-DSS, HITRUST CSF, Microsoft SSPA Attestation, Penetration Testing, GDPR, CCPA, PIPEDA, GLBA, FFIEC, MARS-E and more. In certain states, 360 Advanced may operate under the name of Hiestand, Brand, Loughran, P.A. to meet State Board requirements for CPA firms. To learn more about 360 Advanced, visit http://www.360advanced.com.
For more information on compliance solutions, contact Jim Brennan at jbrennan@360advanced.com.
Media Contact:
Eric Seward
eseward@360advanced.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The guide takes a look at the benefits of proper posture, what exercises will help to reinforce your posture, and more.

BOLINGBROOK, ILL. (PRWEB) DECEMBER 07, 2020
ScripHessco has announced the release of their most recent infographic: A Guide to Having Proper Posture. The infographic breaks down proper posture, exercises and tools that can help improve posture.
According to ScripHessco, "Your posture doesn't have to be completely terrible for it to affect your back either; even leaning forward in your office chair at an angle of 30 degrees can cause 3 to 4 times more stress on your back."
The infographic provides imagery for improper and proper posture. The infographic concludes with signs to watch out for when evaluating posture, and the many benefits associated with proper posture.
To learn more about posture, view the infographic here.
About ScripHessco:
For over four decades we have been a trusted resource to health care practitioners. Throughout the years our company has evolved considerably, but our mission has remained simple. We treat our customers like family, offering them the largest selection of equipment and supplies at the best value possible. Our commitment to this mission has driven us to carry an expansive line featuring over 10,000 products and made us the largest distributor of reconditioned adjusting tables in the world



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The guide takes a look at how our bodies interpret their own genetic code, as well as how scientists can determine or uncover information on a person with this genetic information.

SPRINGFIELD, MO. (PRWEB) DECEMBER 07, 2020
Dynamic DNA Laboratories has announced the release of their newest article: How Does Gene Expression Affect You?
According to Dynamic DNA Laboratories, "Gene expression is the process the cell uses to produce the molecule it needs by reading the genetic code written in the DNA," explains Fabio Candotti, M.D. "The cell acts like a language interpreter by translating genetic code."
The article provides thorough information on Gene Expression so that readers can make an informed decision when taking an at home DNA ancestry test.
Sourced from multiple educational sources such as MIT Technology Review and National Human Genome Research Institute, the article highlights the importance of DNA research.
To learn more about Gene Expression, visit Dynamic DNA Laboratories here.
About Dynamic DNA:
Dynamic DNA Labs is a state-of-the-art genetics lab that specializes in advanced DNA testing. By offering a range of services, including: Family and ancestry testing, Proactive health panels and Personalized medicine reporting, Dynamic DNA Laboratories strives to help their customers better understand themselves and ultimately lead them to healthier and happier lifestyles.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

MedShift Connect celebrates key milestones with new partnerships, tripled revenue, and staff expansion

CHARLOTTE, N.C. (PRWEB) DECEMBER 07, 2020
MedShift Connect, a communications and marketing agency founded in 2018, announced today pivotal growth statistics, highlighted by client wins, staff expansion and increased revenue. Based in Charlotte, North Carolina, MedShift Connect has shown exceptional growth throughout 2020. In the past two years alone, the agency has worked with an ever-growing, diverse clientele list and offered valuable insight for those looking to elevate their brand. With partnerships in North America, Asia, and Australia in a diverse range of business verticals, MedShift Connect has utilized its comprehensive service offerings to maintain a global presence.
Social media management is one of the many comprehensive services offered by MedShift Connect and over the past few years, the agency has seen a major increase in client demand. In early January, the agency partnered with Y LIFT, a New York City-based brand providing the latest cutting edge aesthetic technologies through providers across the United States. The goal of this partnership was to facilitate the brand's internal social media channels and increase awareness surrounding the practices non-surgical face lifting procedure. Since the initial start date of January 1, YLIFT has seen a significant increase in Instagram following and doubled their reach in comparison to the previous year.
Apyx Medical, an innovative, advanced medical device manufacturer and supplier in the aesthetics field, was another valuable win for MedShift Connect. Founded in Clearwater, FL and formerly known as Bovie Medical, Apyx wanted to increase awareness surrounding their Renuvion device following a strategic rebrand. MedShift Connect developed a plan for brand recognition and implemented social media monitoring, a strategy designed to analyze accounts on various social channels for brand misrepresentation and messaging. In April 2020, MedShift Connect officially took over Renuvion's Instagram account and in the past year has seen a notable increase in key metric areas.
Earlier this year, MedShift Connect partnered with leading global aesthetics company, Merz Aesthetics, to lead an influencer campaign for their Cellfina device. The campaign was designed to educate patients about cellulite and the treatment options they had with Cellfina, as well as promote "The Dimple Truth." Eight Instagram influencers participated in the campaign and as a result, drove impressive metrics for combined impressions, reach, and link clicks. Additionally, MedShift Connect's paid search and social strategy increased overall reach, elevating Cellfina's brand and strengthening their digital footprint.
Lumiton, a solar powered infrared technology company based out of Charlotte, NC, also found value in MedShift Connect's offerings and recently concluded their "Wear Healthy" digital influencer campaign. Under the management of MedShift Connect, Lumiton's Instagram account experienced a substantial increase in following and overall reach. The campaign proved to be successful, resulting in a surge in mask sales and amplified brand awareness.
"We're extremely happy with the progress MedShift Connect has made since founding in 2018. Each client lends new opportunities for the team and our rapid growth affirms the value our agency provides. We look forward to continuing this momentum going into the new year and plan to expand into advantageous markets as new partnerships transpire," said Vice President Communications and Marketing, Victoria Olszowy.
Additionally, MedShift Connect has seen strong adoption of other services such as media relations, custom content creation, reputation management, crisis communications strategies and brand development. Recent partner, K&B Management, has found great value in these offerings and plans to further enhance its brand through utilizing the agency's media relations and digital production services. The Charlotte-based plastic surgeons are notable additions to MedShift Connect's unique clientele list and lend credibility to the agency's expertise within the medical aesthetics field.
As MedShift Connect continues to build upon past achievements and future opportunities, the agency has also seen great success with staff expansion, over 60% growth since its founding in 2018. The agency's team of highly experienced individuals offers unique skill sets in traditional and digital marketing, public relations and media relations efforts. With MedShift Connect, clients can expect to observe meaningful and measurable results throughout the duration of their partnership.
About MedShift
MedShift, founded in 2015 in Charlotte, NC, delivers a platform as a service to both medical device manufacturers as well as individual medical practices. Foundationally, MedShift enables access to the latest devices and technology to remain competitive and attract new business. MedShift has partnered with over 330 doctors in North America, Australia, and New Zealand to give practices the latest in cutting-edge treatment modalities, services, and systems.
MedShift is disrupting the traditional aesthetic device market by offering permanent placement, holistic subscription services for surgeons, physicians, and their business. MedShift's broad portfolio of services for practices includes a portfolio of 25 leading aesthetic medical devices from nine manufacturers, an aesthetic eCommerce and subscription platform, in-house communications and marketing services, and inbound lead generation. For manufacturers, MedShift delivers a highly secure IoT platform consisting of both hardware and software assets allowing for real-time visibility, remote management, and big data modeling of entire medical device lineups. MedShift adds value across the manufacturer and provider spectrum and continues to empower robust integration with the leading brands and doctors in the industry. Additionally, in its first year of eligibility, MedShift ranked 185 on the 2020 Inc. 5000 list, leading as the 15th fastest growing health company in the United States.

"We look forward to continuing this momentum going into the new year and plan to expand into advantageous markets as new partnerships transpire," said Vice President Communications and Marketing, Victoria Olszowy.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

As FSA users race to spend remaining funds before the December 31 use-it-or-lose-it deadline, FSAstore.com offers shopping inspiration with its list of best-sellers for 2020

NEW YORK (PRWEB) DECEMBER 07, 2020
For over a decade, FSAstore.com has helped flexible spending account (FSA) users find responsible ways to spend their FSA dollars to manage everyday health conditions or respond to whatever life throws their way. Today, the company released its annual list of top products, based on website traffic and online sales in an effort to help account holders benefit from remaining FSA funds before the December 31, use-it-or-lose-it deadline.
"The fact that 2020 has been anything but a typical year can be seen in how consumers are spending their FSA funds," said Preston Farrington, CEO of Health-E Commerce, the parent brand of FSAstore.com. "With access to clinical services and elective procedures limited, customers tell us they have more money left to spend than in previous years, and they are spending it in different ways, including the consumer products offered on our site."
In fact, according to FSAstore.com customer surveys, more than 50% of FSA users have more money to spend this December than they did in 2019. This is due largely to limitations on scheduling doctor appointments or elective procedures, which are big ticket items for yearly health spending. For many account holders, the health benefits plan year ends on December 31; however, consumers should check with their employer or benefits administrator to confirm deadlines.
To extend a helping hand and provide much needed shopping inspiration to FSA users, FSAstore.com has released its annual list of the Top 10 most popular FSA eligible products, which includes:
1. MyLab Box At-Home COVID-19 Detection Test
The MyLab Box At-Home COVID-19 Detection Test uses saliva sampling for a quick, non-invasive testing method and a prepaid shipping box that will send results to a lab for results. If a test comes back positive, users can plan next steps with a free physician consultation.
2. Sejoy Infrared Forehead Thermometer
The COVID-19 health crisis has only further increased the importance of home health, diagnostics and home health care. Many American families are choosing to upgrade their at-home health monitoring devices, such as thermometers. One of the top sellers in this category is the Sejoy Thermometer, which uses infrared technology to deliver quick, touchless readings in 3 seconds, as well as memory storage to capture the past 10 readings.
3. Welly Bandages
Replenishing first-aid supplies is a smart tactic for FSA deadline shoppers, and when it comes to bandages, Welly is a great choice. Welly premium bandages come in a variety of fun and engaging colors and styles to help turn boo-boos into badges of bravery.
4. Supergoop! Unseen Sunscreen
Sick of sunscreen that leaves blotchy marks behind? Go with a weightless, scentless sun protection that goes on clear with Supergoop! Unseen Sunscreen. With broad spectrum protection and active ingredients that even protect against blue light from smartphones and other devices, shoppers appreciate the full spectrum approach to this sunscreen.
5. Caring Mill Pulse Oximeter
Alongside thermometers, oximeters were among the most popular hi-tech health devices of 2020. These devices clip onto a finger and measure the oxygen levels in the user's blood to help identify a key vital sign that could be the sign of an underlying health condition. FSAstore.com shoppers can now purchase an oximeter from our private label line of healthcare products, Caring Mill. Each sale of a Caring Mill product supports the nonprofit Children's Health Fund, which is committed to providing healthcare to underserved youth populations throughout the United States.
6. Tylenol Extra Strength Caplets
An over-the-counter (OTC) pain reliever may not seem too exciting, but it's actually a pivotal part of a larger story. OTC medicines became fully eligible in 2020, thanks to the passage of the CARES Act, so everything from pain relievers to allergy medicine to acne treatments can now be purchased with FSA funds, without requiring a prescription. Tylenol is a welcoming addition to FSA users' medicine cabinets due to its ability to tackle aches and pains and help reduce fevers.
7. Bug Bite Thing
The Bug Bite Thing has been one of the most popular anti-itch treatments of 2020. The Bug Bite Thing is a drug-free approach that utilizes suction to remove insect venom and stingers to help alleviate itchiness and pain from insect bites.
8. Gold Bond Ultimate Skin Healing Lotion
With OTC medicines now being fully FSA eligible, many products that treat skin conditions are also available. One of the runaway successes of 2020 was Gold Bond Ultimate Skin Healing Lotion, which has been supremely popular with FSAstore.com shoppers. From dry skin conditions to psoriasis to eczema, this lotion is a smart buy that can provide soothing relief.
9. Rael Heating Patch
In addition to OTC medicines, menstrual care products like tampons, pads, period underwear, menstrual cups, and more are now FSA eligible. One OTC item that's also a menstrual care product and a top seller is the Rael Heating Patch, which uses natural, herbal therapy in an instant patch that warms up as soon as it's applied to the abdomen. This promotes increased blood flow and helps muscles relax to alleviate pain.
10. dpl IIa Professional Acne Treatment Light Therapy
As OTC acne treatments have gained interest among consumers, light therapy also continues to be a popular drug-free treatment method for acne among FSA users. The dpl IIa Professional Acne Treatment Light Therapy provides medical-grade infrared (IR) therapy with the largest possible treatment area of any light therapy product available at FSAstore.com. Utilizing powerful IR lights, this device eliminates bacteria on the skin to help reduce breakouts.
There are thousands of ways to spend down FSA funds before the December 31 deadline, so make a plan, visit FSAstore.com, and start early to avoid forfeiting those hard-earned healthcare dollars.
About Health-E Commerce
Health-E Commerce is the parent brand of FSAstore.com, HSAstore.com, and WellDeservedHealth.com, a family of brands serving the 70+ million consumers with tax-free health and wellness accounts. Since 2010, Health-E Commerce's brand portfolio has led the direct-to-consumer e-commerce market for tax-free health and wellness benefits and helped partners and everyday Americans benefit better through its 100% eligible product selection and easy-to-understand educational resources. Health-E Commerce plays an essential role in consumer advocacy in the tax-free health space through both advocating for eligibility of important new categories within the IRS-approved list of eligible medical expenses and leading a committee of industry experts to promote the important national conversation around product safety and authenticity.

With access to clinical services and elective procedures limited, customers tell us they have more money left to spend than in previous years, and they are spending it in different ways, including the consumer products offered on our site.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The latest innovation from Philips Water Solutions uses the power of light to keep your bottle clean, safe, and always ready to go

SUNNYVALE, CALIF. (PRWEB) DECEMBER 07, 2020
AquaShield, a global brand partner of health technology company Philips, is launching an innovative new self-cleaning water bottle that uses the power of UV-C LED light to both clean water and sanitize the bottle itself. The Philips GoZero Smart Bottle is the second entry under the new Philips GoZero label launched just this past October in North America.
Embodying GoZero's mission of helping consumers sustainably enjoy clean, refreshing drinking water on the go from both tap and natural sources, the GoZero Smart Bottle takes a high-tech approach that is unique from most filtered hydration products that leverage physical consumable filter media that need to be replaced regularly.
The GoZero Smart bottle features UV-C LED technology integrated into the cap of the bottle and activated at the touch of a button. Within minutes, the LED light eliminates up to 99.999% bacteria and 99.9% viruses from water, allowing users to enjoy fresh, clean water from virtually any source*.
Additionally, the bottle's UV-C LED light can also disinfect the bottle itself after use - whether you're drinking water, coffee, tea, juice, soda, or other beverages - cleaning the hardest-to-reach corners of the interior to eliminate foul odors, prevent bacterial build-up, and refresh the bottle for a refill.
"We're very excited about the GoZero Smart Bottle, as it gives people a convenient new way to enjoy clean, safe water on the go," said Alex Rishoj, CEO of Aquashield. "As the latest addition to our rapidly-growing lineup, the Smart Bottle is perfect for people who want to use a single bottle for all of their hydration needs throughout the day, whether they're drinking tea at home, coffee at work, or water while out on an adventure."
The GoZero Smart Bottle is designed to be intuitively easy to use. The bottle's high-tech cap features an LED light ring that indicates when the bottle is clean and ready to use. This indicator ring also displays the bottle's battery life. When it's time to charge, simply attach the included magnetic USB cable to the cap and use it for up to 30-days before having to plug it back in. Constructed of a double-walled, insulated food-grade stainless steel, the bottle is dishwasher safe and can keep liquids hot for 12 hours and cold for up to 24 hours.
The self-cleaning GoZero Smart Bottle will be available on Amazon starting November 30, 2020, and will come in two different sizes - 12 oz. and 20 oz. - and four designer colors - black, grey, yellow, and blue. The 12 oz. bottle will retail for $69.99, while the 20 oz. version will sell for $74.99. The GoZero Smart Bottle joins the brand's other product offering, the Philips GoZero Active Bottle, on Amazon. The GoZero Active Bottle features a unique interchangeable filtration system consisting of two complementary filters for different scenarios - one for reducing impurities from tap water and another for cleaning water from natural sources.
For more information visit: http://www.philips.com/water
About AquaShield
AquaShield Health Technology Company, a former Philips company, is the global exclusive brand licensee for Philips Water Solutions. AquaShield is focused on providing a complete water solution to consumers with their water purification, heating and smart-washing product portfolio. AquaShield believes there is always a way to make life better and is committed to improve the health and well-being of people's lives through meaningful innovation and responsible sustainability. AquaShield is active globally, with sales in more than 30 countries.
*https://cfpub.epa.gov/ncer_abstracts/index.cfm/fuseaction/display.highlight/abstract/1128/report/F

"We're very excited about the GoZero Smart Bottle, as it gives people a convenient new way to enjoy clean, safe water on the go," said Alex Rishoj, CEO of Aquashield.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Wellness Workdays' initiative recognizes outstanding achievements of organizations committed to creating best-in-class corporate wellness programs

HINGHAM, MASS. (PRWEB) DECEMBER 07, 2020
Wellness Workdays, a leader in corporate wellness programs, announces the 2021 Best Wellness Employer survey is open and employers can submit an application for the program's 2021 certification. Developed by Wellness Workdays in collaboration with experts from Harvard Medical School, the Best Wellness Employer initiative recognizes the significant accomplishments of employers dedicated to improving employee well-being. Researchers will utilize the reported data to help build knowledge and advance the field of worksite wellness with a focus on current practices and wellness outcomes. Responses from applicants are kept strictly confidential and anonymous with no identification of any employer.
"The certification recognizes the outstanding initiatives and achievements of organizations committed to developing best-in-class corporate wellness programs," said Debra Wein, founder and CEO of Wellness Workdays. "It was developed by industry experts to help employers gauge the overall assessment, strategy, implementation and evaluation of their wellness programs while contributing valuable data to employee wellness research."
The Best Wellness Employer certification provides an opportunity for organizations of all sizes to highlight the successes of their wellness programs. Experts from Wellness Workdays, Harvard Medical School and other leading organizations developed the rigorous evaluation standards used to create the eligibility requirements. All programs are eligible to earn one of three merit levels – gold, silver or bronze. In 2020, nineteen organizations achieved gold status, including Brown University, Cape Cod Healthcare, Maine Veterans' Homes, Maine State Department of Transportation, New Balance, Norway Savings Bank, Putnam Investments, Systems Engineering and Viessmann Manufacturing. To see the full list of certified companies, visit the Best Wellness Employer website.
Representatives from many of the gold certified organizations presented at Wellness Workdays' 7th Annual Emerging Trends in Wellness Conference, which was held virtually. Winners from all levels showcased their trophies onsite at their offices and featured the BWE logo on their website and careers page.
The survey for the 2021 certification can be completed on the Best Wellness Employer website. Surveys must be submitted by January 29 in order to be considered for one of the three merit categories and profiled at Wellness Workdays' 8th Annual Emerging Trends in Wellness Virtual Conference on April 8, 2021.
About Wellness Workdays
Wellness Workdays is a Massachusetts company with offices in New York, Florida and Texas that designs and delivers corporate wellness programs to promote employee health, productivity and a culture of well-being. Our subsidiary, OMC Wellness, based in Portland, Maine, provides population health management solutions utilizing onsite health coaching and proprietary technology to sustain measurable outcomes. A Certified Woman-Owned Business Enterprise, we have earned industry recognition and best practices awards for our clients, which include New Balance, EMD Millipore, Putnam Investments, Cape Cod Healthcare, Brown University, Maine Department of Transportation, Massachusetts Institute of Technology, Rockland Trust, Titan America, Norway Savings Bank and Harvard Business School. Visit us at http://www.wellnessworkdays.com or http://www.OMCWellness.com or follow us on Facebook, Twitter, LinkedIn, and Instagram.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The dualX device expands in both width and height providing a stable foundation for spinal fusion

LAGUNA HILLS, CALIF. (PRWEB) DECEMBER 08, 2020
Amplify Surgical, Inc., a medical device company focused on innovative dual-expanding technology for the lumbar spine, is excited to announce the launch of the dualX T/PLIF 12-Degree hyperlordotic interbody cages. Dr. Nima Salari, MD, FAAOS, from Scottsdale AZ, became the first spine surgeon to implant the new hyperlordotic dualX interbody cage, a TLIF spacer that provides additional lordosis. The minimally invasive procedure was recently performed at Honor Shea Health, one of Arizona's leading hospitals and healthcare networks.
The hyperlordotic implants developed for the TLIF procedure are the company's latest innovative advancement in an effort to improve sagittal plane correction. The implants developed for TLIF procedures offer a 12-degree hyperlordotic footprint in dualX T/PLIF implants and designed to improve sagittal balance restoration capabilities.
"Offering my patients the benefit of smaller incisions and less exposure to potential complications is why I specialize in minimally invasive surgery," said Dr. Nima Salari. "For this TLIF procedure, I needed to fuse L5/S1 posteriorly due to anterior vascular anomalies. The broad footprint and 12 degrees of lordosis provided a similar advantage to an ALIF through a posterior approach."
"The launch of dualX 12-Degree option demonstrates our commitment to improving patient outcomes by commercializing innovative solutions that accommodate the need for increased lumbar lordosis. We look forward to providing more implant options in the near future," said Andy Choi, CEO of Amplify Surgical.
About Amplify Surgical, Inc.
Amplify Surgical is a privately held spinal device company located in Laguna Hills, CA. The Company focuses on developing and commercializing innovative and minimally invasive technologies for spine surgery. Amplify Surgical is a portfolio company of IntuitiveX, a life science innovation incubator.
Contact:
Andy Choi, CEO
Amplify Surgical, Inc.
info@amplifysurgical.com
765-AMPLIFY



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Visikol, a leader in advanced imaging, 3D cell-culture and digital pathology, is now leveraging its multiplex imaging tools to further drug discovery studies. Using the company's proprietary multiplex imaging approach, Visikol will evaluate the ability of Tuberculosis treatments to reach the site of infection. This technology provides researchers with the ability to visualize many biomarkers within a single piece of tissue such that complex research questions can be addressed.

HAMPTON, N.J. (PRWEB) DECEMBER 08, 2020
Tuberculosis (TB) is still one of the top ten leading causes of death globally. Although TB is both preventable and curable, in the last year alone there were approximately 10 million worldwide cases, of which 1.4 million people died. Yet, in the United States and many developed countries the risk of TB exposure is low as 95% of cases are in developing countries. The World Health Organization noted that an estimated 60 million lives have been saved by preventative diagnosis and treatment. However, 6 months of daily treatment with multiple antibiotics are required to cure even the most common form of TB, and the COVID pandemic has a devastating predicted impact on TB burden and deaths worldwide, stressing the critical need for new safe and effective drug regimens.
Visikol and Hackensack Meridian Health (HMH) have partnered to evaluate TB antibiotics through a grant from the Bill & Melinda Gates Foundation. The project will analyze old and new drugs' ability to penetrate into granulomas – the primary site of TB infection in the lungs – and the multiple cell types involved in the interaction with the drugs. Current data from Dr. Véronique Dartois, an HMH researcher and the study's principal investigator, indicates that drugs differentially penetrate TB granulomas. Understanding the co-localization of drugs and immune cells will be important to determine if drugs can access and kill persistent Mycobacterium tuberculosis (Mtb) populations. Mtb is the bacterium that attacks the lungs and causes inflammation and lung tissue destruction. Ultimately, these insights will guide the TB Drug Accelerator and TB drug discovery projects which can potentially lead to more efficacious treatments.
To thoroughly evaluate the effects of drugs and their interactions with the surrounding tissue, Visikol will leverage its proprietary fluorescent multiplexed immunohistochemistry approach combined with MALDI mass spectrometry imaging. This multi-modal approach will be used to automate the quantitative investigation of drug distribution into TB lung lesions. Visikol's highly multiplexed imaging approach relies on simultaneous and sequential detection of multiple cellular markers, using multicolor fluorescent immunohistochemistry combined with automated multispectral slide imaging, and advanced image analysis software to identify and determine the spatial distribution of immune cells.
"Our novel multiplex approach allows Visikol to visualize ten or more targets simultaneously while also providing clients with custom designed and validated panels in combination with high resolution whole slide imaging, image analysis and comprehensive reporting," noted Visikol CSO Tom Villani, Ph.D.
The partnership with Hackensack comes as HMH Hospitals are again recognized as leaders in not only New Jersey but across the country. Of the health care systems in New Jersey, HMH is the largest and has the most top-ranked hospitals. In the time of COVID-19 HMH has continually proven itself to be a leader on the front lines combatting the virus and helping patients towards recovery.
"Hackensack has continually been recognized as not only a top hospital and healthcare system, but also as a top research organization. The opportunity to work alongside such a talented group of scientists with support from the Gates Foundation is an exciting opportunity for us," mentioned Visikol CEO Michael Johnson, Ph.D.
The data from this study will provide beneficial knowledge to researchers in determining what types of drugs are most effective in treating TB. Visikol's approach to multiplex imaging will provide important insights in the TB drug discovery process that are both timely and data driven.
About Visikol Incorporated
Visikol is a CRO that is focused on accelerating drug discovery and development through the use of its imaging, digital pathology and advanced cell culture assay services. The company provides end-to-end preclinical services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, multiplex imaging, high content imaging, digital pathology and custom drug discovery solutions. Visikol's expertise is in transforming tissues and cells into large image-based data sets that can be mined for actionable insights such that pharmaceutical and biotech companies can make more quantitative and informed decision during the drug development process. Additionally, Visikol manufactures and sells a suite of tissue clearing reagents and 3D immuno-labeling kits. These products allow researchers to easily and rapidly image whole tissues and 3D cell culture models in 3D instead of traditional 2D sectioning. For more information about Visikol or its services, please visit http://www.visikol.com.

Our novel multiplex approach allows Visikol to visualize ten or more targets simultaneously while also providing clients with custom designed and validated panels



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Caring Stars Award Helps Seniors and Their Families Find America's Top-Rated In-Home Care Providers

CHARLOTTE, N.C. (PRWEB) DECEMBER 08, 2020
To help seniors and their families research high quality in-home care options, Caring.com — a leading senior care referral service and the nation's top site for senior care reviews — today announced its annual list of the best home care agencies. The Caring Stars of 2021 include 504 agencies in 46 states and Puerto Rico, with California, Florida, and Texas as the states with the most winners.
Caring Stars started in 2012 as the first award of its kind in the senior living industry, and expanded to include home care agencies in 2017. Caring Stars is an important go-to guide for consumers, recognizing service excellence at agencies providing home care, home health, hospice or geriatric care management. The Caring Stars badge of honor signals to seniors and their families that the agency has earned high praise in online consumer ratings and reviews.
"With more than a decade of senior care expertise, we know that seniors and their families have a range of questions, concerns, and pressing needs when researching in-home care options," said Caring.com's CEO Jim Rosenthal. "Our high-integrity consumer reviews program and the Caring Stars annual guide are among the ways we provide relevant information and empathetic guidance. This important information saves seniors and their families time, relieves feelings of stress, and instills confidence in decision-making, particularly if the need is urgent."
To be considered for this distinguished list, Caring Stars 2021 agencies meet a rigorous set of criteria, including: having 10 or more reviews, an average rating of 4.5 stars or higher, and 3 or more new reviews within the qualification time frame (at least one of those being a 5-star review and at least one published in 2020), as well as no unresolved negative reviews. All qualifying consumer reviews are fully visible to anyone on the web via the Caring.com listing on which they're featured. In determining Caring Stars winners, Caring.com also conducts a reviews-integrity audit and takes other quality-assurance measures.
This list of award-winning agencies is published each year for seniors and their families at https://www.caring.com/bestseniorliving. To find a nearby Caring Star agency, consumers can reach a Caring.com Family Advisor at: (844) 484-5997. Caring.com's Family Advisors assist seniors and their family members at no charge. For more information about Caring Stars 2021, please contact reviews@caring.com.
"Congratulations to every agency that has achieved this level of service excellence! We are excited to recognize you, as you truly stand out among the best in the nation for 2021," Rosenthal said.
About Caring.com
With millions of website visitors, Caring.com is a leading senior care referral service and the nation's top site for senior care reviews. Founded in 2007, Caring's mission is to help as many seniors and their caregivers as possible through empathetic, expert guidance. Applying cutting-edge technology to this humane mission, Caring provides relevant senior care information and support, as well as comprehensive senior living and senior care directories for the United States with hundreds of thousands of consumer reviews of senior living and in-home care providers. Through a toll-free line at (844) 484-5997, Caring's empathetic, nationwide team of Family Advisors — who are among the most highly trained, highly skilled, and knowledgeable experts in senior care — help families and seniors research and connect to the most appropriate services and support for their specific situations. For more information about our organization and our free services for seniors and their families, please visit http://www.caring.com/about and join with Caring on Facebook.
Media Contact: Denise Graab, Caring.com Director of Industry Marketing, pr@caring.com or (650) 762-8190



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Dept. of Health and Human Services (HHS) provided CareSet with early access to the data in order to facilitate the creation of a community Frequently Asked Questions (FAQ) document, detailing how to work with the new dataset.

HOUSTON (PRWEB) DECEMBER 08, 2020
Yesterday, the Federal Government released new hospital COVID-19 capacity data at the hospitals-level. Previously released data about hospital capacity had only been released at the state level. The Dept. of Health and Human Services (HHS) provided CareSet with early access to the data in order to facilitate the creation of a community Frequently Asked Questions (FAQ) document, detailing how to work with the new dataset.
The community FAQ for this data release is hosted by CareSet on GitHub, and invites healthcare professionals, data journalists, and researchers to ask questions and comment at https://bit.ly/COV-PUF-FAQ.
"This data release will allow CareSet and other Data Journalists to report on the impacts from the COVID-19 pandemic on each hospital. Previously, this detailed information was available only to local and federal public health officials," reports Ashish Patel, Chief Growth Officer and Data Journalist at CareSet Journal.
The new, more granular, data release aggregates daily hospital reports into a "week at a time" picture in order to protect patient privacy, while still providing a picture of how COVID-19 is specifically impacting hospitals and local communities across the country. You may view this data at https://bit.ly/COV-PUF.
"Social Media continues to promote misinformation about the seriousness of the COVID pandemic. It is easy to disconnect from the negative impacts of COVID-19, if no one you know personally has been seriously ill," says Fred Trotter, CareSet CTO and Editor of the CareSet Journal. "This dataset allows for communities to see how their local hospitals are impacted, which should vividly combat misinformation, and demonstrate the local impact of the pandemic."
According to HHS, with this data release the picture of how hospitals are impacted by COVID-19 will be revealed on a per-hospital basis, allowing researchers, policymakers, and others to have greater insights into local COVID-19 response efforts. This time-series data will update weekly, going back to August 1, 2020.
With aggregated county or state data, the average across all facilities often masks what is happening at each local hospital. Some hospitals might have additional COVID-19 capacity while others are at or over capacity. Using this new data, the public will have access to hospital-specific COVID-19 numbers to understand hyper-localized community impacts. This new level of transparency and increased access will accelerate COVID-19 insights and understanding.
The Community FAQ for this data release was developed in collaboration with researchers from the University of Minnesota COVID-19 Hospitalization Tracking Project, and the COVID Exit Strategy Project.
About CareSet Systems
CareSet (https://careset.com) is transforming the way biomedical companies go to market. We believe in getting the best treatments to the right patients quickly and efficiently. We do that by analyzing government data sources, such as Medicare claims data. With CareSet, biomedical companies become better at serving the patient community.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The study, published in the AAAAI's journal The Journal of Allergy and Clinical Immunology: In Practice, reports findings for participants who received a follow-up oral food challenge after one year on peanut daily maintenance.

MILWAUKEE (PRWEB) DECEMBER 08, 2020
Data published in The Journal of Allergy and Immunology: In Practice (JACI: In Practice), an official journal of the American Academy of Allergy, Asthma & Immunology (AAAAI), demonstrated that peanut oral immunotherapy (OIT) is effective after one year of maintenance in preschool participants who received a follow-up oral food challenge (OFC).
Preschoolers (9-70 months old) enrolled in the real-world study were administered increasing peanut doses in a clinic every two weeks over 8-11 visits until reaching the 300mg peanut protein maintenance dose. After spending approximately 12 months taking maintenance doses, patients were invited to complete a peanut follow-up OFC.
A total of 164 patients completed build-up and three dropped out of maintenance, leaving 161 patients available for follow-up OFC. A total of 117 of the 161 eligible patients received the follow-up OFC. Among them, 92 (78.6%) were able to tolerate a cumulative peanut protein dose of 4,000mg. A total of 115 (98.3%) tolerated a cumulative 1,000mg dose at follow-up, which would protect against accidental peanut exposures.
"The main takeaway for parents is that in this study, OIT provided protection from accidental exposures for 98.3% of preschoolers," said Lianne Soller, PhD, corresponding author of the study and University of British Columbia allergy research manager. "These data, in combination with our previous data demonstrating safety of peanut OIT in preschoolers, suggest that this therapy could be considered for this age group as an alternative to the current recommendations to avoid peanut."
Also of note was that epinephrine use during maintenance dosing remained low with only two participants requiring it, and only 10.5% of participants experienced allergic reactions at all. During the maintenance phase, only one patient needed to go to the emergency department due to an allergic reaction.
"Our study is the first to report on effectiveness of peanut OIT in preschoolers in a real-world setting, as opposed to a clinical trial setting," said Dr. Soller. "We plan to continue to follow-up with this cohort long-term so we can continue to strengthen and solidify our recommendations regarding peanut exposure and oral immunotherapy."
You can learn more about the current state of oral immunotherapy at the AAAAI's website, aaaai.org.
The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI's Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.
###



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Mediaplanet's Fighting the Flu campaign, found within USA TODAY and online, helps shed light on the importance of our health and safety this winter as we navigate through both flu season and the pandemic simultaneously.

NEW YORK (PRWEB) DECEMBER 08, 2020
Helping to conclude National Influenza Vaccination Week, Mediaplanet today announces the launch of this December's edition of "Fighting the Flu." This campaign advocates for the health and safety of not only ourselves but the others around us.
While most people fully recover from bouts of flu, in some cases the illness can become extremely dangerous or even fatal. The CDC estimates that between October 2019 and April 2020, up to 59 million people in the United States became ill with the flu, leading to between 410,000 and 740,000 hospitalizations and between 24,000 and 62,000 deaths. Young children, older adults, pregnant women, and people with chronic disease or weak immune systems are at high risk from the flu, which attacks the lungs, nose, and throat. Symptoms include fever, chills, muscle aches, cough, congestion, runny nose, headaches, and fatigue. Over-the-counter anti-inflammatory pain relievers may help with symptoms, but the flu is treated primarily with rest and fluid to let the body fight the infection on its own. An annual vaccine can help prevent the flu and limit its complications.
The print component of "Fighting the Flu" is distributed within today's edition of USA TODAY in Boston, New York, Los Angeles, Chicago, DC, Dallas, Houston, Detroit, San Francisco, South Florida, Atlanta, Denver, Baltimore, Philadelphia, North/Central Florida, Carolinas, & Seattle, with a circulation of approximately 200,000 copies and an estimated readership of 600,000. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. Find the full campaign online at: https://www.futureofpersonalhealth.com/campaign/fighting-the-flu/
Three years ago, professional photographer Latasha Haynes, who lives with her family in Tacoma, Washington, was healthy, active, and busy. She traveled the world for her photography business and loved to volunteer through educational programs for women. But in January, she started to feel sick. She thought she caught a cold or virus from a family member and figured she'd feel better soon. But weeks passed and her symptoms, including a cough, loss of appetite, and exhaustion, got worse, eventually developing into a life-threatening influenza illness requiring hospitalization.
Haynes' near-death experience with the flu inspired her to become an advocate with Families Fighting Flu (FFF), a national, nonprofit advocacy organization that's dedicated to protecting children, families, and communities against the flu. The women's health advocate encourages all adults and children older than six months to get an annual flu vaccination, the best preventive measure against influenza. As part of this campaign, Haynes is sharing her story and what you can do to prevent flu.
This campaign was made possible with the support of the CDC, Families Fighting Flu, National PTA, American Society for Microbiology, The Allergy and Asthma Network, HealthyWomen, AAOHN, Halosil, Green Goo, Sambucol, Stogo, RTB MED, GoodState, Crane USA, Pro Solutions Direct & Precision Genetics.
About Mediaplanet
Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.
Press Contact:
Abigail Hanania
abigail.hanania@mediaplanet.com
(845) 548-4990



START your own Wordpress site, business or personal website, or online store at www.siteground.com

DrOwl is transforming how businesses, schools, and organizations are combatting the COVID-19 Pandemic to remain open

ALBUQUERQUE, N.M. (PRWEB) DECEMBER 08, 2020
DrOwl, an award-winning medical platform built on patented technology that helps users better understand their medical history-- has surpassed one million electronic screenings by its users. DrOwl includes a free COVID-19 screening tool for people to screen for symptoms and history of exposure to COVID-19, following the CDC guidelines. DrOwl's groundbreaking user-friendly app assists organizations around the country, by eliminating ineffective and time-consuming paper-based questionnaires, while enabling users to easily check-in to businesses, schools, or their favorite restaurants on their smartphone. DrOwl also provides the businesses and schools with a way to give reports to public health departments of visitors to their facilities in just a few clicks.
DrOwl is honored to have reached this landmark number of electronic screenings. We know our check-in/screening feature furthers our work as a medical platform that enables the average person to securely access, understand, and share his/her personal medical information. With uncertainty looming as the pandemic rages on, this key check-in feature will continue to help serve as a lifeline for organizations throughout the pandemic -- while hopefully helping to prevent any additional spread of COVID-19.
"The millionth check-in is an extremely humbling milestone; it demonstrates the power of not only DrOwl's unique tool but also the willingness of communities working together to help mitigate the spread of COVID-19", said Arvind Raichur, CEO, and Co-Founder of DrOwl.
"We've been working hand in hand, tirelessly with community leaders, lawmakers, educators, and small businesses across the country. What we have seen consistently is that business owners and leaders want to keep their employees and visitors safe by following the CDC guidelines", he said.
"We know that there is still much to do, but we are confident that by being more proactive, communities across the nation can help return to their new normal more safely. This, in and of itself, is comforting. To know we are making a difference by enabling people to keep each other safe. At DrOwl, this is how we're doing our part".
The Millionth Check-In
The millionth check-in was completed on November 17, 2020, and shows the ease of use that organizations around the nation are flocking towards. Since screening has become a primary tool for COVID tracking, electronic check-ins are the most efficient tool we have to manage that data.
DrOwl's mobile app enables facilities to have their guests, employees, and visitors check-in, while on the go. Visitors arrive at a given location, electronically check-in, and are automatically shown the organization's customizable screening questions on their smartphone. This makes organizing and maintaining the data more convenient for facilities while simplifying the check-in process for visitors. Restaurant patrons can check-in without hassle, the same way senior living facilities can, and facilities can easily download visitor reports with the click of a button to give to public health departments. And organizations can even generate a custom QR code for their location.
"To date, we have seen that schools really appreciate that we provide an automatically-generated list of check-in questions that they can customize as needed. It enables them to save precious time while helping create a new, safer normal for their community. When organizations such as rehabilitation facilities or senior living communities have specific rules and challenges, customization has become their best friend and ally," said Raichur.
With over one million check-ins completed to date, DrOwl is on the cutting edge on the transformation of how businesses and organizations adapt to our current – and future challenges. With a central database enabling administrators to run on-demand reports, and cross-reference those that have entered a given facility in real-time. Making it easy for organizations to use the data for epidemiological usage and in cases of infection, look at the data to help assess the risks to help limit their potential liabilities. For more information on DrOwl, please visit CheckIn.DrOwl.com. And, users can download DrOwl.com for free from the iTunes or Google Play app stores.
About DrOwl
DrOwl is a medical platform built on patented technology, that provides a safe place to sync, organize, search, and share your digital medical records on-demand.
Once a user securely syncs their medical records, DrOwl uses AI and machine learning to provide users with a Patient Portal based on the Patient's health records that include trusted, doctor-approved sources of information that is customized for each user and makes their medical information easier to understand. DrOwl users can also share their customized Patient Portal with caregivers or family members to include them in the patient's healthcare decisions. Users can also initiate telehealth sessions 24x7 and allow their caregivers or family members to join in the secure telemedicine video call.*
DrOwl also has a free electronic screening and monitoring solution to help protect schools, senior communities, and businesses during infectious disease outbreaks. Where staff, residents, and visitors can electronically "check-in", answering a list of questions that helps screen for symptoms and history of exposure. This creates an electronic log of employee and visitor activity, in real-time. And reports can be run as needed to assist in contact tracing if an infection is reported. In cases of infection, there is electronic tracking with centralized data for epidemiological usage and cross-contamination data to help assess the risks.
*Telemedicine available in select areas with more being added all the time.

To date, we have seen that schools really appreciate that we provide an automatically-generated list of check-in questions that they can customize as needed. It enables them to save precious time while helping create a new, safer normal for their community.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The partnership will allow leading healthcare organizations utilizing PayConex and Bluefin's Epic integration to seamlessly adopt 1-800 Notify's services

ATLANTA AND MIAMI (PRWEB) DECEMBER 08, 2020
Bluefin, the leader in encryption and tokenization payment and data security, and 1-800 Notify, the premier platform for HIPAA compliant automated phone payments (IVR), appointment reminders, billing reminders and notifications, have partnered to provide 1-800 Notify's services through Bluefin's PayConex gateway and Epic integration to leading healthcare organizations.
"Manually accepting a patient payment over the phone ties up already busy staff members, reducing their time to spend on more important and complicated patient requests," said Martin Trautschold, Chief Executive Officer of 1-800 Notify. "We created the 1-800 Notify IVR Autopay by Phone system to seamlessly automate this task. Not only is the automated system 75% less expensive than a staff member, it is available 400% more time every week to accept patient calls 24/7, allowing patients to make payments on their schedule."
"What's even better is that with our Epic integration, patient balances are pulled directly from Epic and payments are posted to Epic in real-time, further reducing staff workload and increasing patient satisfaction," added Mr. Trautschold.
Bluefin provides payment and data security technologies through the company's PayConex gateway, including PCI-validated point-to-point encryption (P2PE) for the protection of point-of-sale (POS) card data and ShieldConex for the tokenization of online card data, PII and PHI.
Bluefin is also integrated with Epic for payments and P2PE, enabling a secure payment experience for healthcare organizations utilizing the Epic platform. The 1-800 Notify solution also provides a seamless integration with Epic, enabling Bluefin's clients to get integrated payments, P2PE and the 1-800 Notify service directly through PayConex and the PayConex/Epic integration.
"Partnering with 1-800 Notify provides our healthcare clients a huge value-added service for HIPAA and PCI compliant patient payments and communications," said Greg Cornwell, Chief Revenue Officer, Bluefin. "Automating manual work and allowing patients to pay in a contactless remote manner are more important than ever because of the current pandemic, as much of the communication with patients has gone virtual. And the fact that 1-800 Notify is integrated with Epic means that our clients utilizing Blueifn's PayConex / Epic integration can easily adopt this service through their current integration."
"We are very excited to partner with the industry-leading, Bluefin PayConex platform and look forward to bringing the time-saving benefits of our industry-leading IVR Autopay by Phone system to more Bluefin clients in the future," added Mr. Trautschold.
About Bluefin
Bluefin specializes in payment and data security technologies that protect point-of-sale (POS) and online transactions. Our security suite includes PCI-validated point-to-point encryption (P2PE) for contactless face-to-face, call center, mobile and unattended payments, and our ShieldConex data security platform for the protection of personally Identifiable Information (PII), Personal Health Information (PHI), and payment data entered online. The company's partner network currently includes over 135 processors, payment gateways and ISV's operating in 34 countries, which provide Bluefin's P2PE solutions direct to merchants, enterprises, healthcare organizations and more. Bluefin is a Participating Organization (PO) of the PCI Security Standards Council (SSC) and is headquartered in Atlanta, with offices in Waterford, Ireland. For more information, please visit http://www.bluefin.com.
About 1-800 Notify
1-800 Notify is a healthcare communications firm that is fully HIPAA and PCI compliant, an Epic App Orchard Partner and integrates with many systems. 1-800 Notify improves patient appointment attendance, wellness and payments while improving efficiency for hospitals, health systems, physician groups, and medical billing firms. Founded in 2011, 1-800 Notify has rapidly grown to support millions of inbound IVR autopay by phone calls, two-way appointment reminders, patient wellness and broadcast messages. 1-800 Notify is proud of its 98% client retention rate. We focus on learning each client's unique needs, tailoring solutions to those needs and providing a highly reliable and scalable service -- all at a price that is difficult for our competition to match. For more information, visit https://www.1800notify.com/.

"Partnering with 1-800 Notify provides our healthcare clients a huge value-added service for HIPAA and PCI compliant patient payments and communications," said Greg Cornwell, Chief Revenue Officer, Bluefin.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Annual honor to recognize young life science entrepreneurs in Massachusetts and the Netherlands; fostering relationships between the two biotechnology sectors

CAMBRIDGE, MASS. (PRWEB) DECEMBER 08, 2020
The Termeer Foundation, a nonprofit organization focused on connecting life science innovators and catalyzing the creation of new medicines, today announced the creation of The Henri Termeer Transatlantic Connections Award.
The Award is part of an agreement signed in July 2019 between the Massachusetts Office of International Trade and Investment and the Dutch Ministry of Economic Affairs and Climate Policy, which created and signed a Memorandum of Understanding laying the basis for a Massachusetts – Netherlands Transatlantic Life Sciences Partnership. The signatories included Top Sector Life Sciences & Health (Health~Holland), MassBio, HollandBIO and the Henri A. Termeer Tribute Committee; all of whom agreed to provide support and organize activities to promote trans-Atlantic collaboration between the two biotechnology ecosystems.
"The establishment of the Henri Termeer Transatlantic Connections Award is the first of many partnerships this group plans to create that will help foster a strong relationship between life science communities in the Netherlands and Massachusetts," said Belinda Termeer, President, Co-Founder and Member of the Board of Directors, The Termeer Foundation. "As a native of Holland, Henri was always interested in establishing working relationships with his homeland and his new business home in Cambridge. We are delighted at the creation of this award and feel that it will provide an excellent platform for identifying future industry ambassadors and the opportunity for collaborations between these two important life science sectors."
The Henri Termeer Transatlantic Connections Award will be an annual award competition for life science entrepreneurs in the Netherlands and Massachusetts. Each year the Termeer Foundation and Health-Holland will select two young life science entrepreneurs, one in Massachusetts and one in the Netherlands, who are leading innovative biomedical research activities, and whose programs have the potential to strengthen transatlantic relations between the two life science regions. Candidates should have already established themselves within the life science industry leading an early-stage company, with a concrete business plan and initial funding in place. Additionally, the recipient will be someone interested in becoming actively involved in mentorship and who agrees to be involved in Termeer Foundation programs. Awardees receive Fellowship status within The Termeer Foundation, which includes access to experienced healthcare mentors, networking with fellow peer entrepreneurs, and recognition at The Termeer Foundation Annual Dinner. Recipients will also have the opportunity to spend a week visiting their fellow awardee's company, and to participate in additional learning, networking and cultural events.
The winners of the 2021 Henri Termeer Transatlantic Connections Award will be announced at the end of April, 2021. Nominations should be submitted here.
"Life science research is increasingly developing into a global experience with partnerships between companies in diverse global locations becoming part of our industry's DNA," said Hans Schikan, board member of Health-Holland and a member of the Henri Termeer Transatlantic Connections Award Steering Committee. "One of the many important elements of the biotechnology business I learned from Henri Termeer during my time at Genzyme and as CEO of Prosensa, with Henri as an inspiring mentor, was the notion of understanding the needs of patients everywhere and applying our research in the development of treatments to address those needs no matter the location."
Members of the Massachusetts – Netherlands Transatlantic Life Sciences Partnership Steering Committee include: Belinda Termeer (Co-Founder and Member of the Board of Directors, The Termeer Foundation), Alan Walts (Treasurer, Secretary, Mentor, Co-Founder and Member of the Board of Directors, The Termeer Foundation), Hans Schikan (Member Board of Directors, Health-Holland), Bob Coughlin (President/CEO, Massachusetts Biotechnology Council), Clémence Ross-van Dorp (Ambassador Life Sciences & Health Sector), Annemiek Verkamman (Managing Director, HollandBIO), John Maraganore (CEO and Director, Alnylam Pharmaceuticals), and Daniel de Boer (Founder and Chief Executive Officer, ProQR Therapeutics).
"I am delighted to support this award that will provide an incredible opportunity each year for two deserving life science entrepreneurs," said Daniel de Boer, Founder and Chief Executive Officer of ProQR Therapeutics. "Reflecting on my personal experience, Henri's influence has been invaluable and he was instrumental in helping me to navigate my entrance into the biotechnology industry as a CEO. We co-founded ProQR together, which is now based in the Netherlands and Massachusetts, embodying the spirit of this initiative and his legacy."
About The Termeer Foundation
Building on the bold legacy of Henri Termeer, who pioneered groundbreaking treatments for rare diseases, The Termeer Foundation connects life science innovators and catalyzes the creation of new medicines. The Foundation's network of emerging and established healthcare innovators cultivates tomorrow's leaders and leverages their collective expertise to solve complex problems in drug development and accessibility. The Foundation also integrates its network with academic institutions, nonprofits, regulatory agencies and other organizations across the global healthcare ecosystem to provide expert counsel, stimulate innovation, eliminate barriers to progress, and ultimately connect the world of healthcare until every patient has a cure. Visit us at http://www.termeerfoundation.org or on LinkedIn @TermeerFoundation.
Contact:
Paul Kidwell
Termeer Foundation
617-680-1088
paulkidwell@comcast.net



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Novant Health President and CEO, Mr. Carl S. Armato, addressing both the quality and affordability of healthcare.

WASHINGTON (PRWEB) DECEMBER 08, 2020
The influential Steven Schroeder Award for Outstanding Healthcare CEO was presented virtually at The Leapfrog Group's annual meeting. This year's recipient was Mr. Carl S. Armato, President and CEO of Novant Health in North Carolina.
The award was created by Costs of Care, a leading non-profit dedicated to curating and disseminating insights from the frontlines of health care to help delivery systems provide better care at lower cost, in conjunction with The Leapfrog Group, to recognize a hospital and/or health system CEO who has demonstrated courageous and ethical leadership addressing the twin issues of affordability and quality of health care in their community.
"Costs of Care believes that every health care CEO in the country should be focused tirelessly on patient safety and affordability. Health system leaders all face similar pressures and constraints, yet there are leaders like Carl Armato who are creating solutions to ensure patients receive safer and more affordable health care," said Chris Moriates, MD, Executive Director of Costs of Care.
Mr. Armato has led the way in fostering a culture that is accessible and equitable by removing barriers for those seeking care within the communities that Novant Health serves. Under his leadership, the health system has taken significant steps to provide fair and transparent billing and pricing practices through innovative payment models that alleviate concerns and confusion about the cost of care. Mr. Armato has also strengthened Novant Health's support for its most vulnerable communities by improving access to high-quality care through initiatives like its community health worker program, which helps address health disparities and socioeconomic determinants of health by connecting patients to important community resources and health education.
The Outstanding Healthcare CEO award is named in honor of Steven Schroeder, MD, Distinguished Professor of Health and Health Care at the University of California San Francisco and former President and CEO of the Robert Wood Johnson Foundation. Dr. Schroeder has spent five decades inspiring and mentoring leaders to forcefully advocate for better quality and more affordable health care, and he has inspired leaders of both Costs of Care and The Leapfrog Group.
Dr. Schroeder said about this year's recipient, "In the face of pandemic-induced lost revenue by hospitals and medical systems, stewardship of medical resources requires visionary leadership and courage. That is why the programs led by Carl Armato of Novant Health are so important and worthy of celebration."
"Novant Health exists to improve the health of our communities, one person at a time," said Armato. "I am proud to receive this award on behalf of our health system for our continued commitment to removing barriers to care and improving health equity across all of our markets."
"Even in the midst of the pandemic, great health system leaders have sustained their commitment to providing high-quality, affordable health care to their community," said Leah Binder, president and CEO of The Leapfrog Group. "With this award we're pleased to join with Costs of Care in recognizing a CEO who boldly faced the extraordinary circumstances of this year while simultaneously tackling patient safety, quality, and cost for patients."
About Costs of Care
Costs of Care is a nonprofit organization dedicated to curating and broadly disseminating insights from the front lines of health care to help delivery systems provide better care at lower cost. Since 2009, Costs of Care has collected more than 500 personal accounts from physicians, nurses, and patients all over the United States that illustrate routine and high yield opportunities to improve the value of care delivery through improved decision-making. Costs of Care has created widely adopted and enduring resources to educate medical trainees and clinicians about how to address health care costs and provide high-value care, including the textbook Understanding Value-Based Healthcare, the "COST" framework for designing value improvement projects, multiple workshops, and free, CME-approved video modules. In December 2019, Costs of Care launched the Affordability Moonshot - envisioning a world in which "no one has to choose between their life and their life-savings" - paired with an Affordability Accelerator to support and collaborate on promising ideas to improve patient affordability.
Connect at https://costsofcare.org, be a part of the Moonshot at https://moonshot.costsofcare.org, and follow on Twitter @CostsOfCare.
About The Leapfrog Group
Founded in 2000 by large employers and other purchasers, The Leapfrog Group is a national nonprofit organization driving a movement for giant leaps forward in the quality and safety of American health care. The flagship Leapfrog Hospital Survey and new Leapfrog Ambulatory Surgery Center (ASC) Survey collect and transparently report hospital and ASC performance, empowering purchasers to find the highest-value care and giving consumers the lifesaving information they need to make informed decisions. The Leapfrog Hospital Safety Grade, Leapfrog's other main initiative, assigns letter grades to hospitals based on their record of patient safety, helping consumers protect themselves and their families from errors, injuries, accidents, and infections.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Survey conducted by CISCRP (Center for Information and Study on Clinical Research Participation) and commissioned by Parexel shows perceptions of clinical research are positive but logistical burdens limit children's participation.

BOSTON (PRWEB) DECEMBER 08, 2020
A 2020 survey of 500 parents and children in the U.S. conducted by the Center for Information and Study on Clinical Research Participation (CISCRP) and commissioned by Parexel has yielded critical insights into why families choose to participate in clinical research and how to design clinical trials to better fit their needs, according to the survey report.
Pediatric participation in clinical trials is essential to understanding how drugs perform in children, whose physiologic responses to medications and unique disease variants are often different from adults.
While survey respondents expressed largely positive views of pediatric clinical research, actual participation in pediatric research remains low. Only 16.7 percent of clinical trials registered on the World Health Organization's (WHO) portal involve pediatric patients, and only 12% of trials registered on clinicaltrials.gov are pediatric trials, even though children contributed to almost 60 percent of the total disease burden of the conditions being studied.1 As a result of low pediatric participation, the majority of drugs prescribed to children are only evaluated in adults.2
"Understanding patient health journeys and study volunteer experiences is critical to designing more patient-friendly trials that ultimately enhance pediatric patient participation, so that we can continue to develop newer, safer and more effective drugs for children," said Ken Getz, Founder and Chairman at CISCRP.
Among the key findings from the survey:

Determinants: Parents cited their pediatrician's recommendation as the most important factor when deciding to enroll their child in a trial, and they ranked the potential risks and benefits of the study drug as the most important information they needed to make a decision

Motivations: Children cited the desire to help scientists and doctors learn more about their disease as a primary motivation for participating

Barriers: 52 percent of children indicated it was very important to have some or all of their study visits at home if they were part of a research study

Diversity: Parents who identified as Black self-reported a better understanding of clinical research and were more willing to enroll their child in a clinical trial than parents who identified as Caucasian

Perceptions: The majority of children reported a positive experience with clinical trials, and 90 percent indicated that they would join another study

"The results from this survey inform tangible steps we can take as an industry to encourage more pediatric participation in clinical trials, including more decentralized clinical trial approaches, enhanced communication with caregivers about clinical trials as a care option and better engagement between industry and pediatric providers," said Sy Pretorius, MD, Executive Vice President and Chief Medical & Scientific Officer at Parexel. "The pandemic has further demonstrated the benefits of bringing trials to patients in their homes, rather than asking patients to come into the clinic for every visit, and this is amplified in the context of pediatric trials."
Pediatric participation in clinical trials is an issue of growing importance as the medical community has embraced the need to better understand the effects of medications in children. In 2012, Congress passed the Food and Drug Administration Safety and Innovation Act to incorporate pediatric evaluations earlier in the drug development process, legislation which has resulted in 500 pediatric-specific drug-labeling changes. 2
The Pediatric Perceptions & Insights Study was created, in part, as an outgrowth of questions included in the baseline CISCRP Perceptions & Insights Study that is conducted biennially in adult populations, which gauges public and patient perceptions, motivations, and experiences regarding clinical research participation. Its goal is to monitor trends and identify opportunities to better inform and engage the public and patients as stakeholders and partners in contributing to the clinical research enterprise.
To view the Pediatric Perceptions & Insights Study final report, visit https://www.ciscrp.org/wp-content/uploads/2020/09/Pediatric-PI-Survey-FINAL-2020.pdf
To hear a podcast about the survey results featuring a parent advocate survey respondent, please visit https://www.podbean.com/media/player/t2u24-f45cc0?from=pb6admin&download=1&version=1&auto=0&share=1&download=0&rtl=0&fonts=Helvetica&skin=1&pfauth=&btn-skin=107
About Parexel
Parexel is focused on supporting the development of innovative new therapies to improve patient health. We do this through a suite of services that help life science and biopharmaceutical customers across the globe transform scientific discoveries into new treatments for patients. From clinical trials to regulatory and consulting services to commercial and market access, our therapeutic, technical and functional ability is underpinned by a deep conviction in what we do. For more information, visit https://www.parexel.com/.
About CISCRP
CISCRP (Center for Information and Study on Clinical Research Participation) is an internationally recognized non-profit organization dedicated to educating and informing the public and patients about clinical research. Located in Boston, Massachusetts, CISCRP works to raise awareness, enhance experiences, and strengthen communication and relationships among participants, research professionals and the public through various services and events. For more information, visit https://www.ciscrp.org/.
References: 1https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345947/#:~:text=Despite%20about%2027%25%20of%20the,Organization%20(WHO)%20portal%2034
2 https://pediatrics.aappublications.org/content/144/4/e20191571
###

"Understanding patient health journeys and study volunteer experiences is critical to designing more patient-friendly trials that ultimately enhance pediatric patient participation," said Ken Getz, Founder and Chairman at CISCRP.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Together, Metavivor and Ciitizen will make clinical trials and research more accessible for those living with stage 4 metastatic breast cancer.

ANNAPOLIS, MD. (PRWEB) DECEMBER 08, 2020
Metavivor Research and Support Inc., a national non-profit organization dedicated to funding research for stage IV metastatic breast cancer (MBC), announced a strategic partnership with consumer health tech company Ciitizen to bring a comprehensive new Clinical Trial Search Tool and Clinical Trial Matching Program to the stage 4 metastatic breast cancer community.
Metavivor took up the mantle for increased clinical trials in 2017 and since that time has been on a mission to improve clinical trials and encourage patient participation. During this time, the organization discovered that trial searches were lacking information or did not connect the right trial to the patients' particular metastatic breast cancer. With the help of Ciitizen, Metavivor can now offer clinical trial search and matching service options to those living with MBC. To transition metastatic breast cancer so that it is no longer a death sentence; increased research investment and participation in clinical trials is desperately needed. Metavivor is a leader on both sides of the equation: funding metastatic breast cancer research and empowering the metastatic breast cancer community to participate in critical research.
"No one dies from a tumor that remains in the breast, it is only when the cancer cells spread beyond the breast and metastasize to other organs in the body that breast cancer becomes fatal," said Metavivor Board President, Jamil Rivers. "Metastatic or stage 4 breast cancer research has been woefully underfunded for a long time. We have to give new treatments a chance, so people with metastatic breast cancer can live longer. Clinical trials are our key to finding life extending treatments."
Clinical trials are a key component in advancing medical treatment in cancer and in particular metastatic cancer. "Metavivor is thrilled to partner with Ciitizen to bring this multi-layered clinical trial search tool to the metastatic breast cancer community. It will help patients narrow down their options for the latest clinical trials and personalize them to their diagnosis," said Rivers. Participating in a trial can also afford patients access to high-quality care and new treatments. A recent large study published in the Journal of Clinical Oncology showed, even when patients are matched for baseline characteristics, those on a clinical trial vs not a clinical trial had superior overall survival at 5 years (95.0% vs 90.2%) and 7 years (90.0% vs 78.0%). Put simply, finding a trial may extend a person's life.
Unfortunately a huge gulf exists between connecting eligible patients to trials, a problem that has only been exacerbated by the current COVID-19 pandemic. There is an urgent need to address this problem now.
METAvivor and Ciitizen are launching a new Clinical Trial Search Tool that makes exploring clinical trials easier and more accessible for stage 4 metastatic breast cancer patients. The tool allows patients to narrow in on applicable trials by answering a few questions about their condition. The tool then narrows potential trial options from the exhaustive set of all US based treatment trials. By streamlining multiple search queries into one report, we can ensure patients are aware of all their options. The user interface is clean, easy to use and accessible for patients with varied technical literacy.
The Clinical Trial Search Tool is accessible as part of METAvivor's MBC Patient Resource and Education Portal (MBC PREP) and can be accessed by visiting Metavivor Clinical Trial Search
To learn more about METAvivor and Ciitizen's partnership, please visit Metavivor Clinical Trial Search
ABOUT METAVIVOR
Metavivor Research and Support Inc. is an Annapolis-based, 501(c)(3), volunteer-led, non-profit organization founded by metastatic breast cancer (MBC) patients in 2009. The organization's main focus is to fund critical research that will lead to advances in treatment options, quality of life and survival for patients diagnosed with MBC. Since 2009, Metavivor has awarded 106 research grants totaling $13.6 million. Metavivor is the only national organization with a peer-reviewed grant program aimed at exclusively funding MBC research, and 100% of all donations go to fund research.
Metavivor also raises awareness of MBC, provides support for people living with this disease, and offers opportunities for others to help make a difference for the metastatic community. Metavivor has gained a rapidly growing following within the breast cancer community and has become a leader in its field. For more information visit us at http://www.metavivor.org, and follow us on Facebook, Twitter and Instagram @metavivor.
ABOUT CIITIZEN
Ciitizen is a leading consumer health technology company whose mission is to help patients get full control of their medical records so they can find better treatment options, participate in research and find clinical trials. As a patient-mediated platform, Ciitizen believes patients should have full control of directing the use of their data, which serves as one of the richest sources of real world evidence, unlocking new options for patients and the community. For more information, visit ciitizen.com or follow @ciitizen



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dermatology Physician Assistant Lauren Smith joins U.S. Dermatology Partner in Belton, Texas

BELTON, TEXAS (PRWEB) DECEMBER 08, 2020
U.S. Dermatology Partners is pleased to welcome Dermatology Physician Assistant Lauren Smith to their Belton, Texas Dermatology office.
Lauren Smith has practiced dermatology since 2012 and has received extensive training in medical, surgical, and cosmetic dermatology.
In 2011, Lauren earned her Master of Physician Assistant Studies degree from Texas Tech University Health Sciences Center. She received academic recognition and graduated summa cum laude. Lauren is certified by the National Commission on Certification of Physician Assistants and is licensed by the Texas State Board of Physician Assistant Examiners. She is a diplomate member of the Society of Dermatology Physician Assistants, which is the highest honor a dermatology physician assistant can hold.
Lauren's interest in dermatology began as a patient when she was diagnosed with melanoma at a young age. Her clinical interests include skin cancer prevention and acne. She enjoys building relationships with her patients and helping them feel confident in their skin.
In her spare time, Lauren enjoys spending time with her family, exercising, and traveling.
Lauren Smith joins Board Certified Dermatologists Lenore Chiles, M.D., Jordon Ilse, M.D., Leo Conger, M.D., and Fellowship Trained Mohs Surgeon Nick Snavely, M.D. The office treats patients of all ages and specializes in medical, surgical, cosmetic dermatology, and Mohs Surgery for the treatment of skin cancer. Lauren is currently accepting new patients in Belton, Texas.
About U.S. Dermatology Partners
As one of the largest physician-owned dermatology practices in the country, U.S. Dermatology Partners' patients not only have access to general medical, surgical, and cosmetic skin treatments through its coordinated care network but also benefit from the practice's strong dermatology subspecialty thought leaders and medical advisory board. To be the best partners to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Professionals in education, aviation and hospitality have been the hardest hit, with many switching careers to less affected sectors.

DUBAI, UNITED ARAB EMIRATES (PRWEB) DECEMBER 08, 2020
The sharp drop in hiring activity resulting from the Covid-19 pandemic has forced many professionals in the Gulf to switch careers, according to the latest findings released by Middle East online recruitment firm, GulfTalent.
The study compared the trends in interview invitations received by jobseekers on GulfTalent.com website during the 9-month period from March to November 2020 against the same period in 2019. It found that the average number of interview invitations per active jobseeker was down by almost 50% for some segments of the market.
Winners and Losers
Among job categories, the drop in employment was most severe for teachers and catering professionals, seeing their interview invitations collapse by 48% and 35% respectively. Most other professions saw moderate drops in demand – including engineers and lawyers, followed by marketing, IT, finance and HR professionals.
Meanwhile, a handful of professions saw employment demand increase during the pandemic – notably medical staff who enjoyed a 19% increase in demand, followed by logistics professionals at 12%, thanks to the rapid growth of online shopping.
Sales professionals experienced a mixed impact, with those in telesales seeing a boost in demand due to the restrictions on travel and face-to-face meetings.
Among sectors of the economy, the biggest drop in hiring activity was in education, aviation and hospitality. The only sectors increasing hiring activity relative to the same period last year were healthcare and logistics.
In terms of location, professionals based locally within the Gulf saw a smaller impact from the pandemic. Interview invitations to candidates based in the UAE and Saudi Arabia dropped by 14% and 3% respectively, while those in Qatar saw interviews increase by 17% as employers were no longer able to fill vacancies with newly imported talent.
By contrast, candidates based in India and Pakistan seeking opportunities in the Gulf saw demand drops of 46% and 41% respectively, as flight cancellations and border closures brought international hiring to a standstill. A similar slowdown was experienced in hiring from Egypt and Lebanon, Arab countries that are common recruiting grounds for Gulf employers.
The pandemic has also resulted in a large drop in salaries, as the supply-demand balance has shifted in favour of employers. Analysis of vacancies posted on GulfTalent.com in the 9 months since the onset of the pandemic reveals an average 24% drop in salaries advertised, compared to the same period last year. The salary drop was greatest for professions most affected by the pandemic, such as teachers and chefs, while less affected roles saw smaller salary drops or no drop at all.
Career transitions
The economic squeeze brought about by the pandemic has resulted in job losses, pay cuts, salary delays and career stagnation for many expatriates in the Gulf. While many have left the region as a result, some have sought to retain their residence and earnings by switching to alternative careers within the region, according to GulfTalent's findings.
Many cabin crew who lost their jobs have transitioned to real estate brokerage roles. Among teachers facing job losses or unpaid leave, admin and secretarial roles have been common destinations. Meanwhile, many catering professionals who were made redundant have taken up employment in customer service roles.
The pandemic has also pushed many into home-based freelance jobs or entrepreneurship. Some teachers reported for the first time teaching students privately from home via Zoom, while a small but growing number of people from different backgrounds are setting up online stores selling goods.
GulfTalent's study was based on analysis of 2019 and 2020 hiring activity, including 6 million job applications submitted by jobseekers, 350,000 interview invitations issued by employers, and survey interviews with a sample of candidates.
About GulfTalent
GulfTalent is a leading online recruitment portal in the Middle East, covering 9 countries across the region. It is a key provider of both national and expatriate talent to over 10,000 employers across all industries, and is used by 9 million professionals and managers for finding top career opportunities in their field.
Media contact
Email: press@gulftalent.com | Tel: +971 4 278 5200



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Content licensing company will boost reach of publisher's orthopedic evidence-based summaries.

ST. THOMAS, U.S. VIRGIN ISLANDS (PRWEB) DECEMBER 08, 2020
Today OrthoEvidence Inc., an orthopedic-focused evidence-based summary provider, announced that it has chosen MEI Global LLC (MEIG), a leader in helping publishers monetize their digital assets, to create third party licensing partnerships to extend its content's reach to a larger audience.
"Our goal is to provide critical information access to orthopedic healthcare providers and their patients everywhere," says Dr. Mohit Bhandari, founder and president of OrthoEvidence. "To save medical professionals time and expand access to high quality research, we have developed a process to identify, critically appraise, and summarize the best of the best in the field of orthopedics." He adds, "MEIG's expertise in identifying, negotiating, and managing deals with licensing partners in order to expand the reach of OrthoEvidence's content means more patients, medical professionals, pharmaceutical companies and others will find the critical information they need, more easily."
MEIG was founded by Randall Marcinko to address the difficulty publishers experience developing new licensing opportunities, which is frequently due to a shortage of in-house licensing personnel.
"The market for content and the associated business models evolve rapidly. In a world of declining budgets, publishers are all too often forced to focus on publishing operations at the expense of a strategic focus on distribution," says Marcinko. "Without the time and resources to focus on licensing or an in-depth understanding of the significant upside it can generate, publishers miss out on lucrative new markets. Having applied our proven analytical approach to OrthoEvidence's content, our team is excited about the licensing opportunities to reach end users of all types via partnerships with aggregators, syndicators and others in the information industry."
"We're pleased that OrthoEvidence recognizes MEIG's ability to quickly and strategically expand their content distribution partnerships," says Chris Broekhoff, MEIG's President. He says, "MEIG's team will bring its acumen, professionalism, and a commitment to safeguarding publishers' intellectual property to the long-term, profitable relationship we look forward to building with OrthoEvidence."
About MEI Global LLC: MEIG provides a suite of services to help publishers monetize their digital assets. MEIG's expertise includes prospecting, negotiating, relationship management, and extensive knowledge of vendors and their needs, thanks to decades of industry experience within MEIG's dealmaker team. The company assists publishers with strategic decision making through a lens of revenue growth, brand extension and intellectual property protection. For additional information, please contact Vice President of Business Development Nancy Davis Kho at ndkho@marcinko.com, +1 510 336 1119.
About OrthoEvidence, Inc.: OrthoEvidence (OE) is a fast-growing online platform of innovative products and services targeted to evidence-based surgical practice, focusing on orthopedics. OE focuses on helping associations and industry architect, analyze, and educate their networks about health care decisions. OE's competitive advantage derives from skilled data scientists, programmers, and analytics teams. Through automation and algorithms using machine learning, OE is building the business intelligence platform "OE M.I.N.D.- Machine learning INsights Database" with over 75 million datapoints to drive new analytics and evidence reports. For additional information, please contact Vice President, Sonia Dosanjh at sonia.dosanjh@myorthoevidence.com, +1 289 337 5717.

MEIG's expertise in identifying, negotiating, and managing deals with licensing partners in order to expand the reach of OrthoEvidence's content means more patients, medical professionals, pharmaceutical companies and others will find the critical information they need, more easily.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A sobering report released last week details a national surge in overdose-related cardiac arrest due to the COVID-19 epidemic in the United States. This report sheds light on the toll the COVID-19 pandemic is taking on vulnerable populations, including those suffering from addiction. Waismann Method Medically Assisted Opioid Treatment views this as a call to action to extend treatment services to those dealing with opioid addiction, including an expansion of mental health treatment to address addiction's underlying causes.

BEVERLY HILLS, CALIF. (PRWEB) DECEMBER 08, 2020
As of December 7, 2020, the United States reports more than 14.7 million confirmed cases of COVID-19 and 282,345 deaths due to the virus. However, the true magnitude of the pandemic is much greater. These death tolls do not include individuals who die due to lack of medical resources, and overburdened medical system, suicide, or mental health-related illnesses such as addiction.
The new report, published in JAMA Psychiatry, included data from the National Emergency Medical Services (EMS) Information System. This system includes information from more than 10,000 EMS agencies across 47 states, providing a comprehensive view of medical events in the United States. The report showed overdose-related cardiac arrests rising sharply in April 2020. By May 4, rates were more than double the baseline from 2018 and 2019. Overdose-related cardiac arrests decreased slightly in the summer months but remained 53.7% above baseline by July 27 and 48.5% above baseline by August 1.
The report also highlighted the relationship between mobility and overdose-related cardiac arrest. As mobility decreased sharply under stay-at-home orders, cardiac arrests rose. The researchers at the University of California-Los Angeles who authored the report speculate that the increase in overdose-related cardiac arrests may be due to more people using substances alone, increased toxicity of the drug supply, and reduced access to treatment. Combined, these factors make each overdose incident more deadly.
In response to the alarming report from JAMA Psychiatry, the Waismann Method Medical Group calls for mental health to be placed at the center of the conversation about the opioid crisis and COVID-19 pandemic. Dr. Michael H. Lowenstein, Director of the Waismann Method Medical Group, stated, "This report highlights what so many of us on the front lines of this crisis already know: the COVID-19 pandemic is making the opioid crisis worse. Mental health is deteriorating, and social isolation is putting people in risky situations. It's time to treat addiction and mental health problems as seriously as COVID-19."
Bold Action Needed to Combat the Twin Epidemics: COVID-19 and the Opioid Crisis
Before the COVID-19 pandemic, the United States was in the midst of an unprecedented opioid epidemic. This left a large portion of the population medically, socially, and psychologically vulnerable. The sharp increase in opioid-related overdose deaths since March 2020 points to the need for immediate action to address these twin crises.
COVID-19 infection contributes to respiratory frailty, which can be deadly for individuals suffering from opioid addiction. Mental health is an equally large concern. Social distancing and other safety measures are critical in reducing the spread of the virus. However, they also contribute to isolation, loneliness, and worsening of mental health symptoms. By late June 2020, 40% of Americans were dealing with substance abuse or mental health problems. Younger adults, essential workers, unpaid adult caregivers, and racial/ethnic minorities are disproportionately affected.
Opioid use disorder does not occur in a vacuum. It is driven by depression, anxiety, trauma, isolation, and other serious mental health problems. Only by treating these underlying mental health symptoms can we help people achieve long-lasting sobriety. Waismann Method Medical Group calls on public health officials to expand funding for education, mental health treatment, and life-saving medical care, including a medical detox. We urgently need to provide mental health and medical treatment to the vulnerable people who need it most.
About Waismann Method
Waismann Method has more than two decades of experience providing top-quality medical care for those suffering from Opioid Use Disorder (OUD). The center is internationally recognized for its hospital-based medically assisted opioid treatment, rapid detox protocol, and exclusive Domus Retreat for post-detox aftercare. The program is located exclusively in Southern California, where thousands of patients from all over the world have been successfully treated.
Clare Waismann SUDCC, RAS, founded the center in 1998. Its goal was and still is to continue providing the most effective, safe, and comfortable medically assisted opioid detoxification. A treatment option that helps individuals achieve an opioid-free state which allows them to be emotionally present for a more accurate psychological assessment and adherence to the indicated therapy. "A comprehensive inpatient medical evaluation, successful medical detox, and an accurate emotional assessment with an individualized plan are the best components to support people in maintaining a healthy journey," Clare Waismann.
Waismann Method and Domus Retreat, together, provide people a scientific and individualized approach to patient care, featuring a multidisciplinary team to ensure safety, comfort, and success.
Find out more about Waismann Method at https://www.opiates.com.
LinkedIn
Facebook
Twitter



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Pacor, Inc., an authorized OEM Fabricating Partner for Aspen Aerogels, is proud to announce that Cryogel is a potential solution for enhanced ultra-cold storage and transport of COVID-19 vaccines.

BORDENTOWN, NJ (PRWEB) DECEMBER 08, 2020
Pacor, Inc., (https://www.pacorinc.com) a leading fabricator of insulation solutions for OEM and Industrial Applications, is proud to announce that Cryogel can extend the sub ambient temperature stability substantially longer than dry ice and traditional insulation materials.
The recent news announcements of the efficacy of Covid-19 vaccines are very encouraging. One particular vaccine, however, requires Ultra-Cold (-70 C) temperatures for transport and storage.
If your company manufactures containers, boxes or coolers for storing or transporting medical supplies like vaccines, the news also made clear that is a large challenge for small or rural medical clinics and facilities.
These facilities have limited resources, personnel and access to dry ice, especially during a dry ice supply shortage and increased competition to acquire the scant amount available.                                                                                                    
How does your company produce a storage container that can stay at -70 C degrees for significant periods of time?
How can your company's containers assist these remote medical facilities that need to replenish dry ice every 5 days, in order to maintain this temperature and not threaten viability of the vaccine?
Pacor has a solution for you: Cryogel insulation. Cryogel is made specifically for sub ambient and cryogenic applications. Cryogel can extend the sub ambient temperature stability substantially longer than the 5 days expected from using dry ice with traditional insulation materials
Pacor can custom fabricate Cryogel to fit any type of container, box or cooler.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss key areas of tumor biology, beyond what is found on typical targeted liquid biopsy panels and assess tumor spatial heterogeneity exome-wide, by complementing liquid biopsy results from tumor tissue analysis using ImmunoID NeXT. Attendees will learn about how the NeXT Liquid Biopsy can help study teams interrogate acquired therapy resistance mechanisms and monitor clonal evolution.

TORONTO (PRWEB) DECEMBER 08, 2020
While solid tumor biopsies remain the standard for the interrogation of the cancer genome, the advent of liquid biopsies and multi-region tissue sampling has demonstrated that there can be more to a cancer's genotypic profile than that found in a single tissue biopsy. NeXT Liquid Biopsy, a first-of-its-kind, high-performance, exome-wide liquid biopsy assay, is designed to complement ImmunoID NeXT, providing a unique ability to further evaluate the cancer ecosystem and advance the development of next-generation therapies.
NeXT Liquid Biopsy enables investigation into key applications, such as spatial and temporal heterogeneity of the tumor, clonal evolution and tumor dynamics in response to therapies, and mechanisms of acquired resistance. NeXT Liquid Biopsy is purpose-built to navigate the inherent variability of circulating tumor DNA (ctDNA), elucidating key areas of tumor biology not often addressed by targeted, commercially available liquid biopsy panels.
To enable sensitive variant detection across 20,000 genes, this enhanced exome assay and chemistry achieves high sequencing depth of approximately 2,000x exome-wide, with additional boosted depth, 5,000x, for 247 cancer-related genes. Personalis has developed a computational pipeline optimized to lower the noise floor for variant detection, providing sensitive monitoring and de novo detection of variants over multiple time points.
Join expert speakers from Personalis, Sean Michael Boyle, PhD, Senior Director, Bioinformatics Applications; and Dan Norton, MBA, Senior Product Manager, in a live webinar on Thursday, December 17, 2020 for a discussion of the data demonstrating the genomic profiling and assay performance enabled by NeXT Liquid Biopsy through the evaluation of various reference standards and actual patient samples. Participants can choose from 2 live broadcasts at 8am EST (1pm GMT/UK) and 4pm EST.
For more information, or to register for this event, visit NeXT Liquid Biopsy: A High-Performance, Exome-Wide Liquid Biopsy Assay to Study Tumor Dynamics.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

COVID-19 Screener and Exposure Alert tools provide critical data needed to safely reopen schools

SAN FRANCISCO (PRWEB) DECEMBER 08, 2020
Hazel Health, the national leader in school-based healthcare, announces the release of essential COVID-19 tools that enable school district officials to reopen schools as safely as possible and meet local health regulations. The availability of the new tools comes at a time when more schools are reopening and COVID-19 cases are surging in the U.S.
Hazel Health's COVID-19 safety tools include:

COVID-19 Screener: To support district health protocols, the COVID-19 screener enables parents to check and confirm symptoms their child may be experiencing before the child enters a school environment. On-demand visits are also available through the screener to address parents' questions and concerns. Hazel Health designed the screener with ease of access and multilingual communities in mind.

Exposure Alert: As schools are notified of COVID-19 cases, Hazel Health's Exposure Alert helps identify all students and staff exposed to each confirmed case and provides support and next steps for students. Notifications of positive cases are delivered instantaneously to district officials, enabling rapid response at the school and district level. Exposure Alert syncs with class schedule data from Clever to provide actionable information for campus safety.

"Hazel Health was founded upon the belief that all children deserve access to quality healthcare in order to excel – a mission that has become even more crucial with the COVID-19 pandemic," said Josh Golomb, CEO at Hazel Health. "Inspiration for our new COVID-19 safety tools came directly from the education leaders we work with every day. Our goal is to support a safe and healthy learning environment and ensure healthcare for all students, in all communities, regardless of financial or immigration status."
Through a secure, web-based platform, school nurses or parents at home can access Hazel Health from any device to coordinate care for students and request telehealth appointments with Hazel's HIPAA and FERPA trained, board-certified healthcare providers.
"As we navigate the fluctuation of in-person and online learning, we're thrilled to partner with Hazel Health and leverage their COVID-19 safety tools so we can provide a safe learning environment for students," said Bridget Phillips, Chief Academic and Operations Officer, The Doral Academy of Nevada, a part of the Academia network of charter schools. "We were previously using Google Sheets to track symptoms, and had to manually comb through information – with Hazel Health's system, there is proactive reporting which saves time and enables students to receive telehealth care sooner if there's a potential positive."
Hazel Health's COVID-19 safety tools are HIPAA and FERPA compliant, with sensitive health data remaining within the secure platform. To learn more, please visit https://get.hazel.co/covid19.
About Hazel Health
Hazel Health is committed to eliminating barriers to quality healthcare for children. As the national leader in delivering pediatric telehealth care, Hazel Health partners with school districts across the U.S. and currently serves over 1.3M children. Hazel's team of experienced pediatricians, educators, and best-in-class engineers are passionate about ensuring all children receive the best care in school or at home. Hazel is based in San Francisco, California. For more information, please visit http://www.hazel.co



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Healthcare Surfaces Institute's cutting-edge collaboration between organizations and professionals now includes Spry's patented soft-surface filter technology – strengthening their efforts to curb infection rates caused by healthcare surfaces.

WHITE PLAINS, N.Y. (PRWEB) DECEMBER 08, 2020
Spry Therapeutics and Healthcare Surfaces Institute today announced they have entered into a strategic partnership, combining the organization's clinical expertise and resources with Spry's deep knowledge in soft-surface contamination – particularly as it pertains to pillows and mattresses. With surfaces playing an increasingly critical role in the fight against healthcare acquired infections (HAIs), both parties recognize the importance of including soft-surface contamination in the discussion around prevention.
Soft surfaces – such as pillows and mattresses – can facilitate the transfer of disease within hospitals, with deadly infections spreading from patient to patient. In fact, ECRI Institute listed soft surfaces second on their list of Top Health Technology Hazards, stating: "Blood and other body fluids that remain on, or within, mattresses or mattress covers after cleaning can contact subsequent patients, posing an infection risk."
Spry Therapeutics is committed to helping healthcare facilities eliminate soft surfaces as vectors for contamination by providing the world's first and only soft-surface filter technology: Pneumapure. The company's patented filter technology is proven effective in blocking even the smallest "superbugs" – down to .02 micron – from entering or exiting any soft surface to which it's applied, helping to prevent the transmission of deadly diseases among patients and caregivers. Pneumapure also reduces costs associated with HAIs from environmental impact to disposal costs, annual purchase expenditures and more.
The company's partnership with Healthcare Surfaces Institute is based on the fundamental understanding that many HAIs are preventable when the problem is understood and proper guidelines, testing and infection prevention protocol are implemented. The Institute is a collaboration of key decision makers in healthcare, manufacturing, academia, professional organizations, standards-setting organizations, regulatory agencies and other nonprofit entities. Each of these specialists is focused on scientific research and creating measures, metrics, and guidelines, as well as outreach and educational programs to reduce preventable infections by interrupting transmission of microbes via surfaces.
"We are thrilled to be partnering with Healthcare Surfaces Institute in their mission to reduce the spread of infection through surfaces," says Bill Purdy, CEO and Co-Founder of Spry Therapeutics. "From inception, Spry's goal has always been to protect patients and caregivers with our breathable barrier solution, and we look forward to bringing soft-surface cleanliness to the forefront of prevention."
"We are really looking forward to including Bill and his team in our certification initiative work," says Linda Lybert, Founder and Executive Director of Healthcare Surfaces Institute. "He brings incredible expertise around the issues facilities face with soft surfaces, specifically pillows and mattresses. Patients are constantly in direct contact with these surfaces, and we need to make sure they can be effectively cleaned and disinfected. Bill will also become a resource to our Scientific Advisory Board and will participate in development of research and guidelines with others in the field."
To learn more about Spry Therapeutics and its fight against HAIs with its virus-blocking filter technology, visit sprytx.com.
About Spry Therapeutics
Spry Therapeutics is a health and wellness technology company that uses a proprietary soft-surface filter technology to block all pathogens from entering or exiting any soft surface to which it's applied. The Company's Pneumapure filter is designed to help prevent cross-contamination among patients and caregivers, and provide a clean sleep solution to businesses and consumers alike. Spry Therapeutics is headquartered in White Plains, NY. For more information, visit sprytx.com. Follow Spry Therapeutics on LinkedIn.
About Healthcare Surfaces Institute
The Healthcare Surfaces Institute is a cutting-edge collaboration of thought leaders who work together to evaluate and understand all aspects of the role surfaces play in transmitting pathogens that cause infection and illness in healthcare settings.
Finding solutions to the spread of infections via surfaces requires an understanding of all contributing factors. This can only be done by bringing together experts that have high levels of understanding and expertise in many different areas – often with very different perspectives and opinions about how the issue must be addressed.
Our mission is to reduce preventable infections through collaboration of industry, academia, science, regulatory, and service sectors by interrupting the transmission of surface-related pathogens in healthcare in support of community and public health.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

United Nations Office on Drug & Crime (UNODC) is launching "Listen First: The Science of Care," ten animated videos and written campaign of information produced by Ethan Films for parents and caregivers worldwide to help them and their children during COVID-19. Based on scientific evidence, the campaign takes an enjoyable and loving approach to inform parents, and it is being highlighted across various organizations including the Walther Center in Global Palliative Care & Supportive Care at Indiana University, Olympic Coach and Athlete networks, on Dr. Koonce's TV show and more.

VIENNA (PRWEB) DECEMBER 08, 2020
On Human Rights Day we commemorate the Universal Declaration of Human Rights. This year's theme is the global COVID-19 pandemic and its aftermath; children worldwide are suffering ever more due to COVID-19. Millions are unable to attend schools, especially girls in developing countries, and many lack access to food, shelter, and healthcare as parents are also under extreme pressure. To that end, United Nations Office on Drug & Crime (UNODC) is launching "Listen First: The Science of Care," ten videos and written campaign of information produced by Ethan Films for parents worldwide to help their children and better prepare them for the future, based on scientific evidence worldwide. Each episode focuses on a parenting tip, offering the scientific reasons why it helps.
For example, one video demonstrates how affection, such as a hug, generates oxytocin, a chemical in the brain, which can stimulate growth, strengthen the immune system and make children grow smarter, healthier, and happier. Equally as important is "patient parenting," because patience makes children feel cared for and loved, plus neuroscience shows that the child's brain is not mature enough to calmly handle frustration. In the current video, the parents' patience leads the children to be successful in their efforts to score a winning touchdown. The campaign is spread online using the hashtags #scienceofcare and #listenfirst, and is highlighted across various organizations including the Walther Center in Global Palliative Care & Supportive Care at Indiana University, Olympic Coach and Athlete networks, on Dr. Koonce's TV show and more. Dr. Koonce, formerly star linebacker for the Superbowl-winning Green Bay Packers and on their Board of Directors, grew up in poverty himself, and is now Senior Vice President for University Relations at Marian University.
"Parents more than ever need proven strategies, based on science," says Giovanna Campello, Chief UNODC Prevention, Treatment & Rehabilitation Section, "to support how they raise their children. As people are forced to work from home, and as Covid-19 contributes to increased stress, more than ever we need to focus on the needs of the children. The buy-in already from governments around the world is extraordinary, ranging from Indonesia to Slovenia, Russia, and France."
The materials, including scientific resources, are all available at:
http://www.unodc.org/listenfirst
The new video on Patience can be seen here:
https://www.unodc.org/unodc/en/listen-first/success-stories/touch-down-for-humanity
It can be downloaded here:

Social Media
Twitter
UNODC_PTRS
Facebook
@UNODCYouthInitiative
@EthanFilms
For interviews with UNODC or the Touchdown for Humanity Team, please contact: miles@ethanfilms.com Phone:+34 632 739 699



START your own Wordpress site, business or personal website, or online store at www.siteground.com

This information is from the Relapsing Polychondritis Foundation Inc. with Race for RP and is not sponsored by, nor a part of, the American College of Rheumatology.

NEW YORK (PRWEB) DECEMBER 08, 2020
The American College of Rheumatology (ACR) held its annual meeting, ACR Convergence 2020, on November 5-9th. The all-virtual meeting included clinical and basic science symposia, notable speakers such as Dr. Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases, a virtual exhibit hall, and patient perspective posters and presentations authored by individuals with rheumatic disease.
This year's annual meeting also featured five relapsing polychondritis patient poster submissions that were selected for presentation. Four of the posters were sponsored by the Relapsing Polychondritis Foundation and one poster was sponsored by the Canadian Society for Relapsing Polychondritis.
"Poster presentations like these are an important part of our efforts," said David Bammert, President of the RP Foundation. "They provide the opportunity for the medical community to better understand the patient's perspective regarding living with RP and facilitate pathways for more efficient patient care."
Nancy Linn presented her poster, Connecting Rheumatology Professionals & Thought Leaders Inspired the Creation of a New Program Focused on Relapsing Polychondritis, a Rare Rheumatic Disease, outlining the ideation and establishment of the Penn RP Fund, a research initiative and partnership between the University of Pennsylvania RP Program and the National Institutes of Health (NIH) sponsored Vasculitis Clinical Research Consortium (VCRC) made possible by relationships fostered at previous ACR meetings and other similar gatherings of clinicians, researchers, patients, and advocates.
Isabel Bautista's poster, Patients With Relapsing Polychondritis and an Advocate Manufactured Custom Cloth Masks to Combat COVID-19: This Mask Project Provided a Sense of Purpose, Created Unity, Increased Awareness of RP, Facilitated Research, and Generated Hope, detailed the story of her team of RP patients who helped patients across the globe by making and distributing free masks and ear savers to protect them from COVID-19 during the pandemic. Ms. Bautisa was one of only four patients selected to present her poster to ACR attendees.
With Coping Through Advocacy – My Story Living With Relapsing Polychondritis, Allegonda Imeson shared her story about founding the Canadian Society for Relapsing Polychondritis as a means of spreading awareness about the disease and supporting patients, including herself.
Tedi LaMere's presentation of My Multidisciplinary Healthcare Team and Patient Advocacy Groups Saved My Life followed her RP story from onset to diagnosis and treatment and revealed how through the help of Friends of Patients, NIH specialists were able to identify and address several life-threatening conditions she faced.
Dan Smith's poster, Only in My Dreams Can I Do the Things I Used To Do: Where There is Research There is Hope, illustrated the positive impacts of finding a support group and new creative pursuits to promote well-being.
While each poster highlights different aspects of patient engagement, intervention, and self-management of this rare disease, an overarching theme of collaboration and partnership emerged. As they worked hard to find purpose and find ways to cope with their illness, the patient-presenters sought out community and support and became relapsing polychondritis and autoimmune disease advocates actively engaged in helping other patients, promoting increased awareness, and pushing for greater research – each in their own way – resulting in improved quality of life for many.
"We were honored to have so many RP patients represented and encouraged by the progress of the research, which was presented to 16,000 attendees. ACR did an outstanding job facilitating this exciting and informative forum," said David DeRosa, Secretary / Treasurer of the RP Foundation.
Additional information regarding ACR Convergence 2020 Patient Perspective Poster Educational Sessions and Oral Abstracts can be found here.
About Relapsing Polychondritis
Relapsing polychondritis (RP) is a debilitating and sometimes fatal systemic inflammatory disease that is characterized by recurrent inflammation of cartilage and other tissues throughout the body. The disease affects multiple organs, particularly cartilaginous structures such as the ears, nose, airways and joints as well as eyes, skin, heart valves and brain. The cause of RP is unknown and there is no cure for RP. For more information, visit https://bit.ly/RP_Poster.
About Relapsing Polychondritis Foundation
The RP Foundation's purpose is to facilitate education, awareness and research initiatives that improve the quality of life for patients with RP. For more information, visit https://www.polychondritis.org.
About Race for RP
Race for RP supports research and awareness programs for relapsing polychondritis and related diseases. For more information, visit http://www.RaceforRP.org or http://www.facebook.com/raceforrp. Follow Race for RP on Instagram and Twitter, @RaceforRP.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

COVID, injectable drug growth drives demand for -25◦C and -70◦C containment.

INDIANAPOLIS (PRWEB) DECEMBER 08, 2020
In response to ever-evolving demand for FDA-regulated, temperature-controlled storage and distribution of pharmaceutical and medical devices, Life Science Logistics (LSL), a leading, national provider of healthcare supply chain solutions, today announced the company plans to add ultra-low frozen storage to its extensive mix of life science product-related storage by the end of December 2020.
Driven by increasing demand for COVID-related and injectable drugs with "live" particulates requiring extreme freezes to preserve vaccine integrity, the company plans to add a significant number of -70-degree Celsius, ultra-low frozen storage ThermoFisher Scientific freezers and -25-degree Celsius ThermoFisher Scientific freezers to its 526,200 sq.ft. Brownsburg facility.
"By offering yet another temperature range service offering that is in high demand, we're showing our current and future clients that Life Science Logistics is committed to being a one-stop shop for healthcare storage and distribution," says LSL CEO Richard Beeny. "More than ever, the healthcare industry needs us to be nimble, creative and responsive as they explore new injectible trials and solutions for large-scale diseases."
According to Beeny, the company had lots of requests pre- and during COVID for ultra-low frozen storage due to significant growth in injectible drugs for myriad diseases. He added that due to the sensitive nature of so many drugs, proper vaccine storage and handling is critical for efficacy of the products.
The company has two existing FDA-regulated storage and distribution facilities – a 526,200 sq. ft. Brownsburg facility and a 280,000 sq.ft. Whitestown facility. An additional Whitestown-based, 200,000 sq.ft. mixed-use storage facility, including cold-chain and controlled room temperature capabilities, is slated to open in early 2021.
About Life Science Logistics
Founded in 2006, DFW-based Life Science Logistics (LSL) is a leading, national provider of end-to-end, high-quality, customizable healthcare supply chain solutions. For clients ranging from Fortune 500 companies to startups, LSL offers its pharmaceutical, medical device, and biotech clients the ability to outsource services ranging from distribution to kitting to back- and middle-office functions. FDA-registered and VAWD-accredited, LSL operates from six locations totaling more than 2 million square feet of cGMP compliant space.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Batson to Lend Deep Experience in CFO and Senior Business Leadership Roles to Help GHX Continue to Reduce Costs in Healthcare

LOUISVILLE, COLO. (PRWEB) DECEMBER 08, 2020
Global Healthcare Exchange (GHX) today announced the promotion of Chris Batson to Chief Financial Officer, effective January 1, 2021. Batson, who has served since 2019 as GHX's vice president, Finance and Accounting, will succeed Rob Gillespie in the role of CFO. Gillespie will continue with the company until the summer of 2021 to ensure a seamless transition. Batson will report directly to CEO Bruce Johnson.
"Rob's impact at GHX the past thirteen years cannot be overstated," said Johnson. "I'm grateful for the care he's put into developing a solid transition plan and his ongoing partnership. Rob has helped our company evolve alongside the industry and create considerable value for our customers and equity holders. On behalf of our Board and everyone at GHX, I'd like to thank Rob and wish him continued success."
Batson brings extensive experience in general management, business strategy, mergers and acquisitions, capital structure management and private and public company management. In his earlier role at GHX, Batson was responsible for the company's Financial Planning & Analysis, Treasury, Tax, Audit, Financial Reporting and Controllership functions.
"Since Chris joined GHX more than a year ago, I've been impressed by his curiosity, work ethic, passion for our customers and colleagues and skill in solving complex challenges," added Johnson. "Having previously served in senior business and CFO roles, Chris brings a well-rounded perspective of GHX's financial needs as well as P&L leadership. I'm confident Chris will help us continue to navigate the ripple effects of COVID-19 and deliver on our mission to enable better patient care and help the healthcare community save more than a billion dollars each year."
"As value-based care becomes the norm and we move toward the creation of more resilient, clinically integrated supply chains, GHX is perfectly poised to support the industry's transformation," said Batson. "I'm excited to solidify our long-term vision during an important industry evolution."
Prior to joining GHX, Batson served as president for ACS Group, a privately held $600 million information technology consulting and staffing company. He also served as senior vice president and general manager, and earlier as CFO, at Ciber Inc., a global information technology consulting, services and outsourcing company. Batson has also served in senior business and finance roles at organizations including TeleTech Holdings and NCR Corporation. Batson has a BS in Industrial Engineering from the University of Tennessee and an MBA from Indiana University's Kelley School of Business.
About GHX
Building on decades of collaboration between providers, manufacturers, distributors and other industry stakeholders, Global Healthcare Exchange, LLC (GHX) is leading the charge in helping organizations run the new business of healthcare. By automating key business processes and translating evidence-based analytics and data into meaningful action, GHX is helping the healthcare ecosystem to move faster, operate more intelligently and achieve greater outcomes. With the support of GHX, healthcare organizations have removed billions of dollars of wasteful healthcare spend. For more information on GHX's suite of world-class, cloud-based supply chain and pharmacy solutions, visit http://www.ghx.com and The Healthcare Hub. GHX has also launched a COVID-19 Information Center that provides a wealth of free resources and access to data and information needed to help serve patients and protect staff during the pandemic



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Proper vaccine handling and storing practices will play a vital role in the distribution of COVID-19 vaccines. The Sentinel monitoring system from Sensaphone can help health care professionals maintain strict ultra-cold storage temperature requirements. When paired with Sensaphone's Ultra Low Temperature Sensor, the Sentinel system can monitor temperatures as low as -85 °C / -109 °F. The system is ideal for hospitals, labs, pharmacies and clinics as they prepare to provide millions of vaccine doses.

ASTON, PA. (PRWEB) DECEMBER 07, 2020
Proper vaccine handling and storing practices will play a vital role in the distribution of COVID-19 vaccines. The Sentinel monitoring system from Sensaphone can help health care professionals maintain strict ultra-cold storage temperature requirements. When paired with Sensaphone's Ultra Low Temperature Sensor, the Sentinel system can monitor temperatures as low as -85 °C / -109 °F. The system is ideal for hospitals, labs, pharmacies and clinics as they prepare to provide millions of vaccine doses.
The Sentinel system delivers 24/7 remote monitoring of temperatures inside medical refrigerators and freezers from -85 °C to 76 °C (-109 °F to 168 °F). When the system detects the temperature has moved out of the desired range, it sends an alert via phone call, text or email to the designated contacts.
In addition to temperature monitoring, each unit can monitor up to 12 different environmental and equipment status conditions. Users can also monitor the freezer's alarm panel for power outages.
The Sentinel system's enhanced data logging capabilities allow users to print, graph or export reports via email, providing an audit trail of all user data activities. This function helps personnel maintain operational efficiency, uphold quality assurance and meet regulatory compliance.
The Sentinel system constantly communicates a signal to the Sensaphone cloud to validate its online status. If the communication link is interrupted—for example by a power outage or someone accidentally switching off the unit—the system generates an alert indicating that internet connection is lost. Users are notified about the disruption through phone, text or email.
The user-friendly system lets users change settings, disable alarms and readjust temperature limits from the Sensaphone iPhone/Android app or sensaphone.net.
For more details, visit Sensaphone's medical cold storage monitoring page: https://www.sensaphone.com/industries/medical-cold-storage.
About Sensaphone
Sensaphone offers a comprehensive line of remote monitoring products that safeguard valuable assets by tracking critical equipment and environmental data such as temperature, humidity and power failures. Sensaphone products provide alerts and proactive monitoring data to homeowners and facility managers in many areas including telecommunications, oil and gas, water and wastewater, HVACR, agriculture, healthcare, data centers and greenhouses. Nearly 500,000 Sensaphone systems are in use today around the world, and they continue to be manufactured in the USA. For more information, call 877-373-2700, email contact@sensaphone.com or visit https://www.sensaphone.com/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The International Association of Eating Disorders Professionals Foundation (iaedp) has announced the opening of early registration for the upcoming 2021 iaedp Symposium, available to February 12, 2021. Given the coronavirus environment, the 2021 iaedp Symposium will be provided to participants in a virtual format. Early registration offers $50 off full price to February 12, 2021.

PEKIN, ILL. (PRWEB) DECEMBER 07, 2020
The International Association of Eating Disorders Professionals Foundation (iaedp) has announced the opening of early registration for the upcoming 2021 iaedp Symposium, available to February 12, 2021. Given the coronavirus environment, the 2021 iaedp Symposium will be provided to participants in a virtual format. Early registration offers $50 off full price to February 12, 2021.
The theme, "As the World Turns: Unforeseen Challenges and Dynamic Solutions," sets the tone as a central focus for the more than 60 presentations and workshops, world-renowned keynote speakers, special networking events from all parts of the globe – all available to registered participants 24/7 from March 18, 2021 to September 1, 2021.
Established in 1985, iaedp (http://www.iaedp.com) provides educational programs in multiple languages and training standards for eating disorder specialists and other medical professionals caring for those suffering from the full spectrum of disordered eating.
"Each year, our mission at iaedp is to bring together the leading authorities in research and treatment of eating disorders and co-occurring addictions. Even with the challenges of Covid, this mission continues," said Bonnie Harken, Managing Director at the iaedp Foundation. "We identify those truly outstanding in our field – those professionals who have accomplished innovative treatment work and research -- to help all of us in the treatment of eating disorders do the best job possible to fight for those who suffer from addictive diseases."    
The 2021 iaedp Symposium in a virtual format offers training sessions and instructive presentations with experts from various disciplines in the field of eating disorders. Over the next several months, speakers, activities, workshops and other presentations as well as special offerings for participants will be announced for the upcoming 2021 iaedp Symposium.
About the iaedp Foundation: Since 1985, the International Association of Eating Disorders Professionals has provided education and training standards to an international and multidisciplinary group of various healthcare treatment providers and helping professions. MemberSHARE.iaedp.com is an iaedp business journal and online member resource to learn about noteworthy member achievements, continuing education webinars and U.S. and international chapter activity and events; for more information, visit MemberSHARE.
The Presidents Council provides iaedp support and includes: Center for Change; Center for Discovery; Eating Recovery Center; Willow Place; Laureate Eating Disorders Program; The Meadows Ranch; Rogers Behavioral Health; Rosewood Centers for Eating Disorders; Selah House; The Renfrew Center; Timberline Knolls; Veritas Collaborative; Alsana Eating Disorder Treatment & Recovery Centers; Walden Behavioral Care, KIPU and SunCloud Health.

"Each year, our mission at iaedp is to bring together the leading authorities in research and treatment of eating disorders and co-occurring addictions. Even with the challenges of Covid, this mission continues," said Bonnie Harken, Managing Director at the iaedp Foundation.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Versilk allows dairy and plant-based dairy alternative manufacturers to achieve high protein products with a clean taste, desirable texture and no off-flavors

WILMINGTON, DEL. (PRWEB) DECEMBER 07, 2020
DuPont Nutrition & Biosciences (DuPont) today announced the North American launch of Versilk, the latest in its range of enzymes to help yogurt and beverage manufacturers achieve optimal texture and taste in yogurts, drinkable dairy products and other drinkable fermented products. Manufacturers can achieve their label-friendly goals with this native enzyme, an easy-to-use processing aid.
Dairy and beverage makers have long struggled with formulation of high protein yogurts. Fortifying dairy or plant-based yogurt to reach higher protein content can result in increased thickness and bitter notes in the final product.
This innovation is a viscosity-modulating enzyme for high protein applications, giving manufacturers a new way to deliver the desired viscosity, mouthfeel and taste profile that meets consumers' needs for an indulgent product with health benefits. It allows manufacturers of dairy and plant-based yogurts to achieve up to 14 percent protein in the final product - a 30 percent increase over what is common today.
Versilk is also simple to implement into an established yogurt production, it is added with the cultures and can help deliver potential improvement to both flavor and fermentation time, depending on the protein base. It is versatile across many types of products.
"Versilk is the latest in our suite of solutions comprising enzymes, cultures, proteins and functional solutions. Together with our leading industry expertise, we can help manufacturers respond to market trends and deliver healthy and indulgent yogurt products to meet consumer demand," said Clementina Dellomonaco, global product manager, Dairy Enzymes, DuPont Nutrition & Biosciences.
Versilk is part of the DuPont Danisco range of enzymes with a wide variety of producer and consumer benefits.
To learn more about Versilk and other DuPont dairy enzyme offerings, visit https://www.dupontnutritionandbiosciences.com/product-range/food-enzymes/dairy-enzymes.html.
About DuPont Danisco
DuPont Danisco is the brand for a range of ingredients that help provide enhanced bioprotection, an improved nutritional profile, and better taste and texture with greater cost efficiency and lower environmental impact, meeting the needs of manufacturers of food and beverages, dietary supplements and pet food. Through the work of the global network of food scientists and technologists in DuPont, the Danisco range is supported by a uniquely broad spectrum of know-how across applications and processing. http://www.danisco.com.
About DuPont Nutrition & Biosciences
DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: http://www.dupontnutritionandbiosciences.com.
About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food, and worker safety. More information can be found at http://www.dupont.com/. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.
# # #
12/07/2020
DuPont, the DuPont Oval Logo, and all trademarks and service marks denoted with , SM or are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

NJ Top Docs has reviewed and approved The Plastic Surgery Center for 2020. The practice's highly trained physicians continue to stand out with their vast knowledge of cutting-edge surgical techniques and advanced technology.

SCOTCH PLAINS, N.J. (PRWEB) DECEMBER 07, 2020
With a staff of more than 150 and offices across New Jersey, New York and the greater Philadelphia area, the physicians at the award-winning Plastic Surgery Center help patients improve how they look and feel.
The Plastic Surgery Center's philosophy is to provide exceptional services to patients throughout their care. From the moment they schedule their first appointments to post-operation, the doctors are with them every step of the way.
"Our practice stands out because of our distinguished surgeons; who have many years of experience and a vast knowledge of cutting-edge surgical techniques and advanced technology," say the doctors. "Our surgeons often collaborate in research aimed at improving surgical methods to provide the best possible care and results."
In addition to improving surgical methods and techniques, the doctors strive to improve their own skillsets by attending various conferences and trainings. They learn from other industry experts while researching new tools and techniques to implement in their daily practice.
As a result of the COVID-19 pandemic, the doctors have increased safety measures at all locations and implemented strict sanitation protocols, pre-screenings and temperature checks. The Plastic Surgery Center also now offers telemedicine appointments.
To learn more about this NJ Top Docs practice, please visit: https://njtopdocs.com/nj-doctors/theplasticsurgerycentermonmouthcounty/
----
About Us
NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.
NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.
For more information, please click here to contact us or visit http://www.njtopdocs.com.
You can also follow us on Facebook, Twitter, & Instagram



START your own Wordpress site, business or personal website, or online store at www.siteground.com

SLCC has benefitted immeasurably from long history of support for the college from donors Tim and Brenda Huval.

SALT LAKE CITY (PRWEB) DECEMBER 07, 2020
Salt Lake Community College is pleased to announce it has named the new Jordan Student Center for long-time SLCC supporters Tim and Brenda Huval. Tim is an SLCC alumnus and former employee at the college. He and Brenda have both committed much time and financial support toward the success of SLCC students.
Currently under construction at the Jordan campus and set to open in January 2021, the Tim and Brenda Huval Student Center will serve as a dynamic hub for students, supporting their success through student engagement opportunities, academic and career advising, financial aid, childcare and a health and counseling center. The Huvals' gift to SLCC will go directly to student scholarships, with particular emphasis on students in health sciences programs.
"Brenda and I are incredibly honored to be a part of this opportunity to help so many students pursue their hopes and dreams," said Tim Huval. "Over the years, we've been fortunate to be given chances that helped us personally and professionally, like the chance SLCC gave me to get the education and confidence needed to get started. In turn, we are passionate about giving back and providing opportunities for others to take the next steps in fulfilling their goals."
Tim and Brenda Huval have a long relationship with SLCC. Tim graduated from the college in 1989 with an associate's degree in business management. He also received an honorary doctorate from SLCC in 2007. Tim is currently the Chief Administrative Officer of Humana, Inc., and he is slated to offer the college's 2021 Commencement keynote address. Over the years, the Huvals have contributed to the college's student scholarship programs, and the South City childcare center carries their name.
"We are honored that the Huvals, our amazing friends, have opted to again support our students," said SLCC President Deneece G. Huftalin. "They have been remarkably generous partners for many years and have personally experienced the transformative power of education. I am so proud that SLCC has been a part of their journey and that together we can continue to impact students' lives. My gratitude for their collaboration, generosity and kindness is immeasurable."
Salt Lake Community College is Utah's largest open-access college, proudly educating the state's most diverse student body in 8 areas of study at 12 locations and online. The majority of SLCC graduates transfer to four-year institutions, and thousands more are trained in direct-to-workforce programs. In 2023, the institution will celebrate 75 years of providing Utahns with education and training in fields that contribute to the state's vibrant economy and high quality of life.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

GuideWell Connect, a provider of health insurance business sales systems, today announced the successful completion of their 2020 System and Organizational Controls (SOC) 2 Type 2 examination. With long-standing experience in the health insurance industry, the company has completed annual SOC examinations for five consecutive years, reflecting a long-standing commitment to secure internal controls.

BRENTWOOD, TENN, (PRWEB) DECEMBER 07, 2020
GuideWell Connect, a provider of health insurance business sales systems, today announced the successful completion of their 2020 System and Organizational Controls (SOC) 2 Type 2 examination. With long-standing experience in the health insurance industry, the company has completed annual SOC examinations for five consecutive years, reflecting a long-standing commitment to secure internal controls.
GuideWell Connect chooses to invest in their SOC 2 program because they take the security and privacy of their clients and customer data seriously. Continuous auditing and validation of their processes and procedures through SOC 2, supports the needs of their current and potential clients expectation of data security and protections.
GuideWell Connect was audited against the AICPA Trust Services Criteria for Security, Availability, Confidentiality and Privacy. The SOC 2 Type 2 examination provided assurance regarding the effectiveness of the company's controls over a period of time.
The effort was completed by the professional and independent third-party audit firm, 360 Advanced, Inc.
"We place great value on serving our customers;" says Dr. LuAna Boykins, COO at GuideWell Connect. An essential part of that service is our continual focus on maintaining high levels of security, privacy, confidentiality and availability for our clients' data. Securing our SOC 2 Type 2 Certification once again demonstrates that commitment to our clients."
About GuideWell Connect
A wholly owned subsidiary of the GuideWell Mutual Holding Corporation ("GuideWell"), GuideWell Connect is a leader in integrated consumer engagement solutions that helps health plans attract, engage and retain members. GuideWell Connect provides technology-enabled services across the member lifecycle to advance health plans' financial performance, grow membership, and drive better health outcomes for members. GuideWell Connect is the consumer engagement business of GuideWell Mutual Holding Corporation. Learn more at http://www.guidewellconnect.com.
For GuideWell Connect inquiries, please contact:
Meg Cook
Sr. Director of Marketing
megan_cook@onlifehealth.com
About 360 Advanced
360 Advanced is "Making Better Businesses" through their Cybersecurity and Compliance offerings. Services provided include SOC 1, SOC 2, SOC 3, SOC for Cybersecurity, SOC for Supply Chain, CSA STAR, HIPAA/HITECH, ISO 27001 and 27701, PCI-DSS, HITRUST CSF, Microsoft SSPA Attestation, Penetration Testing, GDPR, CCPA, PIPEDA, GLBA, FFIEC, MARS-E and more. In certain states, 360 Advanced may operate under the name of Hiestand, Brand, Loughran, P.A. to meet State Board requirements for CPA firms. To learn more about 360 Advanced, visit http://www.360advanced.com.
For more information on compliance solutions, contact Jim Brennan at jbrennan@360advanced.com.
Media Contact:
Eric Seward
eseward@360advanced.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The guide takes a look at the benefits of proper posture, what exercises will help to reinforce your posture, and more.

BOLINGBROOK, ILL. (PRWEB) DECEMBER 07, 2020
ScripHessco has announced the release of their most recent infographic: A Guide to Having Proper Posture. The infographic breaks down proper posture, exercises and tools that can help improve posture.
According to ScripHessco, "Your posture doesn't have to be completely terrible for it to affect your back either; even leaning forward in your office chair at an angle of 30 degrees can cause 3 to 4 times more stress on your back."
The infographic provides imagery for improper and proper posture. The infographic concludes with signs to watch out for when evaluating posture, and the many benefits associated with proper posture.
To learn more about posture, view the infographic here.
About ScripHessco:
For over four decades we have been a trusted resource to health care practitioners. Throughout the years our company has evolved considerably, but our mission has remained simple. We treat our customers like family, offering them the largest selection of equipment and supplies at the best value possible. Our commitment to this mission has driven us to carry an expansive line featuring over 10,000 products and made us the largest distributor of reconditioned adjusting tables in the world



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The guide takes a look at how our bodies interpret their own genetic code, as well as how scientists can determine or uncover information on a person with this genetic information.

SPRINGFIELD, MO. (PRWEB) DECEMBER 07, 2020
Dynamic DNA Laboratories has announced the release of their newest article: How Does Gene Expression Affect You?
According to Dynamic DNA Laboratories, "Gene expression is the process the cell uses to produce the molecule it needs by reading the genetic code written in the DNA," explains Fabio Candotti, M.D. "The cell acts like a language interpreter by translating genetic code."
The article provides thorough information on Gene Expression so that readers can make an informed decision when taking an at home DNA ancestry test.
Sourced from multiple educational sources such as MIT Technology Review and National Human Genome Research Institute, the article highlights the importance of DNA research.
To learn more about Gene Expression, visit Dynamic DNA Laboratories here.
About Dynamic DNA:
Dynamic DNA Labs is a state-of-the-art genetics lab that specializes in advanced DNA testing. By offering a range of services, including: Family and ancestry testing, Proactive health panels and Personalized medicine reporting, Dynamic DNA Laboratories strives to help their customers better understand themselves and ultimately lead them to healthier and happier lifestyles.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

MedShift Connect celebrates key milestones with new partnerships, tripled revenue, and staff expansion

CHARLOTTE, N.C. (PRWEB) DECEMBER 07, 2020
MedShift Connect, a communications and marketing agency founded in 2018, announced today pivotal growth statistics, highlighted by client wins, staff expansion and increased revenue. Based in Charlotte, North Carolina, MedShift Connect has shown exceptional growth throughout 2020. In the past two years alone, the agency has worked with an ever-growing, diverse clientele list and offered valuable insight for those looking to elevate their brand. With partnerships in North America, Asia, and Australia in a diverse range of business verticals, MedShift Connect has utilized its comprehensive service offerings to maintain a global presence.
Social media management is one of the many comprehensive services offered by MedShift Connect and over the past few years, the agency has seen a major increase in client demand. In early January, the agency partnered with Y LIFT, a New York City-based brand providing the latest cutting edge aesthetic technologies through providers across the United States. The goal of this partnership was to facilitate the brand's internal social media channels and increase awareness surrounding the practices non-surgical face lifting procedure. Since the initial start date of January 1, YLIFT has seen a significant increase in Instagram following and doubled their reach in comparison to the previous year.
Apyx Medical, an innovative, advanced medical device manufacturer and supplier in the aesthetics field, was another valuable win for MedShift Connect. Founded in Clearwater, FL and formerly known as Bovie Medical, Apyx wanted to increase awareness surrounding their Renuvion device following a strategic rebrand. MedShift Connect developed a plan for brand recognition and implemented social media monitoring, a strategy designed to analyze accounts on various social channels for brand misrepresentation and messaging. In April 2020, MedShift Connect officially took over Renuvion's Instagram account and in the past year has seen a notable increase in key metric areas.
Earlier this year, MedShift Connect partnered with leading global aesthetics company, Merz Aesthetics, to lead an influencer campaign for their Cellfina device. The campaign was designed to educate patients about cellulite and the treatment options they had with Cellfina, as well as promote "The Dimple Truth." Eight Instagram influencers participated in the campaign and as a result, drove impressive metrics for combined impressions, reach, and link clicks. Additionally, MedShift Connect's paid search and social strategy increased overall reach, elevating Cellfina's brand and strengthening their digital footprint.
Lumiton, a solar powered infrared technology company based out of Charlotte, NC, also found value in MedShift Connect's offerings and recently concluded their "Wear Healthy" digital influencer campaign. Under the management of MedShift Connect, Lumiton's Instagram account experienced a substantial increase in following and overall reach. The campaign proved to be successful, resulting in a surge in mask sales and amplified brand awareness.
"We're extremely happy with the progress MedShift Connect has made since founding in 2018. Each client lends new opportunities for the team and our rapid growth affirms the value our agency provides. We look forward to continuing this momentum going into the new year and plan to expand into advantageous markets as new partnerships transpire," said Vice President Communications and Marketing, Victoria Olszowy.
Additionally, MedShift Connect has seen strong adoption of other services such as media relations, custom content creation, reputation management, crisis communications strategies and brand development. Recent partner, K&B Management, has found great value in these offerings and plans to further enhance its brand through utilizing the agency's media relations and digital production services. The Charlotte-based plastic surgeons are notable additions to MedShift Connect's unique clientele list and lend credibility to the agency's expertise within the medical aesthetics field.
As MedShift Connect continues to build upon past achievements and future opportunities, the agency has also seen great success with staff expansion, over 60% growth since its founding in 2018. The agency's team of highly experienced individuals offers unique skill sets in traditional and digital marketing, public relations and media relations efforts. With MedShift Connect, clients can expect to observe meaningful and measurable results throughout the duration of their partnership.
About MedShift
MedShift, founded in 2015 in Charlotte, NC, delivers a platform as a service to both medical device manufacturers as well as individual medical practices. Foundationally, MedShift enables access to the latest devices and technology to remain competitive and attract new business. MedShift has partnered with over 330 doctors in North America, Australia, and New Zealand to give practices the latest in cutting-edge treatment modalities, services, and systems.
MedShift is disrupting the traditional aesthetic device market by offering permanent placement, holistic subscription services for surgeons, physicians, and their business. MedShift's broad portfolio of services for practices includes a portfolio of 25 leading aesthetic medical devices from nine manufacturers, an aesthetic eCommerce and subscription platform, in-house communications and marketing services, and inbound lead generation. For manufacturers, MedShift delivers a highly secure IoT platform consisting of both hardware and software assets allowing for real-time visibility, remote management, and big data modeling of entire medical device lineups. MedShift adds value across the manufacturer and provider spectrum and continues to empower robust integration with the leading brands and doctors in the industry. Additionally, in its first year of eligibility, MedShift ranked 185 on the 2020 Inc. 5000 list, leading as the 15th fastest growing health company in the United States.

"We look forward to continuing this momentum going into the new year and plan to expand into advantageous markets as new partnerships transpire," said Vice President Communications and Marketing, Victoria Olszowy.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

As FSA users race to spend remaining funds before the December 31 use-it-or-lose-it deadline, FSAstore.com offers shopping inspiration with its list of best-sellers for 2020

NEW YORK (PRWEB) DECEMBER 07, 2020
For over a decade, FSAstore.com has helped flexible spending account (FSA) users find responsible ways to spend their FSA dollars to manage everyday health conditions or respond to whatever life throws their way. Today, the company released its annual list of top products, based on website traffic and online sales in an effort to help account holders benefit from remaining FSA funds before the December 31, use-it-or-lose-it deadline.
"The fact that 2020 has been anything but a typical year can be seen in how consumers are spending their FSA funds," said Preston Farrington, CEO of Health-E Commerce, the parent brand of FSAstore.com. "With access to clinical services and elective procedures limited, customers tell us they have more money left to spend than in previous years, and they are spending it in different ways, including the consumer products offered on our site."
In fact, according to FSAstore.com customer surveys, more than 50% of FSA users have more money to spend this December than they did in 2019. This is due largely to limitations on scheduling doctor appointments or elective procedures, which are big ticket items for yearly health spending. For many account holders, the health benefits plan year ends on December 31; however, consumers should check with their employer or benefits administrator to confirm deadlines.
To extend a helping hand and provide much needed shopping inspiration to FSA users, FSAstore.com has released its annual list of the Top 10 most popular FSA eligible products, which includes:
1. MyLab Box At-Home COVID-19 Detection Test
The MyLab Box At-Home COVID-19 Detection Test uses saliva sampling for a quick, non-invasive testing method and a prepaid shipping box that will send results to a lab for results. If a test comes back positive, users can plan next steps with a free physician consultation.
2. Sejoy Infrared Forehead Thermometer
The COVID-19 health crisis has only further increased the importance of home health, diagnostics and home health care. Many American families are choosing to upgrade their at-home health monitoring devices, such as thermometers. One of the top sellers in this category is the Sejoy Thermometer, which uses infrared technology to deliver quick, touchless readings in 3 seconds, as well as memory storage to capture the past 10 readings.
3. Welly Bandages
Replenishing first-aid supplies is a smart tactic for FSA deadline shoppers, and when it comes to bandages, Welly is a great choice. Welly premium bandages come in a variety of fun and engaging colors and styles to help turn boo-boos into badges of bravery.
4. Supergoop! Unseen Sunscreen
Sick of sunscreen that leaves blotchy marks behind? Go with a weightless, scentless sun protection that goes on clear with Supergoop! Unseen Sunscreen. With broad spectrum protection and active ingredients that even protect against blue light from smartphones and other devices, shoppers appreciate the full spectrum approach to this sunscreen.
5. Caring Mill Pulse Oximeter
Alongside thermometers, oximeters were among the most popular hi-tech health devices of 2020. These devices clip onto a finger and measure the oxygen levels in the user's blood to help identify a key vital sign that could be the sign of an underlying health condition. FSAstore.com shoppers can now purchase an oximeter from our private label line of healthcare products, Caring Mill. Each sale of a Caring Mill product supports the nonprofit Children's Health Fund, which is committed to providing healthcare to underserved youth populations throughout the United States.
6. Tylenol Extra Strength Caplets
An over-the-counter (OTC) pain reliever may not seem too exciting, but it's actually a pivotal part of a larger story. OTC medicines became fully eligible in 2020, thanks to the passage of the CARES Act, so everything from pain relievers to allergy medicine to acne treatments can now be purchased with FSA funds, without requiring a prescription. Tylenol is a welcoming addition to FSA users' medicine cabinets due to its ability to tackle aches and pains and help reduce fevers.
7. Bug Bite Thing
The Bug Bite Thing has been one of the most popular anti-itch treatments of 2020. The Bug Bite Thing is a drug-free approach that utilizes suction to remove insect venom and stingers to help alleviate itchiness and pain from insect bites.
8. Gold Bond Ultimate Skin Healing Lotion
With OTC medicines now being fully FSA eligible, many products that treat skin conditions are also available. One of the runaway successes of 2020 was Gold Bond Ultimate Skin Healing Lotion, which has been supremely popular with FSAstore.com shoppers. From dry skin conditions to psoriasis to eczema, this lotion is a smart buy that can provide soothing relief.
9. Rael Heating Patch
In addition to OTC medicines, menstrual care products like tampons, pads, period underwear, menstrual cups, and more are now FSA eligible. One OTC item that's also a menstrual care product and a top seller is the Rael Heating Patch, which uses natural, herbal therapy in an instant patch that warms up as soon as it's applied to the abdomen. This promotes increased blood flow and helps muscles relax to alleviate pain.
10. dpl IIa Professional Acne Treatment Light Therapy
As OTC acne treatments have gained interest among consumers, light therapy also continues to be a popular drug-free treatment method for acne among FSA users. The dpl IIa Professional Acne Treatment Light Therapy provides medical-grade infrared (IR) therapy with the largest possible treatment area of any light therapy product available at FSAstore.com. Utilizing powerful IR lights, this device eliminates bacteria on the skin to help reduce breakouts.
There are thousands of ways to spend down FSA funds before the December 31 deadline, so make a plan, visit FSAstore.com, and start early to avoid forfeiting those hard-earned healthcare dollars.
About Health-E Commerce
Health-E Commerce is the parent brand of FSAstore.com, HSAstore.com, and WellDeservedHealth.com, a family of brands serving the 70+ million consumers with tax-free health and wellness accounts. Since 2010, Health-E Commerce's brand portfolio has led the direct-to-consumer e-commerce market for tax-free health and wellness benefits and helped partners and everyday Americans benefit better through its 100% eligible product selection and easy-to-understand educational resources. Health-E Commerce plays an essential role in consumer advocacy in the tax-free health space through both advocating for eligibility of important new categories within the IRS-approved list of eligible medical expenses and leading a committee of industry experts to promote the important national conversation around product safety and authenticity.

With access to clinical services and elective procedures limited, customers tell us they have more money left to spend than in previous years, and they are spending it in different ways, including the consumer products offered on our site.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The latest innovation from Philips Water Solutions uses the power of light to keep your bottle clean, safe, and always ready to go

SUNNYVALE, CALIF. (PRWEB) DECEMBER 07, 2020
AquaShield, a global brand partner of health technology company Philips, is launching an innovative new self-cleaning water bottle that uses the power of UV-C LED light to both clean water and sanitize the bottle itself. The Philips GoZero Smart Bottle is the second entry under the new Philips GoZero label launched just this past October in North America.
Embodying GoZero's mission of helping consumers sustainably enjoy clean, refreshing drinking water on the go from both tap and natural sources, the GoZero Smart Bottle takes a high-tech approach that is unique from most filtered hydration products that leverage physical consumable filter media that need to be replaced regularly.
The GoZero Smart bottle features UV-C LED technology integrated into the cap of the bottle and activated at the touch of a button. Within minutes, the LED light eliminates up to 99.999% bacteria and 99.9% viruses from water, allowing users to enjoy fresh, clean water from virtually any source*.
Additionally, the bottle's UV-C LED light can also disinfect the bottle itself after use - whether you're drinking water, coffee, tea, juice, soda, or other beverages - cleaning the hardest-to-reach corners of the interior to eliminate foul odors, prevent bacterial build-up, and refresh the bottle for a refill.
"We're very excited about the GoZero Smart Bottle, as it gives people a convenient new way to enjoy clean, safe water on the go," said Alex Rishoj, CEO of Aquashield. "As the latest addition to our rapidly-growing lineup, the Smart Bottle is perfect for people who want to use a single bottle for all of their hydration needs throughout the day, whether they're drinking tea at home, coffee at work, or water while out on an adventure."
The GoZero Smart Bottle is designed to be intuitively easy to use. The bottle's high-tech cap features an LED light ring that indicates when the bottle is clean and ready to use. This indicator ring also displays the bottle's battery life. When it's time to charge, simply attach the included magnetic USB cable to the cap and use it for up to 30-days before having to plug it back in. Constructed of a double-walled, insulated food-grade stainless steel, the bottle is dishwasher safe and can keep liquids hot for 12 hours and cold for up to 24 hours.
The self-cleaning GoZero Smart Bottle will be available on Amazon starting November 30, 2020, and will come in two different sizes - 12 oz. and 20 oz. - and four designer colors - black, grey, yellow, and blue. The 12 oz. bottle will retail for $69.99, while the 20 oz. version will sell for $74.99. The GoZero Smart Bottle joins the brand's other product offering, the Philips GoZero Active Bottle, on Amazon. The GoZero Active Bottle features a unique interchangeable filtration system consisting of two complementary filters for different scenarios - one for reducing impurities from tap water and another for cleaning water from natural sources.
For more information visit: http://www.philips.com/water
About AquaShield
AquaShield Health Technology Company, a former Philips company, is the global exclusive brand licensee for Philips Water Solutions. AquaShield is focused on providing a complete water solution to consumers with their water purification, heating and smart-washing product portfolio. AquaShield believes there is always a way to make life better and is committed to improve the health and well-being of people's lives through meaningful innovation and responsible sustainability. AquaShield is active globally, with sales in more than 30 countries.
*https://cfpub.epa.gov/ncer_abstracts/index.cfm/fuseaction/display.highlight/abstract/1128/report/F

"We're very excited about the GoZero Smart Bottle, as it gives people a convenient new way to enjoy clean, safe water on the go," said Alex Rishoj, CEO of Aquashield.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Wellness Workdays' initiative recognizes outstanding achievements of organizations committed to creating best-in-class corporate wellness programs

HINGHAM, MASS. (PRWEB) DECEMBER 07, 2020
Wellness Workdays, a leader in corporate wellness programs, announces the 2021 Best Wellness Employer survey is open and employers can submit an application for the program's 2021 certification. Developed by Wellness Workdays in collaboration with experts from Harvard Medical School, the Best Wellness Employer initiative recognizes the significant accomplishments of employers dedicated to improving employee well-being. Researchers will utilize the reported data to help build knowledge and advance the field of worksite wellness with a focus on current practices and wellness outcomes. Responses from applicants are kept strictly confidential and anonymous with no identification of any employer.
"The certification recognizes the outstanding initiatives and achievements of organizations committed to developing best-in-class corporate wellness programs," said Debra Wein, founder and CEO of Wellness Workdays. "It was developed by industry experts to help employers gauge the overall assessment, strategy, implementation and evaluation of their wellness programs while contributing valuable data to employee wellness research."
The Best Wellness Employer certification provides an opportunity for organizations of all sizes to highlight the successes of their wellness programs. Experts from Wellness Workdays, Harvard Medical School and other leading organizations developed the rigorous evaluation standards used to create the eligibility requirements. All programs are eligible to earn one of three merit levels – gold, silver or bronze. In 2020, nineteen organizations achieved gold status, including Brown University, Cape Cod Healthcare, Maine Veterans' Homes, Maine State Department of Transportation, New Balance, Norway Savings Bank, Putnam Investments, Systems Engineering and Viessmann Manufacturing. To see the full list of certified companies, visit the Best Wellness Employer website.
Representatives from many of the gold certified organizations presented at Wellness Workdays' 7th Annual Emerging Trends in Wellness Conference, which was held virtually. Winners from all levels showcased their trophies onsite at their offices and featured the BWE logo on their website and careers page.
The survey for the 2021 certification can be completed on the Best Wellness Employer website. Surveys must be submitted by January 29 in order to be considered for one of the three merit categories and profiled at Wellness Workdays' 8th Annual Emerging Trends in Wellness Virtual Conference on April 8, 2021.
About Wellness Workdays
Wellness Workdays is a Massachusetts company with offices in New York, Florida and Texas that designs and delivers corporate wellness programs to promote employee health, productivity and a culture of well-being. Our subsidiary, OMC Wellness, based in Portland, Maine, provides population health management solutions utilizing onsite health coaching and proprietary technology to sustain measurable outcomes. A Certified Woman-Owned Business Enterprise, we have earned industry recognition and best practices awards for our clients, which include New Balance, EMD Millipore, Putnam Investments, Cape Cod Healthcare, Brown University, Maine Department of Transportation, Massachusetts Institute of Technology, Rockland Trust, Titan America, Norway Savings Bank and Harvard Business School. Visit us at http://www.wellnessworkdays.com or http://www.OMCWellness.com or follow us on Facebook, Twitter, LinkedIn, and Instagram.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The dualX device expands in both width and height providing a stable foundation for spinal fusion

LAGUNA HILLS, CALIF. (PRWEB) DECEMBER 08, 2020
Amplify Surgical, Inc., a medical device company focused on innovative dual-expanding technology for the lumbar spine, is excited to announce the launch of the dualX T/PLIF 12-Degree hyperlordotic interbody cages. Dr. Nima Salari, MD, FAAOS, from Scottsdale AZ, became the first spine surgeon to implant the new hyperlordotic dualX interbody cage, a TLIF spacer that provides additional lordosis. The minimally invasive procedure was recently performed at Honor Shea Health, one of Arizona's leading hospitals and healthcare networks.
The hyperlordotic implants developed for the TLIF procedure are the company's latest innovative advancement in an effort to improve sagittal plane correction. The implants developed for TLIF procedures offer a 12-degree hyperlordotic footprint in dualX T/PLIF implants and designed to improve sagittal balance restoration capabilities.
"Offering my patients the benefit of smaller incisions and less exposure to potential complications is why I specialize in minimally invasive surgery," said Dr. Nima Salari. "For this TLIF procedure, I needed to fuse L5/S1 posteriorly due to anterior vascular anomalies. The broad footprint and 12 degrees of lordosis provided a similar advantage to an ALIF through a posterior approach."
"The launch of dualX 12-Degree option demonstrates our commitment to improving patient outcomes by commercializing innovative solutions that accommodate the need for increased lumbar lordosis. We look forward to providing more implant options in the near future," said Andy Choi, CEO of Amplify Surgical.
About Amplify Surgical, Inc.
Amplify Surgical is a privately held spinal device company located in Laguna Hills, CA. The Company focuses on developing and commercializing innovative and minimally invasive technologies for spine surgery. Amplify Surgical is a portfolio company of IntuitiveX, a life science innovation incubator.
Contact:
Andy Choi, CEO
Amplify Surgical, Inc.
info@amplifysurgical.com
765-AMPLIFY



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Visikol, a leader in advanced imaging, 3D cell-culture and digital pathology, is now leveraging its multiplex imaging tools to further drug discovery studies. Using the company's proprietary multiplex imaging approach, Visikol will evaluate the ability of Tuberculosis treatments to reach the site of infection. This technology provides researchers with the ability to visualize many biomarkers within a single piece of tissue such that complex research questions can be addressed.

HAMPTON, N.J. (PRWEB) DECEMBER 08, 2020
Tuberculosis (TB) is still one of the top ten leading causes of death globally. Although TB is both preventable and curable, in the last year alone there were approximately 10 million worldwide cases, of which 1.4 million people died. Yet, in the United States and many developed countries the risk of TB exposure is low as 95% of cases are in developing countries. The World Health Organization noted that an estimated 60 million lives have been saved by preventative diagnosis and treatment. However, 6 months of daily treatment with multiple antibiotics are required to cure even the most common form of TB, and the COVID pandemic has a devastating predicted impact on TB burden and deaths worldwide, stressing the critical need for new safe and effective drug regimens.
Visikol and Hackensack Meridian Health (HMH) have partnered to evaluate TB antibiotics through a grant from the Bill & Melinda Gates Foundation. The project will analyze old and new drugs' ability to penetrate into granulomas – the primary site of TB infection in the lungs – and the multiple cell types involved in the interaction with the drugs. Current data from Dr. Véronique Dartois, an HMH researcher and the study's principal investigator, indicates that drugs differentially penetrate TB granulomas. Understanding the co-localization of drugs and immune cells will be important to determine if drugs can access and kill persistent Mycobacterium tuberculosis (Mtb) populations. Mtb is the bacterium that attacks the lungs and causes inflammation and lung tissue destruction. Ultimately, these insights will guide the TB Drug Accelerator and TB drug discovery projects which can potentially lead to more efficacious treatments.
To thoroughly evaluate the effects of drugs and their interactions with the surrounding tissue, Visikol will leverage its proprietary fluorescent multiplexed immunohistochemistry approach combined with MALDI mass spectrometry imaging. This multi-modal approach will be used to automate the quantitative investigation of drug distribution into TB lung lesions. Visikol's highly multiplexed imaging approach relies on simultaneous and sequential detection of multiple cellular markers, using multicolor fluorescent immunohistochemistry combined with automated multispectral slide imaging, and advanced image analysis software to identify and determine the spatial distribution of immune cells.
"Our novel multiplex approach allows Visikol to visualize ten or more targets simultaneously while also providing clients with custom designed and validated panels in combination with high resolution whole slide imaging, image analysis and comprehensive reporting," noted Visikol CSO Tom Villani, Ph.D.
The partnership with Hackensack comes as HMH Hospitals are again recognized as leaders in not only New Jersey but across the country. Of the health care systems in New Jersey, HMH is the largest and has the most top-ranked hospitals. In the time of COVID-19 HMH has continually proven itself to be a leader on the front lines combatting the virus and helping patients towards recovery.
"Hackensack has continually been recognized as not only a top hospital and healthcare system, but also as a top research organization. The opportunity to work alongside such a talented group of scientists with support from the Gates Foundation is an exciting opportunity for us," mentioned Visikol CEO Michael Johnson, Ph.D.
The data from this study will provide beneficial knowledge to researchers in determining what types of drugs are most effective in treating TB. Visikol's approach to multiplex imaging will provide important insights in the TB drug discovery process that are both timely and data driven.
About Visikol Incorporated
Visikol is a CRO that is focused on accelerating drug discovery and development through the use of its imaging, digital pathology and advanced cell culture assay services. The company provides end-to-end preclinical services that include both 2D and 3D in vitro models and assays, 3D whole mount tissue imaging, multiplex imaging, high content imaging, digital pathology and custom drug discovery solutions. Visikol's expertise is in transforming tissues and cells into large image-based data sets that can be mined for actionable insights such that pharmaceutical and biotech companies can make more quantitative and informed decision during the drug development process. Additionally, Visikol manufactures and sells a suite of tissue clearing reagents and 3D immuno-labeling kits. These products allow researchers to easily and rapidly image whole tissues and 3D cell culture models in 3D instead of traditional 2D sectioning. For more information about Visikol or its services, please visit http://www.visikol.com.

Our novel multiplex approach allows Visikol to visualize ten or more targets simultaneously while also providing clients with custom designed and validated panels



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Caring Stars Award Helps Seniors and Their Families Find America's Top-Rated In-Home Care Providers

CHARLOTTE, N.C. (PRWEB) DECEMBER 08, 2020
To help seniors and their families research high quality in-home care options, Caring.com — a leading senior care referral service and the nation's top site for senior care reviews — today announced its annual list of the best home care agencies. The Caring Stars of 2021 include 504 agencies in 46 states and Puerto Rico, with California, Florida, and Texas as the states with the most winners.
Caring Stars started in 2012 as the first award of its kind in the senior living industry, and expanded to include home care agencies in 2017. Caring Stars is an important go-to guide for consumers, recognizing service excellence at agencies providing home care, home health, hospice or geriatric care management. The Caring Stars badge of honor signals to seniors and their families that the agency has earned high praise in online consumer ratings and reviews.
"With more than a decade of senior care expertise, we know that seniors and their families have a range of questions, concerns, and pressing needs when researching in-home care options," said Caring.com's CEO Jim Rosenthal. "Our high-integrity consumer reviews program and the Caring Stars annual guide are among the ways we provide relevant information and empathetic guidance. This important information saves seniors and their families time, relieves feelings of stress, and instills confidence in decision-making, particularly if the need is urgent."
To be considered for this distinguished list, Caring Stars 2021 agencies meet a rigorous set of criteria, including: having 10 or more reviews, an average rating of 4.5 stars or higher, and 3 or more new reviews within the qualification time frame (at least one of those being a 5-star review and at least one published in 2020), as well as no unresolved negative reviews. All qualifying consumer reviews are fully visible to anyone on the web via the Caring.com listing on which they're featured. In determining Caring Stars winners, Caring.com also conducts a reviews-integrity audit and takes other quality-assurance measures.
This list of award-winning agencies is published each year for seniors and their families at https://www.caring.com/bestseniorliving. To find a nearby Caring Star agency, consumers can reach a Caring.com Family Advisor at: (844) 484-5997. Caring.com's Family Advisors assist seniors and their family members at no charge. For more information about Caring Stars 2021, please contact reviews@caring.com.
"Congratulations to every agency that has achieved this level of service excellence! We are excited to recognize you, as you truly stand out among the best in the nation for 2021," Rosenthal said.
About Caring.com
With millions of website visitors, Caring.com is a leading senior care referral service and the nation's top site for senior care reviews. Founded in 2007, Caring's mission is to help as many seniors and their caregivers as possible through empathetic, expert guidance. Applying cutting-edge technology to this humane mission, Caring provides relevant senior care information and support, as well as comprehensive senior living and senior care directories for the United States with hundreds of thousands of consumer reviews of senior living and in-home care providers. Through a toll-free line at (844) 484-5997, Caring's empathetic, nationwide team of Family Advisors — who are among the most highly trained, highly skilled, and knowledgeable experts in senior care — help families and seniors research and connect to the most appropriate services and support for their specific situations. For more information about our organization and our free services for seniors and their families, please visit http://www.caring.com/about and join with Caring on Facebook.
Media Contact: Denise Graab, Caring.com Director of Industry Marketing, pr@caring.com or (650) 762-8190



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The Dept. of Health and Human Services (HHS) provided CareSet with early access to the data in order to facilitate the creation of a community Frequently Asked Questions (FAQ) document, detailing how to work with the new dataset.

HOUSTON (PRWEB) DECEMBER 08, 2020
Yesterday, the Federal Government released new hospital COVID-19 capacity data at the hospitals-level. Previously released data about hospital capacity had only been released at the state level. The Dept. of Health and Human Services (HHS) provided CareSet with early access to the data in order to facilitate the creation of a community Frequently Asked Questions (FAQ) document, detailing how to work with the new dataset.
The community FAQ for this data release is hosted by CareSet on GitHub, and invites healthcare professionals, data journalists, and researchers to ask questions and comment at https://bit.ly/COV-PUF-FAQ.
"This data release will allow CareSet and other Data Journalists to report on the impacts from the COVID-19 pandemic on each hospital. Previously, this detailed information was available only to local and federal public health officials," reports Ashish Patel, Chief Growth Officer and Data Journalist at CareSet Journal.
The new, more granular, data release aggregates daily hospital reports into a "week at a time" picture in order to protect patient privacy, while still providing a picture of how COVID-19 is specifically impacting hospitals and local communities across the country. You may view this data at https://bit.ly/COV-PUF.
"Social Media continues to promote misinformation about the seriousness of the COVID pandemic. It is easy to disconnect from the negative impacts of COVID-19, if no one you know personally has been seriously ill," says Fred Trotter, CareSet CTO and Editor of the CareSet Journal. "This dataset allows for communities to see how their local hospitals are impacted, which should vividly combat misinformation, and demonstrate the local impact of the pandemic."
According to HHS, with this data release the picture of how hospitals are impacted by COVID-19 will be revealed on a per-hospital basis, allowing researchers, policymakers, and others to have greater insights into local COVID-19 response efforts. This time-series data will update weekly, going back to August 1, 2020.
With aggregated county or state data, the average across all facilities often masks what is happening at each local hospital. Some hospitals might have additional COVID-19 capacity while others are at or over capacity. Using this new data, the public will have access to hospital-specific COVID-19 numbers to understand hyper-localized community impacts. This new level of transparency and increased access will accelerate COVID-19 insights and understanding.
The Community FAQ for this data release was developed in collaboration with researchers from the University of Minnesota COVID-19 Hospitalization Tracking Project, and the COVID Exit Strategy Project.
About CareSet Systems
CareSet (https://careset.com) is transforming the way biomedical companies go to market. We believe in getting the best treatments to the right patients quickly and efficiently. We do that by analyzing government data sources, such as Medicare claims data. With CareSet, biomedical companies become better at serving the patient community.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The study, published in the AAAAI's journal The Journal of Allergy and Clinical Immunology: In Practice, reports findings for participants who received a follow-up oral food challenge after one year on peanut daily maintenance.

MILWAUKEE (PRWEB) DECEMBER 08, 2020
Data published in The Journal of Allergy and Immunology: In Practice (JACI: In Practice), an official journal of the American Academy of Allergy, Asthma & Immunology (AAAAI), demonstrated that peanut oral immunotherapy (OIT) is effective after one year of maintenance in preschool participants who received a follow-up oral food challenge (OFC).
Preschoolers (9-70 months old) enrolled in the real-world study were administered increasing peanut doses in a clinic every two weeks over 8-11 visits until reaching the 300mg peanut protein maintenance dose. After spending approximately 12 months taking maintenance doses, patients were invited to complete a peanut follow-up OFC.
A total of 164 patients completed build-up and three dropped out of maintenance, leaving 161 patients available for follow-up OFC. A total of 117 of the 161 eligible patients received the follow-up OFC. Among them, 92 (78.6%) were able to tolerate a cumulative peanut protein dose of 4,000mg. A total of 115 (98.3%) tolerated a cumulative 1,000mg dose at follow-up, which would protect against accidental peanut exposures.
"The main takeaway for parents is that in this study, OIT provided protection from accidental exposures for 98.3% of preschoolers," said Lianne Soller, PhD, corresponding author of the study and University of British Columbia allergy research manager. "These data, in combination with our previous data demonstrating safety of peanut OIT in preschoolers, suggest that this therapy could be considered for this age group as an alternative to the current recommendations to avoid peanut."
Also of note was that epinephrine use during maintenance dosing remained low with only two participants requiring it, and only 10.5% of participants experienced allergic reactions at all. During the maintenance phase, only one patient needed to go to the emergency department due to an allergic reaction.
"Our study is the first to report on effectiveness of peanut OIT in preschoolers in a real-world setting, as opposed to a clinical trial setting," said Dr. Soller. "We plan to continue to follow-up with this cohort long-term so we can continue to strengthen and solidify our recommendations regarding peanut exposure and oral immunotherapy."
You can learn more about the current state of oral immunotherapy at the AAAAI's website, aaaai.org.
The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has more than 7,100 members in the United States, Canada and 72 other countries. The AAAAI's Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.
###



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Mediaplanet's Fighting the Flu campaign, found within USA TODAY and online, helps shed light on the importance of our health and safety this winter as we navigate through both flu season and the pandemic simultaneously.

NEW YORK (PRWEB) DECEMBER 08, 2020
Helping to conclude National Influenza Vaccination Week, Mediaplanet today announces the launch of this December's edition of "Fighting the Flu." This campaign advocates for the health and safety of not only ourselves but the others around us.
While most people fully recover from bouts of flu, in some cases the illness can become extremely dangerous or even fatal. The CDC estimates that between October 2019 and April 2020, up to 59 million people in the United States became ill with the flu, leading to between 410,000 and 740,000 hospitalizations and between 24,000 and 62,000 deaths. Young children, older adults, pregnant women, and people with chronic disease or weak immune systems are at high risk from the flu, which attacks the lungs, nose, and throat. Symptoms include fever, chills, muscle aches, cough, congestion, runny nose, headaches, and fatigue. Over-the-counter anti-inflammatory pain relievers may help with symptoms, but the flu is treated primarily with rest and fluid to let the body fight the infection on its own. An annual vaccine can help prevent the flu and limit its complications.
The print component of "Fighting the Flu" is distributed within today's edition of USA TODAY in Boston, New York, Los Angeles, Chicago, DC, Dallas, Houston, Detroit, San Francisco, South Florida, Atlanta, Denver, Baltimore, Philadelphia, North/Central Florida, Carolinas, & Seattle, with a circulation of approximately 200,000 copies and an estimated readership of 600,000. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. Find the full campaign online at: https://www.futureofpersonalhealth.com/campaign/fighting-the-flu/
Three years ago, professional photographer Latasha Haynes, who lives with her family in Tacoma, Washington, was healthy, active, and busy. She traveled the world for her photography business and loved to volunteer through educational programs for women. But in January, she started to feel sick. She thought she caught a cold or virus from a family member and figured she'd feel better soon. But weeks passed and her symptoms, including a cough, loss of appetite, and exhaustion, got worse, eventually developing into a life-threatening influenza illness requiring hospitalization.
Haynes' near-death experience with the flu inspired her to become an advocate with Families Fighting Flu (FFF), a national, nonprofit advocacy organization that's dedicated to protecting children, families, and communities against the flu. The women's health advocate encourages all adults and children older than six months to get an annual flu vaccination, the best preventive measure against influenza. As part of this campaign, Haynes is sharing her story and what you can do to prevent flu.
This campaign was made possible with the support of the CDC, Families Fighting Flu, National PTA, American Society for Microbiology, The Allergy and Asthma Network, HealthyWomen, AAOHN, Halosil, Green Goo, Sambucol, Stogo, RTB MED, GoodState, Crane USA, Pro Solutions Direct & Precision Genetics.
About Mediaplanet
Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.
Press Contact:
Abigail Hanania
abigail.hanania@mediaplanet.com
(845) 548-4990



START your own Wordpress site, business or personal website, or online store at www.siteground.com

DrOwl is transforming how businesses, schools, and organizations are combatting the COVID-19 Pandemic to remain open

ALBUQUERQUE, N.M. (PRWEB) DECEMBER 08, 2020
DrOwl, an award-winning medical platform built on patented technology that helps users better understand their medical history-- has surpassed one million electronic screenings by its users. DrOwl includes a free COVID-19 screening tool for people to screen for symptoms and history of exposure to COVID-19, following the CDC guidelines. DrOwl's groundbreaking user-friendly app assists organizations around the country, by eliminating ineffective and time-consuming paper-based questionnaires, while enabling users to easily check-in to businesses, schools, or their favorite restaurants on their smartphone. DrOwl also provides the businesses and schools with a way to give reports to public health departments of visitors to their facilities in just a few clicks.
DrOwl is honored to have reached this landmark number of electronic screenings. We know our check-in/screening feature furthers our work as a medical platform that enables the average person to securely access, understand, and share his/her personal medical information. With uncertainty looming as the pandemic rages on, this key check-in feature will continue to help serve as a lifeline for organizations throughout the pandemic -- while hopefully helping to prevent any additional spread of COVID-19.
"The millionth check-in is an extremely humbling milestone; it demonstrates the power of not only DrOwl's unique tool but also the willingness of communities working together to help mitigate the spread of COVID-19", said Arvind Raichur, CEO, and Co-Founder of DrOwl.
"We've been working hand in hand, tirelessly with community leaders, lawmakers, educators, and small businesses across the country. What we have seen consistently is that business owners and leaders want to keep their employees and visitors safe by following the CDC guidelines", he said.
"We know that there is still much to do, but we are confident that by being more proactive, communities across the nation can help return to their new normal more safely. This, in and of itself, is comforting. To know we are making a difference by enabling people to keep each other safe. At DrOwl, this is how we're doing our part".
The Millionth Check-In
The millionth check-in was completed on November 17, 2020, and shows the ease of use that organizations around the nation are flocking towards. Since screening has become a primary tool for COVID tracking, electronic check-ins are the most efficient tool we have to manage that data.
DrOwl's mobile app enables facilities to have their guests, employees, and visitors check-in, while on the go. Visitors arrive at a given location, electronically check-in, and are automatically shown the organization's customizable screening questions on their smartphone. This makes organizing and maintaining the data more convenient for facilities while simplifying the check-in process for visitors. Restaurant patrons can check-in without hassle, the same way senior living facilities can, and facilities can easily download visitor reports with the click of a button to give to public health departments. And organizations can even generate a custom QR code for their location.
"To date, we have seen that schools really appreciate that we provide an automatically-generated list of check-in questions that they can customize as needed. It enables them to save precious time while helping create a new, safer normal for their community. When organizations such as rehabilitation facilities or senior living communities have specific rules and challenges, customization has become their best friend and ally," said Raichur.
With over one million check-ins completed to date, DrOwl is on the cutting edge on the transformation of how businesses and organizations adapt to our current – and future challenges. With a central database enabling administrators to run on-demand reports, and cross-reference those that have entered a given facility in real-time. Making it easy for organizations to use the data for epidemiological usage and in cases of infection, look at the data to help assess the risks to help limit their potential liabilities. For more information on DrOwl, please visit CheckIn.DrOwl.com. And, users can download DrOwl.com for free from the iTunes or Google Play app stores.
About DrOwl
DrOwl is a medical platform built on patented technology, that provides a safe place to sync, organize, search, and share your digital medical records on-demand.
Once a user securely syncs their medical records, DrOwl uses AI and machine learning to provide users with a Patient Portal based on the Patient's health records that include trusted, doctor-approved sources of information that is customized for each user and makes their medical information easier to understand. DrOwl users can also share their customized Patient Portal with caregivers or family members to include them in the patient's healthcare decisions. Users can also initiate telehealth sessions 24x7 and allow their caregivers or family members to join in the secure telemedicine video call.*
DrOwl also has a free electronic screening and monitoring solution to help protect schools, senior communities, and businesses during infectious disease outbreaks. Where staff, residents, and visitors can electronically "check-in", answering a list of questions that helps screen for symptoms and history of exposure. This creates an electronic log of employee and visitor activity, in real-time. And reports can be run as needed to assist in contact tracing if an infection is reported. In cases of infection, there is electronic tracking with centralized data for epidemiological usage and cross-contamination data to help assess the risks.
*Telemedicine available in select areas with more being added all the time.

To date, we have seen that schools really appreciate that we provide an automatically-generated list of check-in questions that they can customize as needed. It enables them to save precious time while helping create a new, safer normal for their community.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The partnership will allow leading healthcare organizations utilizing PayConex and Bluefin's Epic integration to seamlessly adopt 1-800 Notify's services

ATLANTA AND MIAMI (PRWEB) DECEMBER 08, 2020
Bluefin, the leader in encryption and tokenization payment and data security, and 1-800 Notify, the premier platform for HIPAA compliant automated phone payments (IVR), appointment reminders, billing reminders and notifications, have partnered to provide 1-800 Notify's services through Bluefin's PayConex gateway and Epic integration to leading healthcare organizations.
"Manually accepting a patient payment over the phone ties up already busy staff members, reducing their time to spend on more important and complicated patient requests," said Martin Trautschold, Chief Executive Officer of 1-800 Notify. "We created the 1-800 Notify IVR Autopay by Phone system to seamlessly automate this task. Not only is the automated system 75% less expensive than a staff member, it is available 400% more time every week to accept patient calls 24/7, allowing patients to make payments on their schedule."
"What's even better is that with our Epic integration, patient balances are pulled directly from Epic and payments are posted to Epic in real-time, further reducing staff workload and increasing patient satisfaction," added Mr. Trautschold.
Bluefin provides payment and data security technologies through the company's PayConex gateway, including PCI-validated point-to-point encryption (P2PE) for the protection of point-of-sale (POS) card data and ShieldConex for the tokenization of online card data, PII and PHI.
Bluefin is also integrated with Epic for payments and P2PE, enabling a secure payment experience for healthcare organizations utilizing the Epic platform. The 1-800 Notify solution also provides a seamless integration with Epic, enabling Bluefin's clients to get integrated payments, P2PE and the 1-800 Notify service directly through PayConex and the PayConex/Epic integration.
"Partnering with 1-800 Notify provides our healthcare clients a huge value-added service for HIPAA and PCI compliant patient payments and communications," said Greg Cornwell, Chief Revenue Officer, Bluefin. "Automating manual work and allowing patients to pay in a contactless remote manner are more important than ever because of the current pandemic, as much of the communication with patients has gone virtual. And the fact that 1-800 Notify is integrated with Epic means that our clients utilizing Blueifn's PayConex / Epic integration can easily adopt this service through their current integration."
"We are very excited to partner with the industry-leading, Bluefin PayConex platform and look forward to bringing the time-saving benefits of our industry-leading IVR Autopay by Phone system to more Bluefin clients in the future," added Mr. Trautschold.
About Bluefin
Bluefin specializes in payment and data security technologies that protect point-of-sale (POS) and online transactions. Our security suite includes PCI-validated point-to-point encryption (P2PE) for contactless face-to-face, call center, mobile and unattended payments, and our ShieldConex data security platform for the protection of personally Identifiable Information (PII), Personal Health Information (PHI), and payment data entered online. The company's partner network currently includes over 135 processors, payment gateways and ISV's operating in 34 countries, which provide Bluefin's P2PE solutions direct to merchants, enterprises, healthcare organizations and more. Bluefin is a Participating Organization (PO) of the PCI Security Standards Council (SSC) and is headquartered in Atlanta, with offices in Waterford, Ireland. For more information, please visit http://www.bluefin.com.
About 1-800 Notify
1-800 Notify is a healthcare communications firm that is fully HIPAA and PCI compliant, an Epic App Orchard Partner and integrates with many systems. 1-800 Notify improves patient appointment attendance, wellness and payments while improving efficiency for hospitals, health systems, physician groups, and medical billing firms. Founded in 2011, 1-800 Notify has rapidly grown to support millions of inbound IVR autopay by phone calls, two-way appointment reminders, patient wellness and broadcast messages. 1-800 Notify is proud of its 98% client retention rate. We focus on learning each client's unique needs, tailoring solutions to those needs and providing a highly reliable and scalable service -- all at a price that is difficult for our competition to match. For more information, visit https://www.1800notify.com/.

"Partnering with 1-800 Notify provides our healthcare clients a huge value-added service for HIPAA and PCI compliant patient payments and communications," said Greg Cornwell, Chief Revenue Officer, Bluefin.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Annual honor to recognize young life science entrepreneurs in Massachusetts and the Netherlands; fostering relationships between the two biotechnology sectors

CAMBRIDGE, MASS. (PRWEB) DECEMBER 08, 2020
The Termeer Foundation, a nonprofit organization focused on connecting life science innovators and catalyzing the creation of new medicines, today announced the creation of The Henri Termeer Transatlantic Connections Award.
The Award is part of an agreement signed in July 2019 between the Massachusetts Office of International Trade and Investment and the Dutch Ministry of Economic Affairs and Climate Policy, which created and signed a Memorandum of Understanding laying the basis for a Massachusetts – Netherlands Transatlantic Life Sciences Partnership. The signatories included Top Sector Life Sciences & Health (Health~Holland), MassBio, HollandBIO and the Henri A. Termeer Tribute Committee; all of whom agreed to provide support and organize activities to promote trans-Atlantic collaboration between the two biotechnology ecosystems.
"The establishment of the Henri Termeer Transatlantic Connections Award is the first of many partnerships this group plans to create that will help foster a strong relationship between life science communities in the Netherlands and Massachusetts," said Belinda Termeer, President, Co-Founder and Member of the Board of Directors, The Termeer Foundation. "As a native of Holland, Henri was always interested in establishing working relationships with his homeland and his new business home in Cambridge. We are delighted at the creation of this award and feel that it will provide an excellent platform for identifying future industry ambassadors and the opportunity for collaborations between these two important life science sectors."
The Henri Termeer Transatlantic Connections Award will be an annual award competition for life science entrepreneurs in the Netherlands and Massachusetts. Each year the Termeer Foundation and Health-Holland will select two young life science entrepreneurs, one in Massachusetts and one in the Netherlands, who are leading innovative biomedical research activities, and whose programs have the potential to strengthen transatlantic relations between the two life science regions. Candidates should have already established themselves within the life science industry leading an early-stage company, with a concrete business plan and initial funding in place. Additionally, the recipient will be someone interested in becoming actively involved in mentorship and who agrees to be involved in Termeer Foundation programs. Awardees receive Fellowship status within The Termeer Foundation, which includes access to experienced healthcare mentors, networking with fellow peer entrepreneurs, and recognition at The Termeer Foundation Annual Dinner. Recipients will also have the opportunity to spend a week visiting their fellow awardee's company, and to participate in additional learning, networking and cultural events.
The winners of the 2021 Henri Termeer Transatlantic Connections Award will be announced at the end of April, 2021. Nominations should be submitted here.
"Life science research is increasingly developing into a global experience with partnerships between companies in diverse global locations becoming part of our industry's DNA," said Hans Schikan, board member of Health-Holland and a member of the Henri Termeer Transatlantic Connections Award Steering Committee. "One of the many important elements of the biotechnology business I learned from Henri Termeer during my time at Genzyme and as CEO of Prosensa, with Henri as an inspiring mentor, was the notion of understanding the needs of patients everywhere and applying our research in the development of treatments to address those needs no matter the location."
Members of the Massachusetts – Netherlands Transatlantic Life Sciences Partnership Steering Committee include: Belinda Termeer (Co-Founder and Member of the Board of Directors, The Termeer Foundation), Alan Walts (Treasurer, Secretary, Mentor, Co-Founder and Member of the Board of Directors, The Termeer Foundation), Hans Schikan (Member Board of Directors, Health-Holland), Bob Coughlin (President/CEO, Massachusetts Biotechnology Council), Clémence Ross-van Dorp (Ambassador Life Sciences & Health Sector), Annemiek Verkamman (Managing Director, HollandBIO), John Maraganore (CEO and Director, Alnylam Pharmaceuticals), and Daniel de Boer (Founder and Chief Executive Officer, ProQR Therapeutics).
"I am delighted to support this award that will provide an incredible opportunity each year for two deserving life science entrepreneurs," said Daniel de Boer, Founder and Chief Executive Officer of ProQR Therapeutics. "Reflecting on my personal experience, Henri's influence has been invaluable and he was instrumental in helping me to navigate my entrance into the biotechnology industry as a CEO. We co-founded ProQR together, which is now based in the Netherlands and Massachusetts, embodying the spirit of this initiative and his legacy."
About The Termeer Foundation
Building on the bold legacy of Henri Termeer, who pioneered groundbreaking treatments for rare diseases, The Termeer Foundation connects life science innovators and catalyzes the creation of new medicines. The Foundation's network of emerging and established healthcare innovators cultivates tomorrow's leaders and leverages their collective expertise to solve complex problems in drug development and accessibility. The Foundation also integrates its network with academic institutions, nonprofits, regulatory agencies and other organizations across the global healthcare ecosystem to provide expert counsel, stimulate innovation, eliminate barriers to progress, and ultimately connect the world of healthcare until every patient has a cure. Visit us at http://www.termeerfoundation.org or on LinkedIn @TermeerFoundation.
Contact:
Paul Kidwell
Termeer Foundation
617-680-1088
paulkidwell@comcast.net



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Novant Health President and CEO, Mr. Carl S. Armato, addressing both the quality and affordability of healthcare.

WASHINGTON (PRWEB) DECEMBER 08, 2020
The influential Steven Schroeder Award for Outstanding Healthcare CEO was presented virtually at The Leapfrog Group's annual meeting. This year's recipient was Mr. Carl S. Armato, President and CEO of Novant Health in North Carolina.
The award was created by Costs of Care, a leading non-profit dedicated to curating and disseminating insights from the frontlines of health care to help delivery systems provide better care at lower cost, in conjunction with The Leapfrog Group, to recognize a hospital and/or health system CEO who has demonstrated courageous and ethical leadership addressing the twin issues of affordability and quality of health care in their community.
"Costs of Care believes that every health care CEO in the country should be focused tirelessly on patient safety and affordability. Health system leaders all face similar pressures and constraints, yet there are leaders like Carl Armato who are creating solutions to ensure patients receive safer and more affordable health care," said Chris Moriates, MD, Executive Director of Costs of Care.
Mr. Armato has led the way in fostering a culture that is accessible and equitable by removing barriers for those seeking care within the communities that Novant Health serves. Under his leadership, the health system has taken significant steps to provide fair and transparent billing and pricing practices through innovative payment models that alleviate concerns and confusion about the cost of care. Mr. Armato has also strengthened Novant Health's support for its most vulnerable communities by improving access to high-quality care through initiatives like its community health worker program, which helps address health disparities and socioeconomic determinants of health by connecting patients to important community resources and health education.
The Outstanding Healthcare CEO award is named in honor of Steven Schroeder, MD, Distinguished Professor of Health and Health Care at the University of California San Francisco and former President and CEO of the Robert Wood Johnson Foundation. Dr. Schroeder has spent five decades inspiring and mentoring leaders to forcefully advocate for better quality and more affordable health care, and he has inspired leaders of both Costs of Care and The Leapfrog Group.
Dr. Schroeder said about this year's recipient, "In the face of pandemic-induced lost revenue by hospitals and medical systems, stewardship of medical resources requires visionary leadership and courage. That is why the programs led by Carl Armato of Novant Health are so important and worthy of celebration."
"Novant Health exists to improve the health of our communities, one person at a time," said Armato. "I am proud to receive this award on behalf of our health system for our continued commitment to removing barriers to care and improving health equity across all of our markets."
"Even in the midst of the pandemic, great health system leaders have sustained their commitment to providing high-quality, affordable health care to their community," said Leah Binder, president and CEO of The Leapfrog Group. "With this award we're pleased to join with Costs of Care in recognizing a CEO who boldly faced the extraordinary circumstances of this year while simultaneously tackling patient safety, quality, and cost for patients."
About Costs of Care
Costs of Care is a nonprofit organization dedicated to curating and broadly disseminating insights from the front lines of health care to help delivery systems provide better care at lower cost. Since 2009, Costs of Care has collected more than 500 personal accounts from physicians, nurses, and patients all over the United States that illustrate routine and high yield opportunities to improve the value of care delivery through improved decision-making. Costs of Care has created widely adopted and enduring resources to educate medical trainees and clinicians about how to address health care costs and provide high-value care, including the textbook Understanding Value-Based Healthcare, the "COST" framework for designing value improvement projects, multiple workshops, and free, CME-approved video modules. In December 2019, Costs of Care launched the Affordability Moonshot - envisioning a world in which "no one has to choose between their life and their life-savings" - paired with an Affordability Accelerator to support and collaborate on promising ideas to improve patient affordability.
Connect at https://costsofcare.org, be a part of the Moonshot at https://moonshot.costsofcare.org, and follow on Twitter @CostsOfCare.
About The Leapfrog Group
Founded in 2000 by large employers and other purchasers, The Leapfrog Group is a national nonprofit organization driving a movement for giant leaps forward in the quality and safety of American health care. The flagship Leapfrog Hospital Survey and new Leapfrog Ambulatory Surgery Center (ASC) Survey collect and transparently report hospital and ASC performance, empowering purchasers to find the highest-value care and giving consumers the lifesaving information they need to make informed decisions. The Leapfrog Hospital Safety Grade, Leapfrog's other main initiative, assigns letter grades to hospitals based on their record of patient safety, helping consumers protect themselves and their families from errors, injuries, accidents, and infections.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Survey conducted by CISCRP (Center for Information and Study on Clinical Research Participation) and commissioned by Parexel shows perceptions of clinical research are positive but logistical burdens limit children's participation.

BOSTON (PRWEB) DECEMBER 08, 2020
A 2020 survey of 500 parents and children in the U.S. conducted by the Center for Information and Study on Clinical Research Participation (CISCRP) and commissioned by Parexel has yielded critical insights into why families choose to participate in clinical research and how to design clinical trials to better fit their needs, according to the survey report.
Pediatric participation in clinical trials is essential to understanding how drugs perform in children, whose physiologic responses to medications and unique disease variants are often different from adults.
While survey respondents expressed largely positive views of pediatric clinical research, actual participation in pediatric research remains low. Only 16.7 percent of clinical trials registered on the World Health Organization's (WHO) portal involve pediatric patients, and only 12% of trials registered on clinicaltrials.gov are pediatric trials, even though children contributed to almost 60 percent of the total disease burden of the conditions being studied.1 As a result of low pediatric participation, the majority of drugs prescribed to children are only evaluated in adults.2
"Understanding patient health journeys and study volunteer experiences is critical to designing more patient-friendly trials that ultimately enhance pediatric patient participation, so that we can continue to develop newer, safer and more effective drugs for children," said Ken Getz, Founder and Chairman at CISCRP.
Among the key findings from the survey:

Determinants: Parents cited their pediatrician's recommendation as the most important factor when deciding to enroll their child in a trial, and they ranked the potential risks and benefits of the study drug as the most important information they needed to make a decision

Motivations: Children cited the desire to help scientists and doctors learn more about their disease as a primary motivation for participating

Barriers: 52 percent of children indicated it was very important to have some or all of their study visits at home if they were part of a research study

Diversity: Parents who identified as Black self-reported a better understanding of clinical research and were more willing to enroll their child in a clinical trial than parents who identified as Caucasian

Perceptions: The majority of children reported a positive experience with clinical trials, and 90 percent indicated that they would join another study

"The results from this survey inform tangible steps we can take as an industry to encourage more pediatric participation in clinical trials, including more decentralized clinical trial approaches, enhanced communication with caregivers about clinical trials as a care option and better engagement between industry and pediatric providers," said Sy Pretorius, MD, Executive Vice President and Chief Medical & Scientific Officer at Parexel. "The pandemic has further demonstrated the benefits of bringing trials to patients in their homes, rather than asking patients to come into the clinic for every visit, and this is amplified in the context of pediatric trials."
Pediatric participation in clinical trials is an issue of growing importance as the medical community has embraced the need to better understand the effects of medications in children. In 2012, Congress passed the Food and Drug Administration Safety and Innovation Act to incorporate pediatric evaluations earlier in the drug development process, legislation which has resulted in 500 pediatric-specific drug-labeling changes. 2
The Pediatric Perceptions & Insights Study was created, in part, as an outgrowth of questions included in the baseline CISCRP Perceptions & Insights Study that is conducted biennially in adult populations, which gauges public and patient perceptions, motivations, and experiences regarding clinical research participation. Its goal is to monitor trends and identify opportunities to better inform and engage the public and patients as stakeholders and partners in contributing to the clinical research enterprise.
To view the Pediatric Perceptions & Insights Study final report, visit https://www.ciscrp.org/wp-content/uploads/2020/09/Pediatric-PI-Survey-FINAL-2020.pdf
To hear a podcast about the survey results featuring a parent advocate survey respondent, please visit https://www.podbean.com/media/player/t2u24-f45cc0?from=pb6admin&download=1&version=1&auto=0&share=1&download=0&rtl=0&fonts=Helvetica&skin=1&pfauth=&btn-skin=107
About Parexel
Parexel is focused on supporting the development of innovative new therapies to improve patient health. We do this through a suite of services that help life science and biopharmaceutical customers across the globe transform scientific discoveries into new treatments for patients. From clinical trials to regulatory and consulting services to commercial and market access, our therapeutic, technical and functional ability is underpinned by a deep conviction in what we do. For more information, visit https://www.parexel.com/.
About CISCRP
CISCRP (Center for Information and Study on Clinical Research Participation) is an internationally recognized non-profit organization dedicated to educating and informing the public and patients about clinical research. Located in Boston, Massachusetts, CISCRP works to raise awareness, enhance experiences, and strengthen communication and relationships among participants, research professionals and the public through various services and events. For more information, visit https://www.ciscrp.org/.
References: 1https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345947/#:~:text=Despite%20about%2027%25%20of%20the,Organization%20(WHO)%20portal%2034
2 https://pediatrics.aappublications.org/content/144/4/e20191571
###

"Understanding patient health journeys and study volunteer experiences is critical to designing more patient-friendly trials that ultimately enhance pediatric patient participation," said Ken Getz, Founder and Chairman at CISCRP.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Together, Metavivor and Ciitizen will make clinical trials and research more accessible for those living with stage 4 metastatic breast cancer.

ANNAPOLIS, MD. (PRWEB) DECEMBER 08, 2020
Metavivor Research and Support Inc., a national non-profit organization dedicated to funding research for stage IV metastatic breast cancer (MBC), announced a strategic partnership with consumer health tech company Ciitizen to bring a comprehensive new Clinical Trial Search Tool and Clinical Trial Matching Program to the stage 4 metastatic breast cancer community.
Metavivor took up the mantle for increased clinical trials in 2017 and since that time has been on a mission to improve clinical trials and encourage patient participation. During this time, the organization discovered that trial searches were lacking information or did not connect the right trial to the patients' particular metastatic breast cancer. With the help of Ciitizen, Metavivor can now offer clinical trial search and matching service options to those living with MBC. To transition metastatic breast cancer so that it is no longer a death sentence; increased research investment and participation in clinical trials is desperately needed. Metavivor is a leader on both sides of the equation: funding metastatic breast cancer research and empowering the metastatic breast cancer community to participate in critical research.
"No one dies from a tumor that remains in the breast, it is only when the cancer cells spread beyond the breast and metastasize to other organs in the body that breast cancer becomes fatal," said Metavivor Board President, Jamil Rivers. "Metastatic or stage 4 breast cancer research has been woefully underfunded for a long time. We have to give new treatments a chance, so people with metastatic breast cancer can live longer. Clinical trials are our key to finding life extending treatments."
Clinical trials are a key component in advancing medical treatment in cancer and in particular metastatic cancer. "Metavivor is thrilled to partner with Ciitizen to bring this multi-layered clinical trial search tool to the metastatic breast cancer community. It will help patients narrow down their options for the latest clinical trials and personalize them to their diagnosis," said Rivers. Participating in a trial can also afford patients access to high-quality care and new treatments. A recent large study published in the Journal of Clinical Oncology showed, even when patients are matched for baseline characteristics, those on a clinical trial vs not a clinical trial had superior overall survival at 5 years (95.0% vs 90.2%) and 7 years (90.0% vs 78.0%). Put simply, finding a trial may extend a person's life.
Unfortunately a huge gulf exists between connecting eligible patients to trials, a problem that has only been exacerbated by the current COVID-19 pandemic. There is an urgent need to address this problem now.
METAvivor and Ciitizen are launching a new Clinical Trial Search Tool that makes exploring clinical trials easier and more accessible for stage 4 metastatic breast cancer patients. The tool allows patients to narrow in on applicable trials by answering a few questions about their condition. The tool then narrows potential trial options from the exhaustive set of all US based treatment trials. By streamlining multiple search queries into one report, we can ensure patients are aware of all their options. The user interface is clean, easy to use and accessible for patients with varied technical literacy.
The Clinical Trial Search Tool is accessible as part of METAvivor's MBC Patient Resource and Education Portal (MBC PREP) and can be accessed by visiting Metavivor Clinical Trial Search
To learn more about METAvivor and Ciitizen's partnership, please visit Metavivor Clinical Trial Search
ABOUT METAVIVOR
Metavivor Research and Support Inc. is an Annapolis-based, 501(c)(3), volunteer-led, non-profit organization founded by metastatic breast cancer (MBC) patients in 2009. The organization's main focus is to fund critical research that will lead to advances in treatment options, quality of life and survival for patients diagnosed with MBC. Since 2009, Metavivor has awarded 106 research grants totaling $13.6 million. Metavivor is the only national organization with a peer-reviewed grant program aimed at exclusively funding MBC research, and 100% of all donations go to fund research.
Metavivor also raises awareness of MBC, provides support for people living with this disease, and offers opportunities for others to help make a difference for the metastatic community. Metavivor has gained a rapidly growing following within the breast cancer community and has become a leader in its field. For more information visit us at http://www.metavivor.org, and follow us on Facebook, Twitter and Instagram @metavivor.
ABOUT CIITIZEN
Ciitizen is a leading consumer health technology company whose mission is to help patients get full control of their medical records so they can find better treatment options, participate in research and find clinical trials. As a patient-mediated platform, Ciitizen believes patients should have full control of directing the use of their data, which serves as one of the richest sources of real world evidence, unlocking new options for patients and the community. For more information, visit ciitizen.com or follow @ciitizen

[https://ww1]

Metavivor is thrilled to partner with ciitizen to bring this multi-layered clinical trial search tool to the metastatic breast cancer community. It will help patients narrow down their options for the latest clinical trials and personalize them to their diagnosis



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Dermatology Physician Assistant Lauren Smith joins U.S. Dermatology Partner in Belton, Texas

BELTON, TEXAS (PRWEB) DECEMBER 08, 2020
U.S. Dermatology Partners is pleased to welcome Dermatology Physician Assistant Lauren Smith to their Belton, Texas Dermatology office.
Lauren Smith has practiced dermatology since 2012 and has received extensive training in medical, surgical, and cosmetic dermatology.
In 2011, Lauren earned her Master of Physician Assistant Studies degree from Texas Tech University Health Sciences Center. She received academic recognition and graduated summa cum laude. Lauren is certified by the National Commission on Certification of Physician Assistants and is licensed by the Texas State Board of Physician Assistant Examiners. She is a diplomate member of the Society of Dermatology Physician Assistants, which is the highest honor a dermatology physician assistant can hold.
Lauren's interest in dermatology began as a patient when she was diagnosed with melanoma at a young age. Her clinical interests include skin cancer prevention and acne. She enjoys building relationships with her patients and helping them feel confident in their skin.
In her spare time, Lauren enjoys spending time with her family, exercising, and traveling.
Lauren Smith joins Board Certified Dermatologists Lenore Chiles, M.D., Jordon Ilse, M.D., Leo Conger, M.D., and Fellowship Trained Mohs Surgeon Nick Snavely, M.D. The office treats patients of all ages and specializes in medical, surgical, cosmetic dermatology, and Mohs Surgery for the treatment of skin cancer. Lauren is currently accepting new patients in Belton, Texas.
About U.S. Dermatology Partners
As one of the largest physician-owned dermatology practices in the country, U.S. Dermatology Partners' patients not only have access to general medical, surgical, and cosmetic skin treatments through its coordinated care network but also benefit from the practice's strong dermatology subspecialty thought leaders and medical advisory board. To be the best partners to its patients, U.S. Dermatology Partners is fervently focused on providing the highest level of patient-first care, and its team, therefore, includes recognized national leaders in areas such as clinical research, psoriasis, and Mohs Surgery. To learn more, visit usdermatologypartners.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Professionals in education, aviation and hospitality have been the hardest hit, with many switching careers to less affected sectors.

DUBAI, UNITED ARAB EMIRATES (PRWEB) DECEMBER 08, 2020
The sharp drop in hiring activity resulting from the Covid-19 pandemic has forced many professionals in the Gulf to switch careers, according to the latest findings released by Middle East online recruitment firm, GulfTalent.
The study compared the trends in interview invitations received by jobseekers on GulfTalent.com website during the 9-month period from March to November 2020 against the same period in 2019. It found that the average number of interview invitations per active jobseeker was down by almost 50% for some segments of the market.
Winners and Losers
Among job categories, the drop in employment was most severe for teachers and catering professionals, seeing their interview invitations collapse by 48% and 35% respectively. Most other professions saw moderate drops in demand – including engineers and lawyers, followed by marketing, IT, finance and HR professionals.
Meanwhile, a handful of professions saw employment demand increase during the pandemic – notably medical staff who enjoyed a 19% increase in demand, followed by logistics professionals at 12%, thanks to the rapid growth of online shopping.
Sales professionals experienced a mixed impact, with those in telesales seeing a boost in demand due to the restrictions on travel and face-to-face meetings.
Among sectors of the economy, the biggest drop in hiring activity was in education, aviation and hospitality. The only sectors increasing hiring activity relative to the same period last year were healthcare and logistics.
In terms of location, professionals based locally within the Gulf saw a smaller impact from the pandemic. Interview invitations to candidates based in the UAE and Saudi Arabia dropped by 14% and 3% respectively, while those in Qatar saw interviews increase by 17% as employers were no longer able to fill vacancies with newly imported talent.
By contrast, candidates based in India and Pakistan seeking opportunities in the Gulf saw demand drops of 46% and 41% respectively, as flight cancellations and border closures brought international hiring to a standstill. A similar slowdown was experienced in hiring from Egypt and Lebanon, Arab countries that are common recruiting grounds for Gulf employers.
The pandemic has also resulted in a large drop in salaries, as the supply-demand balance has shifted in favour of employers. Analysis of vacancies posted on GulfTalent.com in the 9 months since the onset of the pandemic reveals an average 24% drop in salaries advertised, compared to the same period last year. The salary drop was greatest for professions most affected by the pandemic, such as teachers and chefs, while less affected roles saw smaller salary drops or no drop at all.
Career transitions
The economic squeeze brought about by the pandemic has resulted in job losses, pay cuts, salary delays and career stagnation for many expatriates in the Gulf. While many have left the region as a result, some have sought to retain their residence and earnings by switching to alternative careers within the region, according to GulfTalent's findings.
Many cabin crew who lost their jobs have transitioned to real estate brokerage roles. Among teachers facing job losses or unpaid leave, admin and secretarial roles have been common destinations. Meanwhile, many catering professionals who were made redundant have taken up employment in customer service roles.
The pandemic has also pushed many into home-based freelance jobs or entrepreneurship. Some teachers reported for the first time teaching students privately from home via Zoom, while a small but growing number of people from different backgrounds are setting up online stores selling goods.
GulfTalent's study was based on analysis of 2019 and 2020 hiring activity, including 6 million job applications submitted by jobseekers, 350,000 interview invitations issued by employers, and survey interviews with a sample of candidates.
About GulfTalent
GulfTalent is a leading online recruitment portal in the Middle East, covering 9 countries across the region. It is a key provider of both national and expatriate talent to over 10,000 employers across all industries, and is used by 9 million professionals and managers for finding top career opportunities in their field.
Media contact
Email: press@gulftalent.com | Tel: +971 4 278 5200



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Content licensing company will boost reach of publisher's orthopedic evidence-based summaries.

ST. THOMAS, U.S. VIRGIN ISLANDS (PRWEB) DECEMBER 08, 2020
Today OrthoEvidence Inc., an orthopedic-focused evidence-based summary provider, announced that it has chosen MEI Global LLC (MEIG), a leader in helping publishers monetize their digital assets, to create third party licensing partnerships to extend its content's reach to a larger audience.
"Our goal is to provide critical information access to orthopedic healthcare providers and their patients everywhere," says Dr. Mohit Bhandari, founder and president of OrthoEvidence. "To save medical professionals time and expand access to high quality research, we have developed a process to identify, critically appraise, and summarize the best of the best in the field of orthopedics." He adds, "MEIG's expertise in identifying, negotiating, and managing deals with licensing partners in order to expand the reach of OrthoEvidence's content means more patients, medical professionals, pharmaceutical companies and others will find the critical information they need, more easily."
MEIG was founded by Randall Marcinko to address the difficulty publishers experience developing new licensing opportunities, which is frequently due to a shortage of in-house licensing personnel.
"The market for content and the associated business models evolve rapidly. In a world of declining budgets, publishers are all too often forced to focus on publishing operations at the expense of a strategic focus on distribution," says Marcinko. "Without the time and resources to focus on licensing or an in-depth understanding of the significant upside it can generate, publishers miss out on lucrative new markets. Having applied our proven analytical approach to OrthoEvidence's content, our team is excited about the licensing opportunities to reach end users of all types via partnerships with aggregators, syndicators and others in the information industry."
"We're pleased that OrthoEvidence recognizes MEIG's ability to quickly and strategically expand their content distribution partnerships," says Chris Broekhoff, MEIG's President. He says, "MEIG's team will bring its acumen, professionalism, and a commitment to safeguarding publishers' intellectual property to the long-term, profitable relationship we look forward to building with OrthoEvidence."
About MEI Global LLC: MEIG provides a suite of services to help publishers monetize their digital assets. MEIG's expertise includes prospecting, negotiating, relationship management, and extensive knowledge of vendors and their needs, thanks to decades of industry experience within MEIG's dealmaker team. The company assists publishers with strategic decision making through a lens of revenue growth, brand extension and intellectual property protection. For additional information, please contact Vice President of Business Development Nancy Davis Kho at ndkho@marcinko.com, +1 510 336 1119.
About OrthoEvidence, Inc.: OrthoEvidence (OE) is a fast-growing online platform of innovative products and services targeted to evidence-based surgical practice, focusing on orthopedics. OE focuses on helping associations and industry architect, analyze, and educate their networks about health care decisions. OE's competitive advantage derives from skilled data scientists, programmers, and analytics teams. Through automation and algorithms using machine learning, OE is building the business intelligence platform "OE M.I.N.D.- Machine learning INsights Database" with over 75 million datapoints to drive new analytics and evidence reports. For additional information, please contact Vice President, Sonia Dosanjh at sonia.dosanjh@myorthoevidence.com, +1 289 337 5717.

MEIG's expertise in identifying, negotiating, and managing deals with licensing partners in order to expand the reach of OrthoEvidence's content means more patients, medical professionals, pharmaceutical companies and others will find the critical information they need, more easily.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

A sobering report released last week details a national surge in overdose-related cardiac arrest due to the COVID-19 epidemic in the United States. This report sheds light on the toll the COVID-19 pandemic is taking on vulnerable populations, including those suffering from addiction. Waismann Method Medically Assisted Opioid Treatment views this as a call to action to extend treatment services to those dealing with opioid addiction, including an expansion of mental health treatment to address addiction's underlying causes.

BEVERLY HILLS, CALIF. (PRWEB) DECEMBER 08, 2020
As of December 7, 2020, the United States reports more than 14.7 million confirmed cases of COVID-19 and 282,345 deaths due to the virus. However, the true magnitude of the pandemic is much greater. These death tolls do not include individuals who die due to lack of medical resources, and overburdened medical system, suicide, or mental health-related illnesses such as addiction.
The new report, published in JAMA Psychiatry, included data from the National Emergency Medical Services (EMS) Information System. This system includes information from more than 10,000 EMS agencies across 47 states, providing a comprehensive view of medical events in the United States. The report showed overdose-related cardiac arrests rising sharply in April 2020. By May 4, rates were more than double the baseline from 2018 and 2019. Overdose-related cardiac arrests decreased slightly in the summer months but remained 53.7% above baseline by July 27 and 48.5% above baseline by August 1.
The report also highlighted the relationship between mobility and overdose-related cardiac arrest. As mobility decreased sharply under stay-at-home orders, cardiac arrests rose. The researchers at the University of California-Los Angeles who authored the report speculate that the increase in overdose-related cardiac arrests may be due to more people using substances alone, increased toxicity of the drug supply, and reduced access to treatment. Combined, these factors make each overdose incident more deadly.
In response to the alarming report from JAMA Psychiatry, the Waismann Method Medical Group calls for mental health to be placed at the center of the conversation about the opioid crisis and COVID-19 pandemic. Dr. Michael H. Lowenstein, Director of the Waismann Method Medical Group, stated, "This report highlights what so many of us on the front lines of this crisis already know: the COVID-19 pandemic is making the opioid crisis worse. Mental health is deteriorating, and social isolation is putting people in risky situations. It's time to treat addiction and mental health problems as seriously as COVID-19."
Bold Action Needed to Combat the Twin Epidemics: COVID-19 and the Opioid Crisis
Before the COVID-19 pandemic, the United States was in the midst of an unprecedented opioid epidemic. This left a large portion of the population medically, socially, and psychologically vulnerable. The sharp increase in opioid-related overdose deaths since March 2020 points to the need for immediate action to address these twin crises.
COVID-19 infection contributes to respiratory frailty, which can be deadly for individuals suffering from opioid addiction. Mental health is an equally large concern. Social distancing and other safety measures are critical in reducing the spread of the virus. However, they also contribute to isolation, loneliness, and worsening of mental health symptoms. By late June 2020, 40% of Americans were dealing with substance abuse or mental health problems. Younger adults, essential workers, unpaid adult caregivers, and racial/ethnic minorities are disproportionately affected.
Opioid use disorder does not occur in a vacuum. It is driven by depression, anxiety, trauma, isolation, and other serious mental health problems. Only by treating these underlying mental health symptoms can we help people achieve long-lasting sobriety. Waismann Method Medical Group calls on public health officials to expand funding for education, mental health treatment, and life-saving medical care, including a medical detox. We urgently need to provide mental health and medical treatment to the vulnerable people who need it most.
About Waismann Method
Waismann Method has more than two decades of experience providing top-quality medical care for those suffering from Opioid Use Disorder (OUD). The center is internationally recognized for its hospital-based medically assisted opioid treatment, rapid detox protocol, and exclusive Domus Retreat for post-detox aftercare. The program is located exclusively in Southern California, where thousands of patients from all over the world have been successfully treated.
Clare Waismann SUDCC, RAS, founded the center in 1998. Its goal was and still is to continue providing the most effective, safe, and comfortable medically assisted opioid detoxification. A treatment option that helps individuals achieve an opioid-free state which allows them to be emotionally present for a more accurate psychological assessment and adherence to the indicated therapy. "A comprehensive inpatient medical evaluation, successful medical detox, and an accurate emotional assessment with an individualized plan are the best components to support people in maintaining a healthy journey," Clare Waismann.
Waismann Method and Domus Retreat, together, provide people a scientific and individualized approach to patient care, featuring a multidisciplinary team to ensure safety, comfort, and success.
Find out more about Waismann Method at https://www.opiates.com.
LinkedIn
Facebook
Twitter




START your own Wordpress site, business or personal website, or online store at www.siteground.com

Pacor, Inc., an authorized OEM Fabricating Partner for Aspen Aerogels, is proud to announce that Cryogel is a potential solution for enhanced ultra-cold storage and transport of COVID-19 vaccines.

BORDENTOWN, NJ (PRWEB) DECEMBER 08, 2020
Pacor, Inc., (https://www.pacorinc.com) a leading fabricator of insulation solutions for OEM and Industrial Applications, is proud to announce that Cryogel can extend the sub ambient temperature stability substantially longer than dry ice and traditional insulation materials.
The recent news announcements of the efficacy of Covid-19 vaccines are very encouraging. One particular vaccine, however, requires Ultra-Cold (-70 C) temperatures for transport and storage.
If your company manufactures containers, boxes or coolers for storing or transporting medical supplies like vaccines, the news also made clear that is a large challenge for small or rural medical clinics and facilities.
These facilities have limited resources, personnel and access to dry ice, especially during a dry ice supply shortage and increased competition to acquire the scant amount available.                                                                                                    
How does your company produce a storage container that can stay at -70 C degrees for significant periods of time?
How can your company's containers assist these remote medical facilities that need to replenish dry ice every 5 days, in order to maintain this temperature and not threaten viability of the vaccine?
Pacor has a solution for you: Cryogel insulation. Cryogel is made specifically for sub ambient and cryogenic applications. Cryogel can extend the sub ambient temperature stability substantially longer than the 5 days expected from using dry ice with traditional insulation materials
Pacor can custom fabricate Cryogel to fit any type of container, box or cooler.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In this free webinar, the featured speakers will discuss key areas of tumor biology, beyond what is found on typical targeted liquid biopsy panels and assess tumor spatial heterogeneity exome-wide, by complementing liquid biopsy results from tumor tissue analysis using ImmunoID NeXT. Attendees will learn about how the NeXT Liquid Biopsy can help study teams interrogate acquired therapy resistance mechanisms and monitor clonal evolution.

TORONTO (PRWEB) DECEMBER 08, 2020
While solid tumor biopsies remain the standard for the interrogation of the cancer genome, the advent of liquid biopsies and multi-region tissue sampling has demonstrated that there can be more to a cancer's genotypic profile than that found in a single tissue biopsy. NeXT Liquid Biopsy, a first-of-its-kind, high-performance, exome-wide liquid biopsy assay, is designed to complement ImmunoID NeXT, providing a unique ability to further evaluate the cancer ecosystem and advance the development of next-generation therapies.
NeXT Liquid Biopsy enables investigation into key applications, such as spatial and temporal heterogeneity of the tumor, clonal evolution and tumor dynamics in response to therapies, and mechanisms of acquired resistance. NeXT Liquid Biopsy is purpose-built to navigate the inherent variability of circulating tumor DNA (ctDNA), elucidating key areas of tumor biology not often addressed by targeted, commercially available liquid biopsy panels.
To enable sensitive variant detection across 20,000 genes, this enhanced exome assay and chemistry achieves high sequencing depth of approximately 2,000x exome-wide, with additional boosted depth, 5,000x, for 247 cancer-related genes. Personalis has developed a computational pipeline optimized to lower the noise floor for variant detection, providing sensitive monitoring and de novo detection of variants over multiple time points.
Join expert speakers from Personalis, Sean Michael Boyle, PhD, Senior Director, Bioinformatics Applications; and Dan Norton, MBA, Senior Product Manager, in a live webinar on Thursday, December 17, 2020 for a discussion of the data demonstrating the genomic profiling and assay performance enabled by NeXT Liquid Biopsy through the evaluation of various reference standards and actual patient samples. Participants can choose from 2 live broadcasts at 8am EST (1pm GMT/UK) and 4pm EST.
For more information, or to register for this event, visit NeXT Liquid Biopsy: A High-Performance, Exome-Wide Liquid Biopsy Assay to Study Tumor Dynamics.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/



START your own Wordpress site, business or personal website, or online store at www.siteground.com

COVID-19 Screener and Exposure Alert tools provide critical data needed to safely reopen schools

SAN FRANCISCO (PRWEB) DECEMBER 08, 2020
Hazel Health, the national leader in school-based healthcare, announces the release of essential COVID-19 tools that enable school district officials to reopen schools as safely as possible and meet local health regulations. The availability of the new tools comes at a time when more schools are reopening and COVID-19 cases are surging in the U.S.
Hazel Health's COVID-19 safety tools include:

COVID-19 Screener: To support district health protocols, the COVID-19 screener enables parents to check and confirm symptoms their child may be experiencing before the child enters a school environment. On-demand visits are also available through the screener to address parents' questions and concerns. Hazel Health designed the screener with ease of access and multilingual communities in mind.

Exposure Alert: As schools are notified of COVID-19 cases, Hazel Health's Exposure Alert helps identify all students and staff exposed to each confirmed case and provides support and next steps for students. Notifications of positive cases are delivered instantaneously to district officials, enabling rapid response at the school and district level. Exposure Alert syncs with class schedule data from Clever to provide actionable information for campus safety.

"Hazel Health was founded upon the belief that all children deserve access to quality healthcare in order to excel – a mission that has become even more crucial with the COVID-19 pandemic," said Josh Golomb, CEO at Hazel Health. "Inspiration for our new COVID-19 safety tools came directly from the education leaders we work with every day. Our goal is to support a safe and healthy learning environment and ensure healthcare for all students, in all communities, regardless of financial or immigration status."
Through a secure, web-based platform, school nurses or parents at home can access Hazel Health from any device to coordinate care for students and request telehealth appointments with Hazel's HIPAA and FERPA trained, board-certified healthcare providers.
"As we navigate the fluctuation of in-person and online learning, we're thrilled to partner with Hazel Health and leverage their COVID-19 safety tools so we can provide a safe learning environment for students," said Bridget Phillips, Chief Academic and Operations Officer, The Doral Academy of Nevada, a part of the Academia network of charter schools. "We were previously using Google Sheets to track symptoms, and had to manually comb through information – with Hazel Health's system, there is proactive reporting which saves time and enables students to receive telehealth care sooner if there's a potential positive."
Hazel Health's COVID-19 safety tools are HIPAA and FERPA compliant, with sensitive health data remaining within the secure platform. To learn more, please visit https://get.hazel.co/covid19.
About Hazel Health
Hazel Health is committed to eliminating barriers to quality healthcare for children. As the national leader in delivering pediatric telehealth care, Hazel Health partners with school districts across the U.S. and currently serves over 1.3M children. Hazel's team of experienced pediatricians, educators, and best-in-class engineers are passionate about ensuring all children receive the best care in school or at home. Hazel is based in San Francisco, California. For more information, please visit http://www.hazel.co



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Healthcare Surfaces Institute's cutting-edge collaboration between organizations and professionals now includes Spry's patented soft-surface filter technology – strengthening their efforts to curb infection rates caused by healthcare surfaces.

WHITE PLAINS, N.Y. (PRWEB) DECEMBER 08, 2020
Spry Therapeutics and Healthcare Surfaces Institute today announced they have entered into a strategic partnership, combining the organization's clinical expertise and resources with Spry's deep knowledge in soft-surface contamination – particularly as it pertains to pillows and mattresses. With surfaces playing an increasingly critical role in the fight against healthcare acquired infections (HAIs), both parties recognize the importance of including soft-surface contamination in the discussion around prevention.
Soft surfaces – such as pillows and mattresses – can facilitate the transfer of disease within hospitals, with deadly infections spreading from patient to patient. In fact, ECRI Institute listed soft surfaces second on their list of Top Health Technology Hazards, stating: "Blood and other body fluids that remain on, or within, mattresses or mattress covers after cleaning can contact subsequent patients, posing an infection risk."
Spry Therapeutics is committed to helping healthcare facilities eliminate soft surfaces as vectors for contamination by providing the world's first and only soft-surface filter technology: Pneumapure. The company's patented filter technology is proven effective in blocking even the smallest "superbugs" – down to .02 micron – from entering or exiting any soft surface to which it's applied, helping to prevent the transmission of deadly diseases among patients and caregivers. Pneumapure also reduces costs associated with HAIs from environmental impact to disposal costs, annual purchase expenditures and more.
The company's partnership with Healthcare Surfaces Institute is based on the fundamental understanding that many HAIs are preventable when the problem is understood and proper guidelines, testing and infection prevention protocol are implemented. The Institute is a collaboration of key decision makers in healthcare, manufacturing, academia, professional organizations, standards-setting organizations, regulatory agencies and other nonprofit entities. Each of these specialists is focused on scientific research and creating measures, metrics, and guidelines, as well as outreach and educational programs to reduce preventable infections by interrupting transmission of microbes via surfaces.
"We are thrilled to be partnering with Healthcare Surfaces Institute in their mission to reduce the spread of infection through surfaces," says Bill Purdy, CEO and Co-Founder of Spry Therapeutics. "From inception, Spry's goal has always been to protect patients and caregivers with our breathable barrier solution, and we look forward to bringing soft-surface cleanliness to the forefront of prevention."
"We are really looking forward to including Bill and his team in our certification initiative work," says Linda Lybert, Founder and Executive Director of Healthcare Surfaces Institute. "He brings incredible expertise around the issues facilities face with soft surfaces, specifically pillows and mattresses. Patients are constantly in direct contact with these surfaces, and we need to make sure they can be effectively cleaned and disinfected. Bill will also become a resource to our Scientific Advisory Board and will participate in development of research and guidelines with others in the field."
To learn more about Spry Therapeutics and its fight against HAIs with its virus-blocking filter technology, visit sprytx.com.
About Spry Therapeutics
Spry Therapeutics is a health and wellness technology company that uses a proprietary soft-surface filter technology to block all pathogens from entering or exiting any soft surface to which it's applied. The Company's Pneumapure filter is designed to help prevent cross-contamination among patients and caregivers, and provide a clean sleep solution to businesses and consumers alike. Spry Therapeutics is headquartered in White Plains, NY. For more information, visit sprytx.com. Follow Spry Therapeutics on LinkedIn.
About Healthcare Surfaces Institute
The Healthcare Surfaces Institute is a cutting-edge collaboration of thought leaders who work together to evaluate and understand all aspects of the role surfaces play in transmitting pathogens that cause infection and illness in healthcare settings.
Finding solutions to the spread of infections via surfaces requires an understanding of all contributing factors. This can only be done by bringing together experts that have high levels of understanding and expertise in many different areas – often with very different perspectives and opinions about how the issue must be addressed.
Our mission is to reduce preventable infections through collaboration of industry, academia, science, regulatory, and service sectors by interrupting the transmission of surface-related pathogens in healthcare in support of community and public health.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

United Nations Office on Drug & Crime (UNODC) is launching "Listen First: The Science of Care," ten animated videos and written campaign of information produced by Ethan Films for parents and caregivers worldwide to help them and their children during COVID-19. Based on scientific evidence, the campaign takes an enjoyable and loving approach to inform parents, and it is being highlighted across various organizations including the Walther Center in Global Palliative Care & Supportive Care at Indiana University, Olympic Coach and Athlete networks, on Dr. Koonce's TV show and more.

VIENNA (PRWEB) DECEMBER 08, 2020
On Human Rights Day we commemorate the Universal Declaration of Human Rights. This year's theme is the global COVID-19 pandemic and its aftermath; children worldwide are suffering ever more due to COVID-19. Millions are unable to attend schools, especially girls in developing countries, and many lack access to food, shelter, and healthcare as parents are also under extreme pressure. To that end, United Nations Office on Drug & Crime (UNODC) is launching "Listen First: The Science of Care," ten videos and written campaign of information produced by Ethan Films for parents worldwide to help their children and better prepare them for the future, based on scientific evidence worldwide. Each episode focuses on a parenting tip, offering the scientific reasons why it helps.
For example, one video demonstrates how affection, such as a hug, generates oxytocin, a chemical in the brain, which can stimulate growth, strengthen the immune system and make children grow smarter, healthier, and happier. Equally as important is "patient parenting," because patience makes children feel cared for and loved, plus neuroscience shows that the child's brain is not mature enough to calmly handle frustration. In the current video, the parents' patience leads the children to be successful in their efforts to score a winning touchdown. The campaign is spread online using the hashtags #scienceofcare and #listenfirst, and is highlighted across various organizations including the Walther Center in Global Palliative Care & Supportive Care at Indiana University, Olympic Coach and Athlete networks, on Dr. Koonce's TV show and more. Dr. Koonce, formerly star linebacker for the Superbowl-winning Green Bay Packers and on their Board of Directors, grew up in poverty himself, and is now Senior Vice President for University Relations at Marian University.
"Parents more than ever need proven strategies, based on science," says Giovanna Campello, Chief UNODC Prevention, Treatment & Rehabilitation Section, "to support how they raise their children. As people are forced to work from home, and as Covid-19 contributes to increased stress, more than ever we need to focus on the needs of the children. The buy-in already from governments around the world is extraordinary, ranging from Indonesia to Slovenia, Russia, and France."
The materials, including scientific resources, are all available at:
http://www.unodc.org/listenfirst
The new video on Patience can be seen here:
https://www.unodc.org/unodc/en/listen-first/success-stories/touch-down-for-humanity
It can be downloaded here:

Social Media
Twitter
UNODC_PTRS
Facebook
@UNODCYouthInitiative
@EthanFilms
For interviews with UNODC or the Touchdown for Humanity Team, please contact: miles@ethanfilms.com Phone:+34 632 739 699



START your own Wordpress site, business or personal website, or online store at www.siteground.com

This information is from the Relapsing Polychondritis Foundation Inc. with Race for RP and is not sponsored by, nor a part of, the American College of Rheumatology.

NEW YORK (PRWEB) DECEMBER 08, 2020
The American College of Rheumatology (ACR) held its annual meeting, ACR Convergence 2020, on November 5-9th. The all-virtual meeting included clinical and basic science symposia, notable speakers such as Dr. Anthony S. Fauci, Director of the National Institute of Allergy and Infectious Diseases, a virtual exhibit hall, and patient perspective posters and presentations authored by individuals with rheumatic disease.
This year's annual meeting also featured five relapsing polychondritis patient poster submissions that were selected for presentation. Four of the posters were sponsored by the Relapsing Polychondritis Foundation and one poster was sponsored by the Canadian Society for Relapsing Polychondritis.
"Poster presentations like these are an important part of our efforts," said David Bammert, President of the RP Foundation. "They provide the opportunity for the medical community to better understand the patient's perspective regarding living with RP and facilitate pathways for more efficient patient care."
Nancy Linn presented her poster, Connecting Rheumatology Professionals & Thought Leaders Inspired the Creation of a New Program Focused on Relapsing Polychondritis, a Rare Rheumatic Disease, outlining the ideation and establishment of the Penn RP Fund, a research initiative and partnership between the University of Pennsylvania RP Program and the National Institutes of Health (NIH) sponsored Vasculitis Clinical Research Consortium (VCRC) made possible by relationships fostered at previous ACR meetings and other similar gatherings of clinicians, researchers, patients, and advocates.
Isabel Bautista's poster, Patients With Relapsing Polychondritis and an Advocate Manufactured Custom Cloth Masks to Combat COVID-19: This Mask Project Provided a Sense of Purpose, Created Unity, Increased Awareness of RP, Facilitated Research, and Generated Hope, detailed the story of her team of RP patients who helped patients across the globe by making and distributing free masks and ear savers to protect them from COVID-19 during the pandemic. Ms. Bautisa was one of only four patients selected to present her poster to ACR attendees.
With Coping Through Advocacy – My Story Living With Relapsing Polychondritis, Allegonda Imeson shared her story about founding the Canadian Society for Relapsing Polychondritis as a means of spreading awareness about the disease and supporting patients, including herself.
Tedi LaMere's presentation of My Multidisciplinary Healthcare Team and Patient Advocacy Groups Saved My Life followed her RP story from onset to diagnosis and treatment and revealed how through the help of Friends of Patients, NIH specialists were able to identify and address several life-threatening conditions she faced.
Dan Smith's poster, Only in My Dreams Can I Do the Things I Used To Do: Where There is Research There is Hope, illustrated the positive impacts of finding a support group and new creative pursuits to promote well-being.
While each poster highlights different aspects of patient engagement, intervention, and self-management of this rare disease, an overarching theme of collaboration and partnership emerged. As they worked hard to find purpose and find ways to cope with their illness, the patient-presenters sought out community and support and became relapsing polychondritis and autoimmune disease advocates actively engaged in helping other patients, promoting increased awareness, and pushing for greater research – each in their own way – resulting in improved quality of life for many.
"We were honored to have so many RP patients represented and encouraged by the progress of the research, which was presented to 16,000 attendees. ACR did an outstanding job facilitating this exciting and informative forum," said David DeRosa, Secretary / Treasurer of the RP Foundation.
Additional information regarding ACR Convergence 2020 Patient Perspective Poster Educational Sessions and Oral Abstracts can be found here.
About Relapsing Polychondritis
Relapsing polychondritis (RP) is a debilitating and sometimes fatal systemic inflammatory disease that is characterized by recurrent inflammation of cartilage and other tissues throughout the body. The disease affects multiple organs, particularly cartilaginous structures such as the ears, nose, airways and joints as well as eyes, skin, heart valves and brain. The cause of RP is unknown and there is no cure for RP. For more information, visit https://bit.ly/RP_Poster.
About Relapsing Polychondritis Foundation
The RP Foundation's purpose is to facilitate education, awareness and research initiatives that improve the quality of life for patients with RP. For more information, visit https://www.polychondritis.org.
About Race for RP
Race for RP supports research and awareness programs for relapsing polychondritis and related diseases. For more information, visit http://www.RaceforRP.org or http://www.facebook.com/raceforrp. Follow Race for RP on Instagram and Twitter, @RaceforRP.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

COVID, injectable drug growth drives demand for -25◦C and -70◦C containment.

INDIANAPOLIS (PRWEB) DECEMBER 08, 2020
In response to ever-evolving demand for FDA-regulated, temperature-controlled storage and distribution of pharmaceutical and medical devices, Life Science Logistics (LSL), a leading, national provider of healthcare supply chain solutions, today announced the company plans to add ultra-low frozen storage to its extensive mix of life science product-related storage by the end of December 2020.
Driven by increasing demand for COVID-related and injectable drugs with "live" particulates requiring extreme freezes to preserve vaccine integrity, the company plans to add a significant number of -70-degree Celsius, ultra-low frozen storage ThermoFisher Scientific freezers and -25-degree Celsius ThermoFisher Scientific freezers to its 526,200 sq.ft. Brownsburg facility.
"By offering yet another temperature range service offering that is in high demand, we're showing our current and future clients that Life Science Logistics is committed to being a one-stop shop for healthcare storage and distribution," says LSL CEO Richard Beeny. "More than ever, the healthcare industry needs us to be nimble, creative and responsive as they explore new injectible trials and solutions for large-scale diseases."
According to Beeny, the company had lots of requests pre- and during COVID for ultra-low frozen storage due to significant growth in injectible drugs for myriad diseases. He added that due to the sensitive nature of so many drugs, proper vaccine storage and handling is critical for efficacy of the products.
The company has two existing FDA-regulated storage and distribution facilities – a 526,200 sq. ft. Brownsburg facility and a 280,000 sq.ft. Whitestown facility. An additional Whitestown-based, 200,000 sq.ft. mixed-use storage facility, including cold-chain and controlled room temperature capabilities, is slated to open in early 2021.
About Life Science Logistics
Founded in 2006, DFW-based Life Science Logistics (LSL) is a leading, national provider of end-to-end, high-quality, customizable healthcare supply chain solutions. For clients ranging from Fortune 500 companies to startups, LSL offers its pharmaceutical, medical device, and biotech clients the ability to outsource services ranging from distribution to kitting to back- and middle-office functions. FDA-registered and VAWD-accredited, LSL operates from six locations totaling more than 2 million square feet of cGMP compliant space.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Batson to Lend Deep Experience in CFO and Senior Business Leadership Roles to Help GHX Continue to Reduce Costs in Healthcare

LOUISVILLE, COLO. (PRWEB) DECEMBER 08, 2020
Global Healthcare Exchange (GHX) today announced the promotion of Chris Batson to Chief Financial Officer, effective January 1, 2021. Batson, who has served since 2019 as GHX's vice president, Finance and Accounting, will succeed Rob Gillespie in the role of CFO. Gillespie will continue with the company until the summer of 2021 to ensure a seamless transition. Batson will report directly to CEO Bruce Johnson.
"Rob's impact at GHX the past thirteen years cannot be overstated," said Johnson. "I'm grateful for the care he's put into developing a solid transition plan and his ongoing partnership. Rob has helped our company evolve alongside the industry and create considerable value for our customers and equity holders. On behalf of our Board and everyone at GHX, I'd like to thank Rob and wish him continued success."
Batson brings extensive experience in general management, business strategy, mergers and acquisitions, capital structure management and private and public company management. In his earlier role at GHX, Batson was responsible for the company's Financial Planning & Analysis, Treasury, Tax, Audit, Financial Reporting and Controllership functions.
"Since Chris joined GHX more than a year ago, I've been impressed by his curiosity, work ethic, passion for our customers and colleagues and skill in solving complex challenges," added Johnson. "Having previously served in senior business and CFO roles, Chris brings a well-rounded perspective of GHX's financial needs as well as P&L leadership. I'm confident Chris will help us continue to navigate the ripple effects of COVID-19 and deliver on our mission to enable better patient care and help the healthcare community save more than a billion dollars each year."
"As value-based care becomes the norm and we move toward the creation of more resilient, clinically integrated supply chains, GHX is perfectly poised to support the industry's transformation," said Batson. "I'm excited to solidify our long-term vision during an important industry evolution."
Prior to joining GHX, Batson served as president for ACS Group, a privately held $600 million information technology consulting and staffing company. He also served as senior vice president and general manager, and earlier as CFO, at Ciber Inc., a global information technology consulting, services and outsourcing company. Batson has also served in senior business and finance roles at organizations including TeleTech Holdings and NCR Corporation. Batson has a BS in Industrial Engineering from the University of Tennessee and an MBA from Indiana University's Kelley School of Business.
About GHX
Building on decades of collaboration between providers, manufacturers, distributors and other industry stakeholders, Global Healthcare Exchange, LLC (GHX) is leading the charge in helping organizations run the new business of healthcare. By automating key business processes and translating evidence-based analytics and data into meaningful action, GHX is helping the healthcare ecosystem to move faster, operate more intelligently and achieve greater outcomes. With the support of GHX, healthcare organizations have removed billions of dollars of wasteful healthcare spend. For more information on GHX's suite of world-class, cloud-based supply chain and pharmacy solutions, visit http://www.ghx.com and The Healthcare Hub. GHX has also launched a COVID-19 Information Center that provides a wealth of free resources and access to data and information needed to help serve patients and protect staff during the pandemic



START your own Wordpress site, business or personal website, or online store at www.siteground.com

$15 Million Integrated Approach Will Create Grants and New Scientific Resources to Identify Biomarkers, Enable Early Diagnosis and Track the Effectiveness of Potential Treatments

NEW YORK (PRWEB) DECEMBER 08, 2020
Today, Target ALS launched the first-ever comprehensive effort to discover ALS biomarkers — The Target ALS Diagnosis Initiative — through which the organization will invest $15 million in collaborative grantmaking and the development of new scientific resources. The initiative was developed in response to input from over 100 scientists, patients, caregivers and other thought leaders. They universally identified ALS biomarkers as a critical unmet need to diagnose the disease early, track its progression and provide reliable measures for new treatments.
"This is a major milestone for Target ALS, as we've proven our ability to respond to the needs of the scientific community in ways that accelerate their work like never before. We are now increasing this commitment significantly, with The Target ALS Diagnosis Initiative, in order to advance ALS biomarker research," said Target ALS Chief Executive Officer, Manish Raisinghani, MBBS, Ph.D. "It's been gratifying for our team to support scientists over the last seven years and know that we are spearheading access to essential resources that can help them realize life-changing benefits for people with ALS."
The Target ALS Diagnosis Initiative strategically focuses on three promising areas:

Establishing new ALS biomarker-focused collaborative funding opportunities to fuel new projects for discovery and development of ALS biomarkers.

Creating a five-year natural history study that will integrate longitudinal biofluid collection, clinical-grade speech, language and respiratory measures, clinical and demographic information, as well as genomic datasets from ALS and control cases.

Developing an integrated Biofluid and Genomics core that will exponentially improve the impact of human biosamples on research through the integration of longitudinal biofluids, genomic datasets and postmortem tissue with expedited, no-strings-attached access to samples worldwide.

THE TARGET ALS DIAGNOSIS INITIATIVE IN-DEPTH
Components of The Target ALS Diagnosis Initiative, with more to be added potentially in the future based on research needs and opportunity, are as follows:
COLLABORATIVE FUNDING FOR ALS BIOMARKER RESEARCH
Target ALS is building on its collaborative grantmaking efforts to support new ALS biomarker discovery and development projects. It will include both pre-competitive funding, where a panel of experts openly formulate projects by consensus with results shared immediately with the research community, and competitive funding, to encourage ideas from investigators and advance the most promising collaborations.
Pre-competitive research: A working group of over 30 representatives from pharmaceutical, academic and non-profit foundations will collaborate on new, innovative approaches for the discovery, validation and development of novel ALS biomarker candidates. This effort will build upon work initiated in 2017, through which Target ALS funded four ALS biomarker projects as recommended by the working group: Phosphorylated neurofilament; heavy and light chains (in partnership with the Muscular Dystrophy Association); Urinary p75 neurotrophin receptor extracellular domain (in partnership with the Muscular Dystrophy Association); and TDP-43 (in partnership with The ALS Association).
Competitive research: Later this month, Target ALS will announce the results of the first-ever request for proposals focused on ALS biomarker discovery and development that required academic investigators and the pharma/biotech industry to collaborate in order to receive funding. This builds on a $5 million funding call, issued last fall with The Association for Frontotemporal Degeneration, targeting treatments and biomarkers for ALS and FTD.
NATURAL HISTORY STUDY
Expedited no-strings-attached access to longitudinal biofluid samples has been a long-standing barrier for most researchers. These samples are invaluable in the search for ALS biomarkers and drug targets as they are donated by living patients over the course of their disease, thereby offering unique insights into the pathogenic evolution of the disease over time.
Target ALS will launch a five-year natural history study that will aim to integrate collection of biofluids — including CSF, blood and urine along with clinical speech, language and respiratory measures, and demographic information from over 200 ALS and 80 non-disease patients.
Speech and language collection and analysis will be provided by speech neuroscience innovators, Aural Analytics, Inc. They will help bolster the collection of vital biomarker information, drawing upon their expertise in gathering rich, interpretable and validated data on neurological and respiratory health.
In line with the Target ALS mandate, biofluid samples and datasets of the natural history study will be shared with the research community worldwide expeditiously with no strings attached.
INTEGRATED BIOSAMPLES AND GENOMICS CORE
Target ALS already provides ALS researchers worldwide with unprecedented access to critically needed research tools and resources, with no strings attached, through six scientific core facilities: Human Postmortem Tissue, Human Genomic Datasets, Human-Derived Stem Cells, Animal Models, Antibodies and Viral Vectors.
Target ALS is now extending these resources with a first-of-its-kind integrated Biosamples and Genomics core. This new core expands the impact of biosamples and data accessible through the Postmortem Tissue and Genomics cores by linking them to longitudinal collection of biofluid samples from ALS and control cases that will be carried out as part of the natural history study. As with all of the core resources created by Target ALS, the Biosamples and Genomics core will be accessible to researchers worldwide.
Although collection of longitudinal biofluids and postmortem tissue, as well as generation of and genomic datasets, as occurred in the past, unlike the Target ALS effort, they were implemented largely as standalone projects, therefore limiting their impact.
The new Integrated Biosamples and Genomics core is made possible through existing alliances with the ALS Association, the Tow Foundation and the New York Genome Center as well as the new partnership with Aural Analytics. Together, the partnership forms a triadic structure, aiming to offer a more complete picture of the pathogenesis of ALS as provided through patient biofluids — including CSF, blood and urine — as the disease progresses (longitudinal biofluid samples), after death (postmortem tissue) and the genomic, clinical and demographic datasets associated with these samples.
ABOUT TARGET ALS
Target ALS is a 501(c)(3) medical research foundation committed to the search for effective treatments for Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. We envision a world in which no one dies of ALS and play a unique role in the battle against this disease. Founded in 2013 by former New York City deputy mayor Dan Doctoroff – who lost both his father and uncle to ALS – our approach is breaking down barriers and silos that previously inhibited research results. We do this through our Target ALS Innovation Ecosystem, which facilitates unparalleled collaboration between researchers from academia and the pharma/biotech industry. The Target ALS Innovation Ecosystem has revolutionized the field in just seven years through collaborations that have resulted in the first potential treatments since ALS was identified in 1869.
To date, the Target ALS Innovation Ecosystem, which launched in 2013 and set the groundwork for the new Target ALS Diagnosis Initiative, has yielded 175+ research projects, 12+ therapeutic targets and five clinical trials, to date.
###
Contact: Steve Schonberg
Director of Communications
steve.schonberg@targetALS.org
(917) 717-0207



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Even as cancer outcomes have improved, many current diagnostic and treatment methods have been around for decades. Utah-based oncology firm NuView Life Sciences is developing a first-of-its-kind peptide analog, NV-VPAC1, which helps eliminate the need for costly, less accurate diagnostic tests and "scorched earth" treatment methods.

PARK CITY, UTAH (PRWEB) DECEMBER 08, 2020
A Utah oncology firm is developing a cancer diagnostic test and treatment delivery system that will make costly—and invasive—biopsies a thing of the past. For the most part, current diagnostic methods are time-consuming and expensive—most doctors order a battery of tests, including lab work, imaging studies, and surgical biopsies, to confirm malignancy.(1) New technology developed by clinical-stage oncology company NuView Life Sciences is poised to influence cancer diagnosis and treatment, helping doctors provide safer, less expensive, and more accurate care to each patient.
"NV-VPAC1(TM) will dramatically alter the way we diagnose and treat cancer," says Paul Crowe, CEO of NuView Life Sciences. "There is no other technology like it today—the peptide targets a variety of cancer cells with extreme precision, providing a binary approach to cancer diagnosis. We're working to develop the technology so that NV-VPAC1 will enable doctors to inform patients definitively whether they have cancer or not."
NV-VPAC1 is a unique proprietary peptide construct that targets a specific receptor, called vasoactive intestinal peptide receptor type 1 (VPAC1), which is over-expressed on the surface of cancer cells. While normal, healthy cells may have a few of these receptors, cancerous cells typically express millions of them, making them an ideal target for new diagnostic and theranostic technologies. Developed by a team of experts to include Dr's Mathew Thakur, Leonard Gomella, Charalambos Solomides, Edouard Trabulsi from Thomas Jefferson University, and Dr. Jay Bishoff, Urologist with Intermountain Healthcare, and Clinical Collaborator with NuView Life Sciences.
Even more exciting is that this new urine test for prostate cancer, NV-VPAC1, can be combined with Copper-64 (Cu-64), a positron emitter for PET imaging of metastatic prostate cancer and also combined with Copper (Cu-67) to treat prostate cancer, says Dr. Bishoff.
Dr. Bishoff and his colleagues have conducted research using voided urine specimens from men suspected of having prostate cancer after lab work revealed elevated prostate-specific antigen (PSA) levels. Each man included in this initial research received the combination of NV-VPAC1 attached with a fluorescent dye. Then, their urine specimens were examined under a confocal microscope—remarkably, the researchers noted that prostate cancer cells fluoresced under the microscope, while healthy, normal cells did not. Dr. Bishoff also notes that current tests have shown NV-VPAC1 to be extremely precise, with extremely low false positive rates. The next step is to conclude clinical trials and receive FDA approval. This is not an expensive genetic test, but a simple urine test that can be run in the lab and eventually in the doctor's office at a fraction of the cost of expensive genetic tests.
Beyond the obvious benefits to patients, NV-VPAC1 also helps doctors provide better treatment and improve outcomes. According to Dr. Bishoff, the peptide analog series will:

Eliminate unnecessary diagnostic testing. Unlike predictive analysis of specimen samples, NV-VPAC1 uses a binary approach to cancer diagnosis. In the case of prostate cancer, early in vitro studies indicate that voided urine samples are all that is necessary to detect shed prostate or bladder cancer cells.

Reduce diagnostic side effects and discomfort. Each year, almost 2 million prostate biopsies are performed in the United States. (2) These procedures are expensive, invasive, and, in some cases, lead to serious complications like sepsis. Doctors may use NV-VPAC1 as a better diagnostic option that poses no risk to the patient. Additionally, since NV-VPAC1 is engineered to detect cancer in voided specimens, there is no need to perform uncomfortable and invasive tests, such as a digital rectal examination, to help confirm a diagnosis.

Help doctors tailor treatment to individuals. In many cases, standard cancer treatment methods use a "scorched earth" method—high doses of chemotherapy are given, which kill healthy cells along with cancer cells. Or, part of the patient's body is bathed in high doses of radioactivity, which also poses harm to the patient. Unlike these methods, NV-VPAC1 can be combined with Cu-67 and target only cancer cells, killing them while preserving healthy tissue. The technology should make it possible for doctors to deliver lower doses of more precise treatments to better serve their patients.

Allow doctors to monitor response to treatment. Early in vivo studies show that cancerous cells readily bind to NV-VPAC1. When combined with the radionucleotide Cu-64, the peptide analog appears to "light up" on standard imaging studies, such as positron emission tomography (PET) imaging. This technology can, in turn, be used to monitor a patient's response to treatment by comparing the size and location of tumors before and after initiation of various therapies.

Dr. Bishoff says, "Other types of cancers, including breast, bladder, and adrenal cancer, also express VPAC1 at high levels. Our initial successes using NV-VPAC1 to diagnose prostate cancer would pave the way for the technology to eventually be used for other types of cancer, both rare and more common."
Thanks to preliminary testing, NuView Life Sciences is taking NV-VPAC1 into clinical trials to examine the peptide's accuracy in prostate cancer diagnosis. The study, hosted at Intermountain Healthcare, will recruit 150 patients who are scheduled for prostate biopsy to confirm or rule out prostate cancer. Biopsy results will be compared to the results obtained using NV-VPAC1 to analyze voided urine specimens to determine whether NV-VPAC1 is truly more accurate compared to standard prostate cancer diagnostic methods. Eventually, this clinical trial will expand to include other major medical institutions and universities.
"We're confident in our technology and the promise it holds for cancer diagnostics and treatment. We hope that, by undergoing clinical trials, we can prove how beneficial NV-VPAC1 will be in avoiding unnecessary procedures, reducing cancer care cost, and providing better outcomes to patients," says Bishoff.
About NuView Life Sciences
Founded in 2005, NuView Life Sciences is a clinical-stage precision oncology company located in Park City, Utah, advancing the way cancer is diagnosed and treated in our modern healthcare system. NuView is focused on creating precision binary cancer diagnostics and theranostics, providing clinicians more choices to improve patient outcomes while reducing healthcare costs through the development and clinical application of its exclusive proprietary peptide analog technology, NV-VPAC1(TM). Led by a multidisciplinary team of industry experts with decades of combined experience in healthcare and medical imaging technologies, NuView is poised to introduce a new cancer diagnostic technology and subsequently deliver a theranostic approach for effectively treating cancer. To learn more, visit http://www.nuviewlifesciences.com.
1.    "How Cancer Is Diagnosed." National Cancer Institute, 2020, cancer.gov/about-cancer/diagnosis-staging/diagnosis.
2.    "NuView Diagnostics: In Vitro." NuView Life Sciences, 2020, nuviewlifesciences.com/diagnostics/in-vitro-diagnostics/.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

The ISPE Foundation and Gilead Sciences, Inc., have established the ISPE Foundation Diversity Internship Program to provide world-class opportunities to groups that are typically underrepresented in the pharmaceutical industry.

NORTH BETHESDA, MD. (PRWEB) DECEMBER 08, 2020
The ISPE Foundation and Gilead Sciences, Inc., have established the ISPE Foundation Diversity Internship Program to provide world-class opportunities to groups that are typically underrepresented in the pharmaceutical industry.
The ISPE Foundation Diversity Internship Program is a 12-week summer program that offers graduate students and undergraduate students in their junior or senior year the opportunity to spend their summer working on high-priority, impactful engineering and facilities projects and workstreams in Gilead's Corporate Operations organization.
"It is a privilege to partner with Gilead on the launch of a program that will be truly life changing to the careers of a diverse pool of talented students and future leaders in the pharmaceutical field," said Antonio Moreira, PhD, ISPE Foundation Board Chair, Vice Provost, Academic Affairs, University of Maryland Baltimore County. "The ISPE Foundation Diversity Internship Program interns will be immersed in creative and innovative projects, they will be connected with role models and senior leaders at Gilead, and they will be encouraged to let their imagination go to places they had not thought possible. I can't think of a more inspiring and energizing way to start my role as the ISPE Foundation Chair."
"Gilead is committed to investing in the next generation of engineers and are pleased to partner with the ISPE Foundation on this program," said Joydeep Ganguly, Senior Vice President of Corporate Operations at Gilead. "We believe that diverse teams are inherently strong teams and look forward to the ways these interns will contribute to our highest priority projects."
There are currently two summer internship opportunities available at Gilead within the Corporate Engineering and Facilities function:

Mechanical Engineering with Focus on Energy/Sustainability

Electrical Engineering with Focus on Process Control/Automation

The individuals in both internship roles will be expected to engage in a wide range of activities, such as creating standard equipment or discipline specifications with input from subject matter experts, developing standard installation details in AutoCAD as part of GEP, supporting various PI projects, e.g. checking on data integrity (non-GMP related work).
To learn more, please visit ISPEFoundation.org/Diversity-Internship-Program-Sponsored-Gilead.
About ISPE and ISPE Foundation
The International Society for Pharmaceutical Engineering (ISPE) is a not-for-profit association serving its 18,000+ Members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. Founded in 2017 as the philanthropic arm of ISPE, the ISPE Foundation supports education, training, and research for the advancement of innovative technologies and provides solutions to global challenges in the development, manufacture, and supply of quality pharmaceutical products for the benefit of patients around the world. To aide in this endeavor, the Foundation focuses on initiatives related to increasing the technical knowledge of the incoming workforce, fostering diversity within the industry, and supporting efforts to bring quality pharmaceutical manufacturing to new markets. Visit ISPEFoundation.org for more information.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. Visit Gilead.com for more information.
Inquiries related to the program may be directed to:
Catherine Ford
Foundation Operations Manager
cford@ispe.org

The ISPE Foundation Diversity Internship Program interns will be immersed in creative and innovative projects, they will be connected with role models and senior leaders at Gilead, and they will be encouraged to let their imagination go to places they had not thought possible.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Arizona-Based Healthcare Firm Provides Canadian Snowbird Program to Offer Members Access to High-Quality Healthcare Without Unnecessary Costs While Traveling During the Winter

SCOTTSDALE, ARIZ. (PRWEB) DECEMBER 08, 2020
As COVID-19 cases and hospitalizations continue to reach meteoric heights across the U.S., one Arizona-based healthcare firm, Redirect Health, is providing a cost-effective and efficient solution to healthcare for Canadian snowbirds and travelers visiting the U.S.
The new Canadian Snowbird program offers individuals access to high-quality healthcare while avoiding unnecessary costs, providing peace of mind during these turbulent times.
The program allows members to schedule and fast track virtual and in-office appointments with no out-of-pocket costs, as well as coordinate discounted prescription refills, x-rays, COVID-19 testing plus treatments and more through call, text, or video, 24/7. The Canadian Snowbird program also features referral and personalized care navigation and cost negotiation to help guide members through the U.S. healthcare system. On top of this, the program offers physician-to-physician case management to provide important communication between U.S. physicians and Canadian physicians.
"The pandemic has further highlighted the need for all individuals to have access to quality care, without surprise bills or unnecessary costs," said Dr. Janice Johnston, medical director and co-founder of Redirect Health. "As a Canadian myself, I understand that Canadians need the comfort of knowing they can receive proper medical care when they are away from home."
Membership includes no cost access to 24/7 virtual primary care, primary care office visits, routine lab work, and chiropractic office visits at Redirect Health's three Maricopa County medical centers. It also includes access to a prescription discount program, discounted imaging, hospitalization and catastrophic protection, and emergency travel back to Canada.
"Canadian snowbirds increasingly need their healthcare to be portable, easy, and affordable. No one should have to worry about having access to quality care when they come to Arizona," said Paul Johnson, CEO and co-founder of Redirect Health. "Our program offers a cost-effective solution for Canadians that avoids the unnecessary stress of getting medical attention for everyday or emergency situations."
The Canadian Snowbird program is $12.99 per day for individuals, $19.99 per day for a couple, and $29.99 per day for a family membership.
"Canadians rent or own about 100,000 homes in Arizona and, even with COVID-19, many are still making their way down here this winter," said Glenn Williamson, CEO of Canada Arizona Business Council. "Now more than ever, it's important for them to have a healthcare option that is affordable and offers so much."
For more information about Redirect Health, please visit https://www.redirecthealth.com/canada/
###
ABOUT REDIRECT HEALTH
Redirect Health is a Scottsdale-based direct care provider and advocate for small business -- the result of over 20 years of innovative work in healthcare with a focus on putting people, and the businesses that employ them, first. Dr. David Berg, Dr. Janice Johnston and, past-Phoenix mayor, Paul Johnson started Redirect Health with a goal to simplify healthcare and lower costs.
Simply removing waste, unnecessary administration and streamlining care created a huge positive change that has allowed Redirect Health to grow exponentially, and now offer services across the country. By pushing back on the traditional healthcare system, Redirect Health has put the focus back on people and away from billing codes, copays and unnecessary use of hospital care. Redirect Health now serves over 11,000 people and has a staff of over 200 employees.
The Redirect Health model is so effective, the company not only offers free healthcare to all their employees and families, but they help companies all over the nation do the same. This unique offering gives companies an advantage in the job market for both recruiting and retaining quality employees.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

The World's Largest Cannabis SuperStore joins forces with Green Life Productions to provide much appreciated help to the Las Vegas Rescue Mission and SafeNest, thanks to generous gifts from Planet 13 customers, staff and sponsored vendors

LAS VEGAS (PRWEB) DECEMBER 08, 2020
Planet 13, a leading vertically-integrated Nevada cannabis company, is famous for doing everything bigger and that also applies to spreading hope and joy.
Known for its award-winning brands, cultivation, production and dispensary operations, Planet 13 is proud to celebrate the holidays by giving back to the community. On Dec. 7, Planet 13 donated 25,000 Cans of food and toys to the Las Vegas Rescue Mission and SafeNest.
Two semi-trailer trucks loaded the donations at the SuperStore at 2548 W Desert Inn Rd, Las Vegas. Customers, vendors, and staff contributed to this colossal donation.
Along with Planet 13 and Green Life Productions (GLP), sponsored vendors including TRENDI, ROVE, Dreamland Chocolates, Cannabella, Evergreen Organix, MOXIE, OMG THC, MEDIZIN, Nature's Chemistry, HaHa, and LEAF & VINE gave generously.
"This has been a very tough year for many families, so it only makes sense for us to do what we can to help," said David Farris Planet 13 V.P. of Sales and Marketing. "We are incredibly appreciative of everyone who donated to our holiday canned food and toy drive along with the GLP team and sponsored vendors. Our mission is to make the holidays brighter for as many local families as possible."
The Las Vegas Rescue Mission campus takes up two city blocks in downtown Las Vegas, helping hundreds of men, women and their children daily, and providing approximately 30,000 meals each month. SafeNest is Nevada's largest, most comprehensive nonprofit dedicated to ending domestic violence.
The donations will continue to come-in at Planet 13 until Dec.15, 2020.
About Planet 13
Planet 13 (http://www.planet13holdings.com) is a vertically integrated cannabis company based in Nevada, with award-winning cultivation, production and dispensary operations in Las Vegas - the entertainment capital of the world. Planet 13's mission is to build a recognizable global brand known for world-class dispensary operations and a creator of innovative cannabis products. Planet 13's common shares trade on the Canadian Securities Exchange (CSE) under the symbol PLTH and on the OTCQX under the symbol PLNHF.
Cautionary Note Regarding Forward-Looking Information
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as "expects", or "does not expect", "is expected", "anticipates" or "does not anticipate", "plans", "budget", "scheduled", "forecasts", "estimates", "believes" or "intends" or variations of such words and phrases or stating that certain actions, events or results "may" or "could", "would", "might" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward looking-statements relate to, among other things, future expansion plans.
These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: final regulatory and other approvals or consents; fluctuations in general macroeconomic conditions; fluctuations in securities markets; expectations regarding the size of the Nevada cannabis market and changing consumer habits; the ability of the Company to successfully achieve its business objectives; plans for expansion; political and social uncertainties; inability to obtain adequate insurance to cover risks and hazards; and the presence of laws and regulations that may impose restrictions on cultivation, production, distribution and sale of cannabis and cannabis related products in the State of Nevada; and employee relations. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational and medicinal cannabis marketplace in the United States through its subsidiary MMDC. Local state laws where MMDC operates permit such activities however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company's business are contained under the heading "Risk Factors" in the Company's annual information form dated April 30, 2019 filed on its issuer profile on SEDAR at Sedar.com.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.




START your own Wordpress site, business or personal website, or online store at www.siteground.com

MA-CAR provides a safer in-car environment and peace of mind for consumers and ride-shares.

DEERFIELD, FLA. (PRWEB) DECEMBER 08, 2020
Medify Air, the leading brand in providing solutions to improve indoor air quality, today announced the MA-CAR air purifier, designed to comfortably attach to the back of any vehicle's headrest and provide clean, purified air. With air quality top of mind for most consumers during the COVID-19 pandemic, MA-CAR features HEPA H13 filters and a high clean air delivery rate (CADR) to effectively cycle all the air in a sedan or SUV every 10-15 minutes.
"The MA-CAR brings the clean, quality air standards provided in homes and businesses by our other air purifiers right to your car," said J Henry Scott, CEO of Medify Air. "Designed to meet the rigorous standards of the World Health Organization, this in-vehicle air purifier adds another level of security for families and ride-share drivers while on the road."
A lightweight, compact device, the MA-CAR is the ideal on-the-road air purifying solution for families, ride-shares and taxis, effectively removing up to 99.9% of airborne particles down to 0.1 microns. Additional features include:

Ability to Improve air quality for cars with seven seats or less, or up to 40 sq. ft.

Touch controls and three fan speeds

Velcro strap to conveniently secure the air purifier to any headrest

The MA-CAR is available for $99 on Amazon.com and MedifyAir.com. For more information on Medify Air's complete portfolio of professional grade air purifiers, visit http://www.medifyair.com.
About Medify Air
Medify Air is the leading brand in providing improved and efficient air quality to help relieve the crisis of indoor air pollution. Our mission is to provide better and cleaner air for our customers to help them live longer and healthier lives. We do so by developing professional grade air purifiers utilizing highest-quality HEPA H13 filters in every model. We believe that the filter makes all the difference in producing healthier air for our customers. For more information, visit MedifyAir.com.
Press Contact
Cori Hays
medifyair@matternow.com



START your own Wordpress site, business or personal website, or online store at www.siteground.com

With more than 350,000 readers, Franchise Dictionary Magazine is a leading franchise publication in both digital and print format. Griswold Home Care is included in Franchise Dictionary Magazine's 2020 Top 100 Game Changers.

BLUE BELL, PA. (PRWEB) DECEMBER 08, 2020
Griswold Home Care is included in Franchise Dictionary Magazine's 2020 Top 100 Game Changers. With more than 350,000 readers, Franchise Dictionary Magazine is a leading franchise publication in both digital and print format.
Targeting prospective franchisees in an informative and educational manner, Franchise Dictionary Magazine is well-respected throughout the industry. Being named a Game Changer is recognition of excellence in franchising.
"Franchise development is a top priority for Griswold Home Care," said Griswold Home Care CEO Michael Slupecki. "We have some innovative incentives for franchise brokers and some top territories available for buyers. We are motivated for some real growth in the new year."
Alesia Visconti is the CEO and Publisher of Franchise Dictionary Magazine. "Franchise ownership allows people to follow their dreams of being their own boss and taking control of their futures," she said. "It supports people working for themselves but not by themselves. It's a community of professionals all supporting successful business ownership. A brand that earns the Top 100 Game Changers designation raises the bar and clearly sets itself apart."
For more information about the Franchise Directory Magazine's 2020 Game Changers visit https://franchisedictionarymagazine.com/2020-game-changers/.
About Griswold Home Care
With 200 locations in 30 states, Griswold Home Care is one of the country's top home care companies, delivering compassionate care 24/7 to its clients. Its purpose is to give people the help they need to live in the place they love. Through this purpose, Griswold Home Care helps adults maintain quality of life despite advanced age or onset of illness through services including companion care, home services, personal care, and respite care. Founded by the late Jean Griswold in 1982, the company has maintained its founder's profound sense of empathy for older and disabled adults and those living with chronic conditions. For more information, visit http://www.griswoldhomecare.com or call 215.402.0200.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Month-long Social Media Programming Offers Actionable Tips on How to Cope with the Challenges of Infertility During the Holidays

NORWALK, CONN. (PRWEB) DECEMBER 08, 2020
RMA of Connecticut, a leading fertility practice whose exceptional quality and care helps couples and individuals grow their family, is spearheading a Holidays at Home social media initiative aimed at helping those suffering with infertility during the holidays. The month-long initiative will take place via RMA of Connecticut's social media channels beginning Monday, December 7th.
The Integrated Fertility and Wellness team at RMA of Connecticut will share a short-form video series to combat unique fertility hurdles associated with those suffering with infertility and offer tactical ways to destress, move, eat, and breathe during the holiday season. The videos will be published in a rolling manner to RMA of Connecticut's social channels from December 7th through December 10th, with the cumulative content to be reshared on their Learning Center blog at the end of the week.
Additionally, the RMA of Connecticut-produced podcast, FertilityU, will be releasing a special multi-interview podcast on December 18th to round out the Holidays at Home event. It will feature the Integrated Fertility and Wellness experts, sharing even more tips to overcoming feelings of anxiety, loneliness, and stress during this 2020 holiday season.
"Going through fertility treatments during the holidays can be a heavily emotional experience, and with COVID-19's restrictions on family gatherings, this experience can seem even more isolating," says Amy Matton, Acupuncturist and Director of the Integrated Fertility and Wellness Program. "The Integrated Fertility and Wellness team at RMA of Connecticut created this campaign to deliver actionable tips to those suffering through infertility during the holidays, providing additional support they can experience from the comfort of their homes."
The Holidays at Home social media content includes:
Holidays at Home: Fertility Acupressure - Amy Matton, Acupuncturist, will guide viewers through the activation of the Shen men acupuncture point through acupressure, or physical pressure to an acupuncture point. This particular point helps relieve anxiety, fear, stress, among many other mental/emotional/nervous system responses.
Holidays at Home: Fertility-Friendly Holiday Swaps - Our in-house fertility Dietitian Nutritionist, Jill Hickey, walks patients through mindful holiday nutritional swaps. She offers alternatives to those traditional holiday beverages like hot cocoa and eggnog, helps us pack our plates for holiday dinners, and yes, she even digs into dessert!
Holidays at Home: Meditation for the Fertility Warrior - Lisa Rosenthal, RMA of Connecticut's patient advocate and yoga instructor, takes the viewer through guided meditation, quieting stress and feelings of isolation, while increasing feelings of control and calmness.
Holidays at Home: Mood Shifting - Lisa Schuman, Director of Mental Health Services, offers a real way to calm feelings of stress and turns them in a more positive direction.
FertilityU Podcast Release: Holidays at Home with the IFW Team - Host and Reproductive Endocrinologist, Dr. Spencer Richlin, shares a podcast that features each Integrated Fertility and Wellness specialty. This compilation will be back-to-back short interviews with the Integrated Fertility and Wellness experts, highlighting even more tactics for feeling less stressed, anxious, or lonely during the holidays.
To view the Holidays at Home social media programming, visit our feeds on Facebook and Instagram (@fertility_rmact).
About Reproductive Medicine Associates of Connecticut (RMA of Connecticut)
RMA of Connecticut is a leader in fertility care, specializing in a range of infertility treatments. Our assisted reproductive technologies (ART) include intrauterine insemination (IUI), in-vitro fertilization (IVF) and pre-implantation genetic testing (PGT). RMA of Connecticut is Fairfield County's largest fertility clinic and egg donation center. Through RMA of Connecticut's Integrated Fertility and Wellness Center, we offer nutrition counseling, individual and couples psychological counseling, acupuncture and yoga, as well as financing and support services for our patients going through infertility treatment.
Our internationally recognized Gay Parents To Be program at RMA of Connecticut specializes in LGBTQ family building. For the last four years, RMA of Connecticut has been recognized as a Leader in Healthcare Equality by the Human Rights Campaign.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Join us as we explore how COVID has been affecting industries across the globe.

JUPITER, FLA. (PRWEB) DECEMBER 08, 2020
The award-winning series, Advancements with Ted Danson, will broadcast on Saturday, December 12, 2020 @2:30p ET via CNBC. Check local listings for more information.
In this episode, Jupiter, FL— Advancements will educate about Nanoform's multi-patented award-winning CESS technology, which has the potential to double the number of lead compounds progressing into clinic. Audiences will hear how the advanced production of nanoparticles provides pharmacokinetic improvements, commercial opportunities, and novel avenues for drug delivery.
Viewers will learn how MissingLogic is revolutionizing the healthcare industry by helping executives in healthcare systems see their most significant challenges through a polarity lens. Leveraging its H20 FrameworkSM to help healthcare leaders navigate the complexity and uncertainties in healthcare today, the show will explore how MissingLogic enables executives to break through complexity and the never-ending cycle of re-occurring issues, while navigating their organizations through COVID-19 and beyond.
Hearing from doctors in the field, spectators will see how ChenMed is reinventing preventative, VIP care for seniors. With 24-7-access to doctors, on-site medications, and transportation to appointments, the show will explore how ChenMed's replicable, successful model puts primary care physicians in charge of outcomes and the patient experience.
Advancements will also showcase the intellectual and technical expertise behind Complete Phytochemical Solutions, LLC, a phytochemistry company dedicated to developing, manufacturing, and marketing high quality and efficacious botanical and food products for human and animal nutrition.
"This episode will take a look at how COVID has been affecting the healthcare sector and beyond, as we explore impact it's had on drug development, burnout, telehealth, and quality standards," said Creative Director, Sarah McBrayer.
###
About Advancements and DMG Productions:
The Advancements television series is an information-based educational program, targeting recent advances across a number of industries and economies. Featuring state-of-the-art solutions and important issues facing today's consumers and business professionals, Advancements focuses on cutting-edge developments, and brings this information to the public with the vision to enlighten about how technology and innovation continue to transform our world.
Backed by experts in various fields, and a team dedicated to education and advancement, DMG Productions consistently produces commercial-free, educational programming on which both viewers and networks depend.
For more information visit Jupiter, FL— http://www.AdvancementsTV.com or call (866) 496-4065



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Under the Agreements, Kemp Proteins will gain access to ArtiaBio proprietary parental cell and vector technology for development of highly productive cell lines and cost effective, rapid manufacturing processes.

FREDERICK, MD. (PRWEB) DECEMBER 08, 2020
Kemp Proteins LLC, a leading provider of gene-to-protein, and monoclonal antibody development services, today announced that the company signed Strategic Partnership and Material Transfer Agreements with ArtiaBio Inc, a company specialized on the development of biopharmaceuticals, parental cell lines and highly productive expression vectors. The agreements demonstrate Kemp's commitment to building a broad complement of bioservices focused on providing biopharmaceutical and diagnostic clients with world-class protein related development services.
Under the Agreements Kemp Proteins will gain access to ArtiaBio proprietary parental cell and vector technology for development of highly productive cell lines and cost effective, rapid manufacturing processes. ArtiaBio has the experience and history of developing highly productive recombinant cell lines and media for cGMP-ready manufacturing processes and will transfer its own cell lines, vectors and technical know-how to enable Kemp Proteins to consistently provide cell development services under ISO quality systems to meet client requirements. The cell lines developed using the ArtiaBio technology will not be royalty bearing and no license fee is applied on success, a distinct delineation between Kemp Proteins and other cell line development companies using their own proprietary technology.
"Since Six.02 Bioservices purchased Kemp in 2019, it has been our goal to develop the company into so much more than a world class gene-protein service company. Building out the hybridoma development facility and now the Stable Cell Line Development Service all under our ISO Quality System, demonstrates a continuing successful implementation of our strategy plan," said Michael Keefe, CEO for Kemp Proteins. "The addition of a proprietary technology for Stable Cell Line Development represents an important milestone and reflects our commitment to growing our company with high-quality bioservices technologies."
Sadettin Ozturk, President and CEO of ArtiaBio commented, "The Agreements with Kemp Proteins represent a strategic direction for ArtiaBio as the company becomes more focused on developing our own biopharmaceuticals while providing services to the industry. Working with the team at Kemp we will ensure that our highly productive, proprietary vectors and cell lines will enable others to develop stable cell lines expressing proteins of interest. This technology has been used to develop a number of novel and biosimilar processes and I am sure others will benefit from using this technology in their own programs."
About Kemp Proteins (http://www.kempproteins.com)
Kemp Proteins (formerly Kempbio) is a leading provider of gene-to-protein, hybridoma and cell line development services. For more than 20 years, Kemp's team of protein problem-solvers has delivered best-in-class services that optimize productivity and mitigate risk for life sciences innovators developing protein-based products, including human and veterinary diagnostics, biopharmaceuticals, and vaccines. Kemp Proteins is a Six.02 Bioservices member company.
About ArtiaBio (http://www.artiabio.com)
ArtiaBio is a dynamic company focused on the development of biopharmaceuticals. The advanced technology in cell line and process development combined with the utilization of advanced bioprocess technology enables development of highly effective manufacturing processes that can provide the biotechnology-based drugs at an affordable price. The company has experience and expertise in a broad range of product development, including monoclonal antibodies, blood coagulation factors, therapeutic enzymes, and fusion proteins.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

Banner Health, The CU Healthcare Innovation Fund, The Froedtert & Medical College of Wisconsin Health Network, WellSpan Health Provide Support to Babyscripts Through Strategic Partnerships and Investments

WASHINGTON (PRWEB) DECEMBER 08, 2020
Babyscripts, the leading virtual care platform for managing obstetrics, today announced a new round of investments through their Strategic Partners Program, a unique investment bloc composed of health systems interested in forwarding Babyscripts' cutting-edge digital solutions for pregnant populations. Partners include Phoenix-based Banner Health, one of the largest nonprofit health care systems in the country; the CU Healthcare Innovation Fund, located on the University of Colorado Anschutz Medical Campus in Aurora, Colorado; the Froedtert & the Medical College of Wisconsin health network, an integrated health care system based in Wisconsin; and WellSpan Health, an integrated health system serving central Pennsylvania and northern Maryland.
This investment round is structured to leverage the input and support of clinical and health system partners, ensuring that Babyscripts' product development and future roadmap aligns with customer needs.
"From the beginning, we've set ourselves apart from other tech companies by partnering with physicians to make sure that we're developing solutions that will actually be useful and improve outcomes, not just look and feel 'cutting-edge'," said Juan Pablo Segura, co-founder and President of Babyscripts. "This investment is validation that health systems see the value of our solution — and they're willing to put their money on it."
"We believe the future of healthcare is combining virtual patient management and remote monitoring technologies in ways that increase access and improve outcomes at lower cost," said Steven Lindseth, General Partner, CU healthcare Innovation fund, "Babyscripts has perfected this model against the societal imperative to improve maternal health, a mission that we can all agree is critical to fixing US healthcare."
The majority of the investors are current customers of Babyscripts, uniquely qualifying them to offer support and demonstrating their confidence in the company's value.
"Banner is proud to invest in Babyscripts' highly innovative offerings for virtual maternity care, which we hope to scale across our six-state system," said Scott Nordlund, chief strategy and growth officer at Banner Health and head of Banner Innovation Group. "Central to our innovation strategy are partners like Babyscripts, with whom we can tailor streamlined digital solutions for our patients to make health care better, simpler, and easier to access."
"We know that meeting our patients where they are and connecting in a personal and meaningful way outside of the clinic walls can improve the health and well-being of expectant moms and their babies," said Michael L. Anderes, FACHE, chief innovation and digital officer, Froedtert & the Medical College of Wisconsin health network.
"Our partnership with Babyscripts began in response to what we hear from new moms," said Megan Lecas, Senior Vice President of Service Lines at WellSpan Health. "They want greater access, more convenience, healthier outcomes and fewer appointments when appropriate. Babyscripts complements the expert care provided by our women's health team while providing more flexibility for consumers."
Babyscripts has spent the last six years building a clinically-validated, virtual care platform to allow OBGYNs to deliver a new model of prenatal care. Using internet-connected devices for remote monitoring, Babyscripts offers risk-specific experiences to allow providers to manage up to 90% of pregnancies virtually, allowing doctors to detect risk more quickly and automate elements of care.
About Banner Health
Headquartered in Arizona, Banner Health is one of the largest nonprofit health care systems in the country. The system owns and operates 30 acute-care hospitals, two rehabilitation hospitals, Banner Health Network, Banner – University Medicine, academic and employed physician groups, long-term care centers, outpatient surgery centers and an array of other services; including Banner Urgent Care, family clinics, home care and hospice services, pharmacies and a nursing registry. Banner Health is in six states: Arizona, California, Colorado, Nebraska, Nevada and Wyoming. For more information, visit bannerhealth.com.
About The CU Healthcare Innovation Fund
The CU Healthcare Innovation Fund is located on the University of Colorado Anschutz Medical Campus in Aurora, Colorado. The fund invests in companies that have developed meaningful partnerships with the institutions on the campus. The $50 million fund invests across digital health, therapeutics and devices. For more information visit http://www.cuvcfund.com
About Froedtert & the Medical College of Wisconsin
The Froedtert & the Medical College of Wisconsin regional health network is a partnership between Froedtert Health and the Medical College of Wisconsin supporting a shared mission of patient care, innovation, medical research and education. Our health network operates eastern Wisconsin's only academic medical center and adult Level I Trauma Center at Froedtert Hospital, Milwaukee, an internationally recognized training and research center engaged in thousands of clinical trials and studies. The Froedtert & MCW health network, which includes five hospitals, one of which is a nationally ranked academic medical center, more than 1,600 physicians and nearly 40 health centers and clinics, draws patients from throughout the Midwest and the nation. In our most recent fiscal year, outpatient visits exceeded 1.1 million, inpatient admissions to our hospitals were 49,250 and visits to our network physicians totaled 932,000. For more information, visit froedtert.com.
About WellSpan Health
WellSpan Health is an integrated health system that serves the communities of south central Pennsylvania and northern Maryland. The organization includes a clinically integrated network of approximately 2,600 physicians and advanced practice providers (APPs), including more than 1,600 employed physicians and APPs; a regional behavioral health organization; a home care organization; eight respected hospitals; approximately 20,000 employees; and more than 200 patient care locations. WellSpan is a charitable, mission-driven organization, committed to exceptional care for all, lifelong wellness and healthy communities. Visit WellSpan.org.
About Babyscripts
Babyscripts is delivering a new model for prenatal and postpartum care that is transforming the way expectant mothers use technology to work with their healthcare providers. We've spent the last six years delivering the most-implemented mobile clinical solution for remote monitoring in pregnancy, with the mission to eliminate maternal mortality and improve access to care for all mothers. Babyscripts was named to the 2020 Digital Health 150, CB Insights' annual ranking of the 150 most promising private digital health companies in the world. For more information on our virtual care solution and to request a demo, visit http://www.babyscripts.com.



START your own Wordpress site, business or personal website, or online store at www.siteground.com

In response to COVID-19 pandemic, the American Foundation of Savoy Orders will transition the in-person 23rd annual Ballo di Savoia (Savoy Ball) to a "Virtual Gala," originally scheduled in the Metropolitan Club in New York City, to an online fundraising campaign on the evening of December 12, 2020. The evening will present a video presentation highlighting the Foundation's work and past in-person galas. The prime charitable beneficiary will be The New York Foundling's Community Habilitation Services for Children with Developmental Disabilities in keeping with the Foundation's mission - Chivalry For Children's Causes.

NEW YORK (PRWEB) DECEMBER 08, 2020
In response to COVID-19 pandemic, the America Foundation of Savoy Orders will transition the in-person 23rd annual Ballo di Savoia to a "Virtual Gala," originally scheduled in the Metropolitan Club in New York City, to an online fundraising campaign on the evening of December 12, 2020. The evening will present a video presentation highlighting the Foundation's work and past in-person galas. The prime charitable beneficiary will be The New York Foundling's Community Habilitation Services For Children with Developmental Disabilities, in keeping with the Foundation's mission - Chivalry For Children's Causes.
All subscribers to the Savoy Foundation's on line gala will be invited to view a very special virtual gala video presentation, highlighting the Foundation's work, retrospectives of in-person galas and a unique video ball journal. The online giving event begins now and runs through December 31, 2020. To date $125,000 has been raised from our Patrons, Benefactors and Sponsors.
The New York Foundling provides habilitation and skills training for hundreds of children with developmental disabilities in the community every year. Skills therapists visit children in their homes and work with them and their families to help build independence. These therapists also help to advocate for the child with their school and teach important social skills. Throughout the pandemic, the NY Foundling has continued to provide $500 for 1 month of weekly skills training and therapy for a child with a developmental disability. The Savoy Foundation is asking its supporters to donate online now, perhaps in the amount they originally planned to give or spend on gala tickets at the Ballo di Savoia. Tickets for the 23rd anniversary gala can be purchased here. For more information about the philanthropic causes supported by the Savoy Foundation, please click here.
The Savoy Foundation is grateful to the following Patrons, Benefactors and Sponsors: Grand Patrons: Florentina and Daniel J. McClory, Carl J. Morelli, Esq., Janice and Thomas Pecora, Paula and Anthony Viscogliosi, Elizabeth and George C. White; Benefactors: Vivian Cardia, Gift of Sight NYSOSDIA Grand Lodge Foundation; Patrons: Anthony J. Cipriano, Richard A. Cuneo, Barbara and Frank J. Desiderio, Esq., Joseph Sciame; Grand Sponsors: The Hon. E. Wayne Bachus, Cecelia and Victor D. Cho, Brent Freeman, Kathleen and Joseph B. Giminaro, Esq., Prof. Eric J. Ierardi, Prof. Theodore H. Jacobsen, Anthony Schembri, Jr., Eniko-Mara and Dr. Stephen Somkuti, Dr. Catherine Stevenson, Larissa and John Van Duser, Esq., Andrea Ward; Sponsors: Andrea and Dr. William Caccese
ABOUT THE SAVOY FOUNDATION AND THE AMERICAN DELEGATION OF SAVOY ORDERS
The American Delegation of Savoy Orders, which includes the United States of America, is among 35 delegations of the Savoy Orders located throughout Europe, the Americas and Japan. The Dynastic Orders of the Royal House of Savoy are among the oldest orders of chivalry in the world. Their origins and their principles, traditions and humanitarian goals, like those of the Royal House of Savoy that has the hereditary right to confer them, date back a thousand years. The American Delegation of Savoy Orders through its charitable arm, The American Foundation of Savoy Orders, Incorporated, contributes to humanitarian, hospitaller and charitable projects and initiatives in the United States and abroad, particularly in healthcare and hospice care, disaster relief, education programs and children's causes.
The American Foundation of Savoy Orders, Incorporated, a 501(c) (3) charitable organization headquartered in New York City, has supported local, national, and international charities focusing on medical, educational, social assistance and humanitarian fields, including philanthropy for hospitals, relief agencies, children's causes and hospice care for the poor, infirm and elderly. The Foundation whose current mission is "Chivalry for Children's Causes," is a Non-Governmental Organization (NGO) in Roster Consultative Statues with the Economic and Social Council of the United Nations.
For more information on supporting the causes of the American Foundation of Savoy Orders, see below.
CONTACT:
Larissa Van Duser, Executive Director, American Foundation of Savoy Orders
amsavoy@aol.com, +1 646 489-1242
For more information, visit https://www.savoyfoundation-usa.org/ballo-di-savoia-2020-virtual.html



START your own Wordpress site, business or personal website, or online store at www.siteground.com

NJ Top Docs has reviewed and approved board-certified orthopedic surgeon, Dr. Richard Seldes for 2020.

SCOTCH PLAINS, N.J. (PRWEB) DECEMBER 08, 2020
NJ Top Docs has reviewed and approved board-certified orthopedic surgeon, Dr. Richard Seldes for 2020. After completing his fellowship in total joint replacements of the hip, knee and shoulder at The Hospital For Special Surgery, Dr. Richard Seldes became one of the most sought after orthopedic surgeons in the tristate area.
Dr. Richard Seldes stays on the cutting-edge of orthopedic techniques and always incorporates the most beneficial treatments into his practice. A few recently integrated services include minimally invasive knee, hip and shoulder surgery, as well as robotic joint-replacement surgery.
Dr. Seldes' expertise is always in high-demand as he is one of the area's top experts in hip arthroscopy. He performs a high volume of total joint-replacement surgeries, including Mako robotic joint-replacement surgery.
"We treat every patient as if they were our family member to ensure they have the safest, most efficient, state-of-the-art orthopedic care," Dr. Seldes says.
In addition, Dr. Seldes has continued to serve on the frontline during the COVID-19 crisis to treat patients with orthopedic emergencies throughout the tri-state area.
He has gone above and beyond to make sure patients feel safe returning to his office throughout the pandemic and has implemented multiple safety protocols. A few of these protocols include regular temperature checks, required PPE gear for all staff, and mandatory COVID-19 testing for all patients undergoing surgery. He is also offering telemedicine appointments for existing patients as needed.
To learn more about this NJ Top Doc, please visit: https://njtopdocs.com/nj-doctors/drrichardseldes/.
About Us
NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.
NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.
For more information, please click here to contact us or visit http://www.njtopdocs.com.
You can also follow us on Facebook, Twitter, & Instagram



START your own Wordpress site, business or personal website, or online store at www.siteground.com